Since when do these symptoms last almost continuously?
All chest pains should be treated that way, especially at your age.
And in addition to the fever,
You also need to check your cholesterol pressure.
And you're having a fever now?
And you're feeling this chest pain right now?
Besides, are you having trouble breathing?
And can you tell me what other symptoms you have besides this?
And how hot are you?
And I'm coughing too.
And I'm having a little cold and cough.
I'm having some serious chest pains today.
And is this the right time for your hay fever?
And there's chest pain.
And I think I have a little bit of a fever.
And I want you to describe where it feels like chest pain.
They're also suffering from some fever.
And with your history of diabetes,
And, you know, I feel like my chest's gonna break.
And, you know, people cough at me all the time.
And you're feeling chest pain.
And you said it was a pressure on your chest.
Any member of the family has a heart problem, heart disease, heart attack, high cholesterol, or high blood pressure.
Are there any other symptoms or problems you've noticed besides muscle pain?
Are there other people in the house with the same symptoms as you?
Do you feel any other symptoms?
Do you feel any shortness of breath?
Are you still feeling chest pain?
Because this is flu season.
But we shouldn't ignore the chest pain caused by heart disease either.
But the most important problem right now is this chest pain.
But I'm having trouble breathing.
But I know a lot of people who are begging for me.
But we need to deal with every chest pain with the utmost seriousness.
But you're breathing right now, aren't you?
I completely forgot because of this chest pain.
Do you feel like someone's pressing your chest?
Do you still have a feeling of shortness of breath?
Are they complaining about similar symptoms?
Do you have any other chronic illness like hypertension or anything like that?
Do you have any other chronic medical problems like diabetes?
Are you feeling any shortness of breath with that chest pain?
Do you have high blood pressure?
Do you feel any shortness of breath, though?
Do you know the symptoms she was feeling?
Do you see the picture?
He drank a lot of fluid today.
I'm still running diabetes tests, though.
Still, she has exactly the same symptoms as I do.
How high is your fever?
What about your blood pressure?
If your fever keeps rising,
If you get a fever, you have a hundred and two or more.
If you think your symptoms or problems need to be examined better,
I had a fever yesterday.
I got a mild fever, too.
I had a fever yesterday.
I'm having severe chest pain here.
I'm also having a little trouble breathing.
I'll send you a picture.
I'm having some chest pain today.
I'm just having some headaches and fever today.
In my opinion, it's the flu.
In my opinion, it's a simple flu.
Does it look like someone heavy is sitting on your chest?
It all started with headaches and fever at almost the same time.
There's pain in the middle of my chest.
It's like chest pain.
It's in my chest.
It's in the middle of my chest.
It's in the middle of the chest.
I felt a pain in my chest.
I'm so worried about that chest pain.
I need you to describe this chest pain to me.
Like high blood pressure or diabetes.
It's like he's right in the middle of the chest.
Now you can have tachipirina for the fever.
Now, Mary, how many days have you suffered these symptoms?
Now you said you had chest pain.
I have chest pains every now and then.
Well, do you have any other symptoms besides that other than pain?
Or do you feel like someone's sitting on your chest?
It's pretty much like fever and headaches from coughing and muscle pain.
Right in the middle of my chest.
Specify where the pain feels on this picture.
Since you had a fever.
So do you think some of these symptoms might be related to pregnancy?
So do your kids have some similar symptoms?
Tell me about your chest pain.
The fever increases at night.
The fever I've had in the last two days.
I started to increase the fever last night.
This is Dr. Porter in the emergency room at the casualty screening center.
Well, can you tell me more about your chest pain?
Well, I feel pain in the front of my body right here in my chest.
Well, I'm having a lot of pain in my chest.
Well, when I felt this pain in my chest,
What kind of chest pain do you have?
When did this chest pain start?
What's the location of the pain in your chest?
Where you feel this chest pain, you feel this chest.
You've got a feeling about your chest.
You know I have diabetes and stuff.
You said you had this chest pain.
Rapidly increasing cumulative number of the Corona virus disease (Coved-19) in the European Union/European Economic Area and the United Kingdom, from 1 January to 15 March 2020
The cumulative number of the Corona virus disease (Coved-19) shows similar trends in the EU/EEA countries and the UK, confirming that although the stage varies from state to state, the Coffid-19 pandemic is rapidly increasing in all countries.
Based on Italy ' s experience, States, hospitals and intensive care units should increase their readiness to increase the number of Koped-19 patients who will need health care, especially intensive care.
On December 31, 2019, a series of cases of pneumonia of unknown pathogens were reported in Wuhan City, Hubei Province, China.
On January 9, 2020, the China Center for Disease Control and Prevention stated that the causative factor, the new Corona virus, is now referred to as the Corona 2 virus associated with severe acute respiratory syndrome (SARS-KOV-2).
Since then, the disease caused by SARS-Koff-2 has been called the Corona virus disease (Coved-19).
So far, the evidence is that almost 80% of individuals with code 19 suffer from a mild disease; that is, respiratory infection with or without symptoms, and most of them recover.
In approximately 14%, the incidence of Coved-19 has worsened into a more severe illness requiring hospitalization, while the remaining 6% suffer from a serious disease requiring intensive care.
The death rate of patients who stayed in hospital because of Koed-19 was about 4%.
In this study, we assess the trends in the cumulative number of Coved-19 in each EU/EEA and UK (UK) countries and compare them with those from Hobei County, China.
We also compare the current number of Koed-19 cases in the EU/EEA countries and the UK with the number in Italy between January 31 and March 15, 2020.
Coved-19 cases in EU/EEA and UK States
After what happened in China, Koed-19 has increasingly spread geographically and followed the dynamic of the Koed-19 pandemic in the rest of the world today.
On March 11, 2020, the Director-General of the World Health Organization (WHO) announced Koed-19 as a pandemic.
In the Eurosorvilles issue of March 5, 2020, Spiteri et al. reported the first confirmed European Koped-19 cases as defined by the World Health Organization (WHO).
In the European Union/European Economic Area, the first three confirmed cases were reported by France on 24 January 2020 for persons returning from Wuhan, Hubei Province, China.
As of March 15, 2020, Koed-19 cases have been detected in all 30 EU/EEA countries and the United Kingdom (UK), where between December 31, 2019 to date, 39,768 cases and 1.727 deaths have been reported, with 17,750, and 1,441 deaths in Italy alone.
Cumulative number and rate of Koed-19 cases obtained
At the European Center for Disease Control and Prevention (ECCDC), the number of reported Koped-19 cases in every country around the world, obtained only from official sources such as the Ministry of Health of countries, national and regional health bodies and the World Health Organization (WHO), is updated daily at 8 a.m.
This data has been used to assess and compare Coffide-19 trends in the European Union/European Economic Area and the United Kingdom with those in Italy.
As a measure of the prevalence of Coved-19's active cases, we calculated the cumulative number of intermittent Koved-19 cases within 14 days, and then took into account the natural trajectory of Coved-19, in all EU/EEA countries and the UK, between 1 January and 15 March 2020.
We also presented the cumulative number of reported cases from each country as of March 15, 2020 at 8:00 a.m., compared to the number in Italy between January 31 and March 15, 2020.
Koffid-19 trends in the EU/EEA and the United Kingdom
Trends in the cumulative number of Koed-19 cases cut over a period of 14 days have been followed in the EU/EEA and United Kingdom countries of Hubei Province (China) (figure 1).
For the European Union/European Economic Area and the United Kingdom in general, the cumulative number of Coved-19 began to increase on approximately 21 February, and then sharply on 28 February 2020 (supplementary material).
This was often driven by a rapid increase in the number of cases reported from Italy, but all EU/EEA countries and the UK showed trends similar to the cumulative number of Coved-19 (supplementary material).
Figure 2 shows the cumulative number of Koed-19 cases in the EU/EEA countries and the UK compared to Italy for the period from 31 January to 15 March 2020.
It highlights that, as of March 15, 8 a.m., 15 other EU/EEA countries and the UK reported the total number of cases actually similar to that in Italy only three weeks ago or less.
Our findings indicate that the number of reported Koed-19 cases is rapidly increasing in the European Union/European Economic Area and the United Kingdom.
The trends observed in the cumulative number of Coved-19 indicate that the pandemic is increasing at a similar pace in all States.
This is despite the fact that States are at different stages, despite different national public health responses, and possible differences in the definition of the state of affairs in States and the different protocols for selecting patients who must be tested to confirm that they have been exposed to code 19, including follow-up testing.
In early March 2020, doctors in affected areas in Italy described the situation, where approximately 10% of Koped-19 patients needed intensive care. Media sources reported that hospitals and intensive care units in those areas had already reached their maximum capacity.
Data on admission to hospitals and/or intensive care units for Koed-19 cases are currently available at the EU/EEA level for 6% and 1% of cases respectively (data not presented).
However, they need to be systematically collected to complement existing surveillance data focusing on the number of reported cases and the number of deaths.
A study conducted in 2010–11 showed a great diversity in the availability of intensive and intermediate care beds in Europe, ranging from 29.2 in Germany to 4.2 beds per 100,000 in Portugal.
This means that countries may have more or less resources than Italy (12.5 beds for intensive care and intermediate care per 100,000 people in 2010–11).
Modelling scenarios associated with the satisfaction of health-care capacity, with estimates for each EU/EEA country and the UK of the prevalence of Koed-19 cases that have entered hospital associated with the risk of fgt; 90% of the population of intensive care is available in the 6th update of the ECCDC rapid risk assessment.
Since the cases collected so far in certain areas in the EU/EEA countries and the United Kingdom, and the fact that hospitals and ICUs usually serve specific regional population groups, it is preferable to provide information on cases and ICUs at the naming level of the regional units of Statistics 2 (NUTS-2).
The experience of Italy and current trends in other countries show that the Coffid-19 pandemic is rapidly worsening in the European Union/European Economic Area and the United Kingdom.
States, hospitals and intensive care units should therefore prepare themselves for a scenario of sustainable community transition for SARS-KOV-2 and an increase in the number of Koped-19 patients in need of health care, particularly intensive care, such as that in affected areas in Italy.
As indicated in the European Center for Disease Control and Prevention rapid risk assessment, a proactive and comprehensive approach is essential to delay SARS-2 with a shift from containment to mitigation, as the expected rapid increase in the number of cases may not provide decision makers and hospitals with sufficient time to understand and accept and adjust their response accordingly if they are not implemented in advance.
The rapid risk assessment also lists public health measures to mitigate the impact of the pandemic.
There is a limited opportunity for countries to increase their control efforts to slow the spread of SARS-KOV-2 and reduce the pressure on health care.
If this fails, health-care systems in other EU/EEA countries are likely to face an increase in the number of patients requiring intensive care over the coming days or weeks.
The outbreak of the Corona 2019 virus (Coved-19), caused by the Corona 2 virus (SARS-KOV-2) causing severe acute respiratory syndrome (SARS), resulted in more than 3,000 deaths and more than 80,000 injuries in China and elsewhere in the world, causing a humanitarian disaster.
SARS-KOV-2, like its own virus, SARS-Koff, which caused thousands of people to become infected with SARS in 2003, can also travel from bats and cause similar symptoms through a similar mechanism.
However, Koved-19 has a lower risk and mortality rate than Sars, but it is more mobile and influential among older persons than young people and men than women.
In response to the rapidly increasing number of publications on the emerging disease, this article seeks to provide a comprehensive and timely review of the rapidly evolving topic of research.
We will address the basics of the epidemiology of the disease, its causes, virology, diagnosis, treatment, prognosis and prevention.
Although many questions still need to be answered, we hope that this review will help to understand and eliminate the disease that is a threat.
The Spring Festival on January 25, 2020 became an unprecedented and unforgettable memory of all Chinese who were urged to stay in their homes for the duration of the holiday and for many weeks thereafter due to an outbreak of an emerging viral disease.
The virus is very similar to the Corona (Koff) virus, which caused SARS in 2003; it was then named Saras-Koff-2 by the World Health Organization (WHO) on February 11, 2020, and the disease associated with COVED-19 (Coved-19).
The epidemic began in Wuhan, China, and soon spread throughout the country, as well as nearly 50 other countries around the world.
As of 2 March 2020, the virus has led to 80,000 confirmed cases of code 19, with more than 40,000 patients discharged from hospitals and more than 3,000 dead.
The World Health Organization warns that Coved-19 is a “public enemy #1” and is likely to be stronger than terrorism.
According to PubMed (https://www.ncbi.nlm.nih.gov/pubmed/), in less than two months, more than 200 research papers have been published on Koped-19, including virus science, epidemiology, pathogens, diagnosis, and treatment, since the first report on 7 January 2020, which determined the sequence of the isolated virus through many patients.
The objective of this review is to summarize the research progress in the new subject area, which is evolving rapidly.
Whenever possible, we will try to compare Koved-19 with SARS and another disease caused by Cove, Middle East Respiratory Syndrome (Merce, an outbreak in 2012).
We will also discuss what we have learned so far with regard to disease prevention and forecasting, as well as some pressing questions that remain.
Corona viruses have traditionally been identified as non-lethal pathogens in humans, mainly causing about 15% of the four common colds.
Yet, in this century, we faced Corona viruses causing severe human illnesses twice, i.e. Sars-Koff and Mirs-Koff, which caused an outbreak of disease originally in China in 2003 and Saudi Arabia in 2012, respectively, and soon spread to many other countries with alarming prevalence and mortality.
Therefore, the current Kovald-19 is a third outbreak of the Corona virus in recorded human history.
As shown in figure 1.1, on 31 December 2019, groups with unknown pneumonia were first reported to the China National Health Committee.
Seven days later, the Corona virus sequence was released.
On January 15, 2020, Wuhan reported the death of his first case.
In the meantime, the epidemic has spread rapidly to neighbouring cities, provinces and countries.
On January 20, infections were reported among health-care providers, indicating the possibility of transmission from one person to another.
On January 23, the city of Wuhan was closed down with all public transportation stopped.
On January 24, the first clinical study on the disease stated that of the 41 confirmed cases of infection, only 21 patients were in direct contact with the Wuhan seafood market, which was considered to be the site of the onset of infection from an unknown animal source.
On January 30, the World Health Organization (WHO) declared the outbreak a global health emergency.
At the time of this report, the disease has already spread throughout China and about 50 other countries worldwide (figure 2).
As the situation develops rapidly, the final extent and gravity of the outbreak has yet to be determined.
On February 11, 2020, a multi-centre study of 8,866 patients, including 4,021 patients confirmed as having been exposed to a more up-to-date disease (https://mp.wixin.qq.com/s/UlBi-HX_rHPXa1qHA2bhdA).
SARS-KOV-2 infected people of all age groups, but mainly in the 30-65 age groups.
Nearly half of the infected (47.7%) were over 50 years of age, very few were under 20, and only 14 were under 10.
Sars-Koff-2 hit more men (0.31/100,000) than women (0.27/100,000).
Coved-19 expanded between groups in and around Hobei mainly.
Koved-19 took an average of 5 (2-9) days from initiation to diagnosis.
The average duration of daycare was 4.8 (3.0-7.2) days.
The average time of injury from beginning to death was 9.5 (4.8.13 days).
The basic reproduction figure (basic reproduction number) was 3.77 (the confidence range is 95%: 3.51-4.05), and the adjusted base reproduction figure was 2.23-4.82.
The number of people affected increased dramatically before January 23, 2020, in line with the many travels before the spring festival in China.
The ratio of deaths among confirmed patients was 1.44% (Credity range is 95%: 1.10-1.86%), and the adjusted mortality rate for all patients was 3.06% (Credity range is 95%: 2.02-4.59%).
The three main risk factors of Cod-19 were gender (male), age (*60) and acute pneumonia.
Corona viruses are a species of large and encased viruses that contain a single DNA genome of a positive-direction chain.
They can be divided into four species, alpha, beta, gamma and delta, and the Corona viruses of alpha and beta nationality are known to affect humans.
The coated fork (S) of the sugar protein is associated with its cellular receivers, i.e. the angiotensine conversion enzyme 2 (ACE2) and dibitadiel bptidas 4 (DP4) of Sars-Koff and Mirs-Koff, respectively, and then the membrane fusion occurs.
The viral reposy DNA genome is released to the cytoplasm; after cloning the viral genome, the DNA is formed by the genotoxic reposy proteins and the serapuse proteins of virion-containing phyrons, which merge with the plasma membrane to release the virus afterwards.
The first Gnome sequence of SARS-KOV-2 was reported on January 10, 2020.
Sars-Koff-2 was discovered to be a new type of beta-koff with a genetic identity exceeding 99.98% of the 10 sequenced samples collected from the original outbreak site, the Huanan Seafood Market of Bohan.
Sars-Koff-2 is genetically more like Sars-Koff than Mirs-Koff.
The electronic microscopic examination of transport revealed that Sars-Koff-2 is located in very thin sections of human airstream back.
Human enzyme converted to angiotensine 2 is found to be the future of Sars-Koff-2 as well as Sars-Koff.
However, the S-protein of Sars-Koff-2 is associated with the human enzyme transgenic 2 that is weaker than Sars-Koff, which is consistent with the fact that Sars-Koff-2 causes a less severe infection in patients than Sars-Koff.
Sars-Koff-2 can also create an updated short protein coded by orf3b and a dissect protein encrypted by orf8.
ORf3b in SARS-KOV-2 may play a role in viral pathogenicity and limit the expression IFN. However, ORF8 does not contain any range or pattern with a known function.
On February 18, 2020, Cho et al. reported on the structure of the complete length of the human enzyme converted to angiotensin 2 under the super-cold electronic microscope with an accuracy of 2.9 Ö within a compound with the amino acid vector B0AT1.
They discovered that the compound, which had open and closed structures, had gathered to form a dymer and that ACE2-B0AT1 could link the protein S, providing evidence of the identification of the Corona virus and the infection.
Sodium-based neutral amino acid vector may become a therapeutic target for testing drugs to suppress the infection of SARS-K-2.
Original host and intermediate host
It's been known that Sars-Koff and Mirs-Koff grew up from bats and were transported to humans through yogurt and camel cats, respectively.
By comparing Sars-Koff-2 synaptic development with other Corona viruses, bats were considered the original host of Sars-Koff-2, where the new virus corresponds by 96% to the Corona virus resembling Sars of bats called Bat-SL-CoVZX45 and Bat-SL-CoVZX21.
However, the intermediate host that helped the virus cross the divide between factions remains unknown to humans, and has yet to explain the route of transition.
G and others suggested snakes as carriers of the virus from bats to humans, which involved the recombination of a symmetric protein.
According to a study, researchers in Guangzhou, China, suggested that sarcophagus - long tongue ant-eating mammals mostly used in traditional Chinese medicine - were the potential intermediate host of SARS-Koff-2 based on a 99% genetic symmetry in the Corona virus detected in sars-Kov-2 sars.
However, the 1% difference spread across GNOMES remains significant; therefore, we are waiting for conclusive results in concrete evidence (figure 33).
The physical and chemical properties of SARS-KOV-2 remain largely unknown.
Sars-Koff and Mirs-Koff can survive in the laboratory for 48 hours in a dry environment up to 5 days at temperatures below 20 degrees Celsius and humidity between 40% and 50%.
SARS-KOV-2 may have similar characteristics.
Sars-Koff-2 is reported to be sensitive to UV radiation and temperature at 56°C for 30 minutes; ether, ethanol at 75% concentration, chlorine-containing disinfectants, peroxyacetic acid, chloroform and other fat solvents, but not chlorohoxydine, can effectively discourage the virus.
The entire human race generally lacks immunity against Sars-Koff-2, and is therefore more vulnerable to emerging HIV infection.
Currently, no detailed study on Sars-Koff-2's immune response has been received.
Therefore, we can only refer to previous studies on other Corona viruses, in particular Sars-Koff and Mirs-Koff (figure 4).
In general, following the invasion of a host virus, the natural immune system is recognized through PRS-type recognition receivers, including linen-like type C receivers, TLR-like receivers, NLR-type metabolites, RIG-I-like futures.
Through different pathways, the virus induces the emergence of inflammation agents, the maturity of the substrate cells, and the installation of IIFN-type interferon, which reduces the spread of the virus and accelerates large bulimia cells for viral antigens.
However, protein N in Sars-Koff can help the virus escape immune responses.
The adaptive immune response quickly joins the fight against the virus.
T lymphocytes, including CD4+ and CD8+, play an important role in defence.
The T cells induce CD4+Bay cells to produce anti-virus objects, and the T cells kill CD8+ cells directly infected with the virus.
T-cells produce activated cytokines to assist defensive cells.
However, the Corona virus can reduce T cell functions by stimulating programmed death of T cells.
Mixed immunity, including complementary proteins such as C3a and C5a and antibodies, is also necessary in the fight against viral infection.
For example, isolated antibodies were neutralized by a sick Mers-Koff recovering.
On the other hand, the overreaction of the immune system generates a large number of locally free roots that can cause severe damage to the lungs and other organs, and, at worst, multiple organ function failure and death.
Sars-Koff-2 infection, which initially appeared in groups, is likely to affect older persons with multiple diseases and more pregnant women.
It is common for people who are exposed to a large number of viruses or whose immune functions have been affected to have a greater chance of infection than others.
The estimated average duration of Sars-Koff-2 custody is 1-14 days, or mostly 3-7 days, based on a study of the first 425 cases in Wuhan.
However, a study of 1,099 cases shows that the average period of custody was 3 days, ranging from 0 to 24 days.
A more recent study, as explained above, showed that the period of custody was 4.8 (3.0-7.2) days based on a demographic of 8,866 cases.
It is very important that health authorities adjust effective quarantine time based on the most accurate period of custody, thus preventing people infected but not suffering from symptoms from transmitting the virus to others.
As a common practice, people exposed to or infected with HIV are usually required to be quarantined for 14 days.
Should quarantine time be extended to 24 days?
The fever is often the primary and primary symptom of code 19, and can not be accompanied by any other symptoms, such as dry cough, shortness of breath, muscle pain, dizziness, headaches, sore throat, nasal thrombosis, chest pain, nausea and vomiting.
Some patients suffered from respiratory distress and/or hypoxia one week after the onset of the disease.
In severe cases, the condition of patients has evolved rapidly to suffer from acute respiratory syndrome, septic shock, metabolic acid, and mitosis.
Patients with fever or severe respiratory symptoms and fever must be examined, even without screening for pneumonia, in search of the virus for early diagnosis.
A demographic study in late December 2019 showed that the percentages of symptoms were 98% for fever, 76% for dry cough, 55% for respiratory distress, and 3% for diarrhoea; 8% of patients needed respiratory support.
Similar results were reported in two recent studies of a group of families and groups infected by someone who did not show symptoms.
By comparison, a 2012 demographic study showed that Myrs-Koff patients also suffered from fever (98%), dry cough (47%) and respiratory distress (55%) as major symptoms.
However, 80 percent of them needed much more respiratory support than Coved-19 patients and were consistent with the M.O. of Mirs above Kofeed-19.
Diarrhoea (26%) and sore throat (21%) were also observed in Myers patients.
In SARS patients, both fever (99% - 100%), dry cough (29% - 75%), respiratory distress (40% - 42%), diarrhoea (20 - 25%) and sore throat (13 - 25%) proved to be the most important symptoms, and respiratory support was required for about 14% - 20% of patients.
By February 14, the death rate from Koped-19 was 2%, while confirmed cases were 66.576 worldwide.
In comparison, by November 2002, SARS had a mortality rate of 10% of the 8,096 confirmed cases.
For Mirs, the mortality rate was 37% of the 2,494 confirmed cases, based on a demographic study conducted in June 2012.
An earlier study stated that the basic reproduction figure for SARS-Koff-2 was as high as 6.47 with a CI confidence range of 95% from 5.71 to 7.23, while the basic reproduction figure for SARS-Koff ranged from only 2 to 4.
A comparison of Sars-Koff-2 and Mirs-Koff-Sars-Koff in terms of their respective symptoms, mortality and the basic reproduction figure is shown in table 1.1.
The above figures indicate that Sars-Koff-2 has a greater diffusion potential than Mirs-Koff and Sars-Koff, but less lethal than the latter.
Therefore, the Sars-Koff-2 epidemic is much more difficult to control than the Meres-Koff and Sars-Koff epidemics.
The onset of the disease occurs mostly in the same family or from the same group or vehicle, such as a cruise ship.
Patients often have a history of travelling to or staying in Wuhan or other affected areas, or mixing people or patients during the last two weeks before the onset of the disease.
However, it has been reported that people can carry the virus without symptoms for more than two weeks, and recovering patients who have come out of hospitals can re-carry the virus, which sends a warning to increase quarantine time.
Patients have a natural or low number of oceanic white blood cells (especially lymphocytes) at the early stage.
For example, the lack of lymphocytes was detected with the number of white blood cells; 4×109/L, including the number of lymphocytes; 1×109/L; and high levels of amniotic tankers and blood ferrets in 1,099 patients infected with 19 cuvide.
The levels of liver enzymes, muscle and muglobin have increased in the blood of some patients, and the increase in the reaction protein C and the rate of red carcinogens in the blood of most patients.
In patients with severe conditions, the level of D-demer has risen, resulting from fibrin fractures in blood, and the number of lymphocytes has gradually decreased.
Disorders in x-rays appear in most of Koped-19 patients and are characterized by double filamentary shades or a darked glass in the lungs.
Patients sometimes suffer from abnormal pneumonia, severe lung injury, and acute respiratory stress syndrome (ARDS).
When acute respiratory stress syndrome occurs, uncontrolled inflammation, fluid build-up, and advanced fibrosis severely affect the exchange of gases.
The functional dysfunction of type 1 and type 2 pulmonary cells reduces surface activity level and increases surface tension, thereby reducing the ability of the lungs to expand and increasing the risk of lung collapse.
So, the worst results of chest X-rays are often compared to the extreme severity of the disease.
On February 18, 2020, the first pathological analysis of Coved-19 showed the fragmentation of the pulmonary cells, the formation of the healini membrane, the pneumocococococcal leachate, and the multi-cellular cellular cells in the lungs of a patient who died of the disease, in line with the pathology of viral infection and acute respiratory stress syndrome and similar to that of patients with SARS and MERS.
The detection of SARS-COFF-2 reversion sequence polymerase (PTBCR) was used as a key criterion for the Koed-19 diagnosis.
However, because of the high rate of negative false results, which may accelerate the epidemic, clinical forms of diagnosis (which no longer depend individually on RTPR) began to be used in China on February 13, 2020.
A similar situation also occurred in SARS' diagnosis.
Therefore, a combination of history of illness, clinical appearances, laboratory tests, and radiation imaging discoveries is essential for an effective diagnosis.
On February 14, 2020, Feng Chang Group described a protocol for using the Cresper-based Sherlock technique to discover SARS-Koff-2, and discovers pieces of SARS-KOV-2 DNA at a rate of 20 x 10-18 Molly/L to 200 x 10-18 Molly/L (10-100 copies per microlitre of inputs) using a diaphragm in less than an hour without the need for precision devices.
We hope that the new technology will be able to significantly improve sensitivity and suitability if it is verified in clinical samples.
Due to a lack of experience with the new Corona virus, doctors are able to provide mainly supportive care for Koped-19 patients, while experimenting with a variety of treatments that have been used or proposed previously for other Corona viruses, such as Sars-Koff and Mirs-Koff, and other viral diseases (table 2).
These include existing and potential antiretroviral treatments, immunosuppressants, steroids, plasma from recovering patients, Chinese medicine, and psychological support.
Even plasma from recovering patients has been proposed for treatment.
Pharmaceutical companies are racing to develop antibodies and anti-virus vaccines.
Sars-Koff-2 primarily attacks the lungs at first, and to a lesser extent, it may also attack other organs that release the transgenic enzyme of neotensine 2, such as the digestive system, the intestines and the kidneys.
However, respiratory failure and failure are the most serious threat to patients and the main cause of death.
Therefore, respiratory support is necessary to mitigate symptoms and save lives, and includes general oxygen therapy, high oxygen flow, non-synthetic respirators, and synthetic respirators that are made based on the severity of the disease.
Patients with acute respiratory symptoms must be supported by an out-of-body membrane oxification (ECM-O), a pulmonary heart-licencing technique used to treat heart failure or life-threatening respiratory failure.
In addition, maintaining fluid balance, preventing and treating secondary infection and infection, and protecting vital organ functions are also essential for SARS-K-2 patients.
The cytokin storm is known to result in an overreaction to the immune system of Sars and Mers patients.
The cytokin storm is a form of systematic inflammation reaction characterized by the release of a series of cytokines, including TNF, IL-1, IL-2, IL-6, IFN, IFN, IFN, and MCP-1.
These cytokines induce immune cells to release a large number of free roots and are the main cause of acute respiratory stress syndrome and multiple organ failure.
In the treatment of cytokin storms, particularly for acute patients, immunosuppressants are essential.
Activated hormones, tosilizomb and an anti-introlequin-6 anti-selic antibodies were used to treat the cytokin storm.
Other treatments for cytokin's immunosuppressants include modification of the immune reaction to T-cells; the IFN-1 and TNF blockade; the inhibition of Janos Kinaz; the belenatomump; the captor of the cytokin 4 signals; and the Heston Distelez inhibitors.
Stimulants and immunosuppressants have been widely used in SARS treatment to reduce the severity of inflammation damage.
However, with severe lung injury in SARS and Coved-19 patients, steroids at larger doses were not useful.
Instead, it has caused severe side effects, especially anemic osteoporosis, which has a severe impact on disease prediction.
Nevertheless, it was recommended that short cycles of activated hormones be used at small to medium doses with caution for critical Koed-19 patients.
At the time of writing, no antiretroviral treatment had been confirmed.
However, it has been discovered that the giving of a remedicifer, a New Clementine isotope, was effective with a 19-American patient.
Remedicifer is an emerging antiviral developed initially by Geliad to treat diseases caused by Ebola and Marburg.
Later, Raiddzivir also showed potential discouragement to other single-chain reposi DNA viruses, including the Mirs and SARS viruses.
Based on these viruses, Glyad introduced the compound to China to conduct some experiments on individuals infected with SARS-KOV-2, and the results are very much awaited.
In addition, Parisienb, interferon-alpha, Lubinavir/retunavir and Repaverine were proposed as possible treatments for patients with acute respiratory symptoms.
Diarrhoea, nausea, vomiting, liver damage and other reactions can occur after Plubinavir/Retunavir combination therapy.
The interaction of these treatments with other medications used with patients should be carefully monitored.
Plasma from recovering patients and the generation of antibodies.
The collection of blood from patients who have recovered from a contagious disease to treat other patients with the same disease or to prevent healthy individuals from contracting the disease has a long history.
Indeed, recovering patients often have a relatively high level of antibodies against the pathogen in their blood.
Antibodies are immunoglobulin (IG) produced by B-flammable cells to control pathogens and other alien objects, and they recognize and directly neutralize unique molecules in pathogens.
Based on this, plasma was collected from the blood of a group of patients who recovered from Coved-19 and injected into 10 seriously ill patients.
Their symptoms improved within 24 hours, coupled with reduced inflammation and viral loads and improved oxygen saturation of blood.
However, verification and clarification are necessary to introduce this method for widespread use before specific remedies can be found.
In addition, given the therapeutic effects, some plasma-related defects have to be carefully taken into account.
For example, antibodies can induce hyper-invulnerative reaction and cause cytokina release syndrome, which is likely to be life-threatening toxic.
The concentration of antibodies in blood is usually low, and the demand for plasma is high for the treatment of patients in critical situations.
It is difficult to develop and produce specific antibodies quickly enough to combat a global epidemic.
Therefore, insulation of B-cells from recovered patients and identification of genetic codes that encode effective antibodies, or screening for effective antibodies against the essential proteins of the virus, is more decisive and practical.
That way, we can easily increase the production of antibodies.
Traditional Chinese medicine has been used to treat a variety of diseases in China for thousands of years.
However, its effects depend heavily on a variety of multiple components in a combination that varies according to the diagnosis of the disease based on traditional Chinese medicine theories.
Most active components remain unknown or ambiguous as they are difficult to extract and verify or optimize their composition.
Currently, because of the lack of effective and specific treatment for code 19, traditional Chinese medicine has become one of the important alternative treatments for patients with mild to moderate symptoms or those recovering from severe stages.
For example, the effectiveness of the Cho Feng Ji Do capsules and the Lean Hua King Win capsules have been discovered for the treatment of Koffid-19.
The highest recovery rates in the treatment of Koed-19 patients were observed in several provinces of China, where traditional Chinese medicine was used in 87% of their patients, including Ganzo (63.7%), Ningxia (50%), and Hunan (50%), while Hobei Province, which used only traditional Chinese medicine with about 30% of Koed-19 patients, had the lowest recovery rate (13%).
However, this is a very rough comparison, as many other influence factors, such as the number of patients and the severity of their cases, must be included in the assessment.
On February 18, 2020, Paulie Chang and his co-workers published a study to compare the treatment of Western medicine (WWM) alone with the treatment common to Western medicine and traditional Chinese medicine.
They discovered that the periods needed to recover from high body temperature, loss of symptoms, and hospitalization were much shorter in the Western medicine plus traditional Chinese medicine group than in the Western medicine only.
Most impressively, the rate of escalation of symptoms (ranging from mild to severe) was much lower in the GMT+C group compared to the GTG only (7.4% versus 46.2%), and the mortality rate was lower in the GTG+C compared to the GTG only (8.8% versus 39%).
Nevertheless, the effectiveness and safety of traditional Chinese medicine is still awaiting more well-considered experiments on larger scales and in more centres.
It would also be interesting to describe the mechanism of procedure and to clarify the effective components of traditional Chinese medicine treatments or their combinations if possible.
Patients suspected of or confirmed to have had a code 19 often feel very afraid of a highly contagious disease and even fatal disease, and those under quarantine are bored, alone and angry.
In addition, symptoms of infection such as fever, hypoxia and cough, as well as the negative effects of treatments, such as insomnia resulting from activated hormones, can lead to further anxiety and mental disorder.
In the first phase of the SARS outbreak, a range of psychiatric diseases were reported, including permanent depression, anxiety, panic attacks, motor psychoactiveness, psychotic symptoms, delirium and even suicidal tendencies.
As part of the public health responses to the Koped-19 outbreak, mandatory symbiosis and quarantine can make people more concerned and guilty about the effects of infection, quarantine and stigmatization of their families and friends.
Therefore, mental health care must be provided to Koed-19 patients, suspected patients, persons involved, as well as the general public who need it.
Psychological support must include the establishment of multidisciplinary mental health teams, clear contact points with regular and accurate updates on the SARS-KOV-2 outbreak and remediation plans, and the use of specialized electronic devices and applications to avoid direct mixing.
Effective vaccines to cut the chain of transmission of HIV from animal reservoirs and infected humans to vulnerable hosts are necessary and often complementary to antiretroviral therapy in the fight against epidemics caused by emerging viruses.
Efforts have been made to develop protein-based vaccines for the generation of neutral, effective, long-range antibodies and/or preventive immunity against Sars-Koff.
The debilitating living vaccines were evaluated in animal models for SARS treatment.
However, the effectiveness of these candidate vaccines in the living body of older persons and lethal challenge models and their prevention of infection with an animal-based virus was not determined prior to the start of a clinical study.
Maybe it's because Sarse disappeared 17 years ago and no new cases have been reported since.
In contrast, isolated cases and groups of Mers continue to emerge in the Middle East and spread to other regions because of the continued presence of animal sources in endemic areas.
Meres immunization strategies have been developed using an inactive virus, hypoxia DNA plasma, viral vectors, nanoparticles, virus-like particles and sub-units of synthetic protein, some of which have been evaluated in animal models.
The development of a safe and effective vaccine against Sars-Koff-2 for vulnerable individuals is an urgent and critical task to control the ongoing epidemic.
However, overcoming the difficulty is a challenge because of the length of time (an average of 18 months) required to develop a vaccine and the dynamic changes of the Corona viruses.
Coved-19, as an emerging disease, has just begun to show its full clinical path through thousands of patients.
In most cases, patients can recover gradually with no means of support.
However, like Sars and Mers, Koped-19 is also associated with high prevalence and mortality rates in severe patients.
Therefore, building a model of disease health-care forecasting is necessary for health-care agencies to prioritize their services, especially in resource-limited areas.
Based on the clinical studies reported to date, the following factors may affect or be associated with the disease's life expectancy of Coved-19 patients (table 33):
Age: The age was the most important factor for determining the health prospects of SARS, which also applies to Koped-19.
The 30-65 age groups were mainly affected by code 19, with 47.7 per cent of these patients over 50 years of age in a study of 8,866 cases, as explained above.
Patients in need of intensive care were more vulnerable to underlying co-infections and complications and were much older than those who did not (at average age 66 to 51), indicating age as a predictive factor for the results of Koped-19 patients.
Sex: Sars-Koff-2 infected more men than women (0.31/10000 versus 0.27/10000), as explained above.
Accompanying diseases and complications: Coved-19 patients in need of intensive care are more likely to suffer from acute heart injuries and heart failure.
Heart events were also the leading cause of death in SARS patients.
It was reported that SARS-KOV-2 could also be associated with positive ZPMs with an Angiotin 2 converter enzyme, which could lead to liver dysfunctions in Koped-19 patients.
It should be noted that the underlying age and disease are strongly related and may overlap.
Unnatural laboratory results: The level of protein reaction C (CRP) in blood reflects severe inflammation or tissue injury, and it is suggested that it be a predictive factor for disease, treatment response, and final recovery.
It was also suggested that the level of the reaction protein C be associated with the intensity of Koed-19 disease and its prognosis.
In addition, the emphysema of LDH, ATST, ALT and CK could also help predict the outcome.
These enzymes appear strongly in many organs, especially in the heart and liver, and are released during tissue damage.
Therefore, they are traditional signs of functional imbalances in the heart or liver.
Main clinical symptoms: Chest X-rays and progress of clinical symptoms have to be taken into account together with other problems in predicting Koide-19 results and complications.
Stimulant use: As explained above, stimulants are immunosuppressants commonly used as ancillary treatment for infectious diseases to reduce the severity of inflammation damage.
Since the widespread use of high doses of activated hormones in SARS patients, many survivors have suffered from anemic osteoporosis with lifelong impairment and poor quality of life.
Stimulants must therefore be used at a low dose and for a short period of time in Koped-19 patients, if necessary.
Mental stress: As explained above, during the Koped-19 outbreak, many patients suffered exceptional stress; they often endured long periods of quarantine, extreme uncertainty, and witnessed the death of family members and their sick colleagues.
Counselling and long-term support are necessary to help those patients recover from stress and return to normal life.
According to demographic studies so far, Koed-19 appears to have a different epidemiological profile than Sars.
In addition to reincarnation in the lower respiratory system, Sars-Koff-2 can replicate effectively in the upper respiratory system and cause mild symptoms or no symptoms at the early stage of infection, similar to the other corona viruses that cause common colds.
Therefore, patients infected at the early stage or incubation period can produce a large amount of HIV during daily activities, making it difficult to control the epidemic.
However, SARS-Koff transmission was considered to occur when patients were in severe illness, while most HIV transmissions did not occur at the early stage.
Therefore, the current outbreak of code 19 is much greater and more difficult to control than the SARS outbreak.
Currently, strenuous efforts are under way in China, including the closure of Wuhan and surrounding cities and the ongoing quarantine of almost all residents in the hope of impeding Sars-Koff-2’s transition.
Although these measures have severely affected the economy and other sectors of the country, the number of new patients is declining, indicating a slow-down of the epidemic.
The most optimistic estimate is that the outbreak will end by March and the decline will continue for three to four months.
However, some other experts do not have the same level of optimism.
Paul Hunter et al. estimated that Coved-19, which appears to be far more contagious than Sars, will not end in 2020.
Ira Longini and others created a model for predicting the outcome of the epidemic and suggested that Sars-Koff-2 might affect two thirds of the world's population.
A Canadian group reported that Sars-Koff-2 was detected in mid-couple and throat surveys of patients who recovered and left the hospital two weeks ago, suggesting that the newly detected virus could become a flu-like circulatory seizure.
Nevertheless, promising signs have emerged in China based on the declining number of new cases, which suggests that current strategies may have been working.
Ebola was originally expected to cause up to 1 million casualties with half a million deaths.
Nevertheless, the disease was eventually controlled by strict quarantine and isolation measures.
Like Sars-Koff, SARs-Koff-2 can become weaker in terms of causing infection and eventually disappear or become a less pathogenic virus that coexists with humans.
A comparison of the Coffid-19 epidemic is provided below (figure 55).
SARS-KOV-2 travels at a higher rate through cough or sneeze, and can also be transmitted through direct contact with HIV-contaminated substances.
The virus was also found in the faeces, creating a new possibility of moving from faeces to mouth.
According to a recent study of 138 cases, 41% of cases may have resulted from hospital infections, including 17 patients with other previous illnesses and 40 health-care providers.
Considerable precautions are therefore needed to protect human beings, particularly health-care providers, social workers, family members, colleagues and even passers-by who have had contact with infected patients or persons.
Wearing face masks is the first line of defence that can be used to reduce the risk of infection; the use of both surgical masks and N95 respiratory masks (series 1860s) helps to control the spread of viruses.
Surgical face masks prevent liquid droplets from a potentially infected person from moving through air or sticking to material surfaces, where they can be passed on to others.
However, only N95 masks (series No. 1860s) can protect against inhalation of small phyrons of between 10 and 80 nanometers, with only 5% of phyrons able to fully penetrate; SARS-Koff-2-Sars-Koff is roughly 85 nanometers in size.
Since particles can penetrate up to five surgical masks stacked together, directly mixed health-care providers must wear N95 masks (series 1860s) but not surgical masks.
In addition to masks, health-care providers must wear suitable insulation robes to further reduce communication with the virus.
The viruses can also infect someone through the eyes.
On January 22, 2020, a Dr. Saras-Koff-2 was injured even though he wore a N95 mask; the virus may have entered his body through his inflamed eyes.
Therefore, health-care providers should also wear transparent face protections or glasses while working with patients.
For the general public in affected or potentially affected areas, it is strongly recommended that everyone wash their hands with more purified soap than usual, try to stay home for self-immolation and limit contact with potential injured individuals.
Three feet is an appropriate distance to keep people away from the patient.
These measures are effective ways to reduce the risk of infection as well as prevent the spread of the virus.
Although Sars-Koff-2 came as a new virus to the human world, its close resemblance to Sars-Koff as reported on 7 January 2020 would have caused a high alert in China based on its deep memory of the SARS outbreak in 2003.
However, the director of the Center for Disease Control in Wuhan did not assure citizens until January 19, 2020 that the new virus had a low infection rate and a limited human-to-human reproduction. There was no problem in preventing and containing the disease.
This message severely reduced public preparedness, especially when the entire country was preparing for the Spring Festival, and a critical time was lost to contain the disease at its lowest range in Wuhan.
China’s disease control agencies may benefit from this harsh lesson and implement substantial improvements in the future.
For example, these agencies must be (1) more cautious when issuing public statements because every word is important to citizens and can change their behaviour and decisions; (2) more sensitive and interactive with unusual information from clinics rather than waiting for official reports from doctors or officials; (3) more restrictive to contain a potential epidemic in its early stages than to try to reassure the public; and (4) more effective and targeted training to increase public awareness of epidemic diseases and periodically test and improve the community response system.
The Coffid-19 outbreak of the Sars-Koff-2 virus began at the end of December 2019.
It spread in less than two months all over China and about 50 other countries worldwide at the time of writing these lines.
Given that the virus is very much like SARS-Koff and the symptoms are also similar between Koped-19 and SARS, the Koped-19 outbreak has given rise to a sense of repeated SARS infection.
Nevertheless, there are some salient differences between Koed-19 and Sars, which are necessary to contain the epidemic and treat the sick.
Koved-19 affects older individuals than young people and men more than women, and the rate of distress and mortality is also higher among older persons than among young people.
SARS has a higher mortality rate than Koved-19 (10.91% versus 1.44%).
Coved-19 patients transmit the virus even when they have no symptoms, while Sarss patients usually do so when they are severely ill, making it more difficult to contain the spread of Coved-19 from Sars.
Partly explains why Sars-Koff-2 spread much faster and wider than Sars-Koff.
Normal SARS-KOV-2 DNA tests can be negative for some of Koped-19 patients.
On the other hand, HIV-infected patients can be infected again.
These results significantly increase the risk of the spread of the virus.
With this rapid progress in research around Koved-19, there are still many critical issues to be resolved, as follows:
Where did Sars-Koff-2 come from?
Despite the discovery of 96% Gini symmetry between Sars-Koff-2 and the similar Corona virus of Sars in bats, we still cannot conclude that Sars-Koff-2 comes from bats.
What kind of animal was the intermediate that transmitted the virus from the original host, like bats, to humans?
Without knowing the answers to the numbers 1 and 2, we can't efficiently stop the transition, and the outbreak can come back at any time.
Although molecular modelling and biochemical tests have shown that Sars-Koff-2 is associated with an Angiotin 2 transformer enzyme, how exactly does the virus enter anaerobic tract cells and cause subsequent pathological changes?
Is the virus also associated with the dispersing cells of the angiogenogenin 2 enzyme in the other organs?
Without clear answers to these questions, we cannot make a rapid and accurate diagnosis and provide effective treatment.
How long will this plague last?
How does the virus develop genetically during human transmission?
Will it become a worldwide pandemic, or will it fade like Sars, or will it come back periodically like a flu?
It is necessary, but it may take some time to look for answers to the above and many other questions.
However, at whatever cost it may take, we have no choice but to stop the epidemic as soon as possible and bring our lives back to normal.
Animal assets of the Corona human viruses
The mutation and adaptation have led the development of the corona virus and its hosts, including humans, for thousands of years.
Before 2003, it was known that two types of human Corona viruses (human Corona viruses) caused a mild disease, such as a cold.
The outbreak of severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) has shown the other side to reveal how serious and life-threatening the infection of the Corona human viruses can be.
The emergence of Sarse Koff-2 in Central China at the end of 2019 led to the re-emergence of the Corona viruses, and we were surprised by its rapid spread but with the ability to cause the disease compared to his brother Sars-Koff.
The Corona human virus is an animal-born disease, so our understanding of the animal origins of the Corona human viruses will serve us well.
Most human Corona viruses come from bats where they are not pathogenic.
Intermediated hosts of some of Corona's human viruses have also been identified.
The identification of host animals is considered to have a direct impact on the prevention of human diseases.
Exploring the interactions between the Corona virus and the animal host also provides an important insight into the emergence of the Corona virus in humans.
In this review, we provide an overview of the information available on the seven Corona human viruses, with a focus on the date of their discovery as well as their animal assets and interspecies transmission.
The most important thing is that we compare and differentiate between the different human viruses of Corona from the perspective of the evolution of the virus and the reshaping of the genome.
The disease caused by the current Corona virus epidemic of 2019 (Coved-19) is discussed in this context.
In addition, it also highlights the successful replacement requirements of the host and the impact of the implications of HIV development on the severity of the disease.
Corona viruses belong to the family of coronary viruses, which include a series of single-chain repository DNA-coated viruses.
These viruses contain the largest genome of DNA viruses with a range of 26 to 32 kilobases and are called coronary viruses because their composition is like a crown under an electronic microscope.
In terms of synthetic properties, Corona viruses contain undivided genes that share a similar organization.
Nearly two thirds of the genome contains two large open-ended reading templates (ORF1a and ORF1b), which are converted into multiple-reproduced proteins (pp1a and pp1ab).
Multiple proteins are additionally treated for the generation of 16 non-structural proteins, referred to as nsp1~16.
The remaining part of the genome contains open reading templates for structural proteins, including Spike (S), cover (E), membrane (M) and nuclear protein (N).
Different strains of Corona viruses also encode a number of additional proteins from special strains.
Based on the difference in protein sequences, Corona viruses are classified into four types (the Corona Alpha virus, the Corona Beta virus, the Corona Gamma virus and the Corona Delta virus), including the Corona Beta virus types, which cover most of the Corona human viruses and are divided into four strains (a, b, c, d).
The evidence of genetic evolution has shown that bats and rodents act as the genetic origin of most of the Corona Alpha viruses and the Corona Beta viruses, while birds are the main repository of the Corona Gamma viruses and the Corona Delta viruses.
Over thousands of years, Corona viruses have consistently crossed species barriers and some have emerged as causes of serious human diseases.
So far, seven human krona viruses (Krona human viruses) are known.
Among them is the Corona Human virus .229E and the Corona Human virus-NL63, which belong to the Corona Alpha viruses.
The other five Corona Beta viruses include the Corona Human virus-OC43, the Corona Human virus-HKU1, the Corona virus associated with SARS-Koff, the Corona virus associated with the Meres-Koff respiratory syndrome, and SARS Cove-2.
The Corona human virus .229E, the Corona human virus-OC43, the Corona human virus-HKU1 and the Corona human virus-NL63 usually cause mild symptoms, such as cold, diarrhoea or both.
In contrast, Sars-Koff and Mirs-Koff and the newly identified virus SARs Cove-2 are all highly pathogens, causing severe lower respiratory infections to a larger number of patients with a higher probability of acute respiratory stress syndrome (SARS) and non-pulmonary symptoms.
Isolated from the Corona human virus .229E, the first strain B814, from nasal secretions of cold patients in the mid-1960s.
Much information has been collected since then through extensive studies of the Corona human virus 229E and the Corona human virus-OC43, whose symptoms are automatically cured.
In fact, it was generally recognized that the infection of the Corona human viruses was harmless until SARS was rampant.
The SARS outbreak in 2003 is one of the most deadly epidemics in our present history, with 8,000 people infected, with approximately 10% of deaths.
Ten years later, Middle East Respiratory Syndrome (MERS) spread, creating a constant epidemic in the Arabian Peninsula with a spread scattered to the rest of the world.
The new Corona human virus 2019 (the new Corona human virus 2019), renamed SARS Cove-2, is the driver of the current epidemic, the Corona virus 2019 (Coved-19), which killed more than 3,120 people and infected more than 91,000 people on March 3, 2020.
The alarm rings and the world has to prepare for the next SARS Cove-2 pandemic.
All of Corona's seven human viruses have animal origins of bats, rats, or pets.
Multiple evidence supports that the evolutionary origins of all human Corona viruses are bats, where viruses are well adapted, not pathogenic, but exhibit significant genetic diversity.
The Coffid-19 epidemic has raised enormous medical, scientific, social and ethical challenges for China and the world.
Tracking the animal assets of the Corona human viruses has shown a framework for understanding natural history, driving force and limiting factors of interspecies mobility.
This may also guide or facilitate the search for the warehouse, the intermediate host and the amplified host animal (the inflated host animals) of SARS Cove 2, with significant impacts to prevent future repercussions.
In this review we provide an overview of animal assets, interspecies transmission, and the human viruses of Corona cause disease.
In particular, we highlight and discuss the common belief that the original viruses of the Corona human viruses are usually not pathogenic in their naturally stored hosts but become pathogens after they move between species to a new host.
We also review the evaluation of the human path of the Corona virus, where the increase in its transportability is often accompanied by a reduction in the severity of the disease.
We are also discussing in this context the results of the current SARS Cove-2 outbreak.
Corona's animal viruses have been known since the late 1930s.
Before the first isolation of the B814 strain of the Corona human virus 229E from the nasal secretions of cold patients, various types of Corona viruses were removed from various infected animals, including turkey, mice, cows, pig, cat and dog.
In the past decades, seven species of human Corona viruses have been identified.
A brief summary of the history of the discovery of the Corona human virus in chronological order (table 1) would be educational and indicative.
The first strain of the Corona human virus was removed from the respiratory system for patients with upper respiratory infections in 1966, and then adapted to live in the ranks of the WI-38 lung cells.
Patients living with the human corona virus .229E suffer from common cold symptoms, including headaches, sneezing, dysentery, sore throat, fever, and coughing in approximately 10.1% of cases.
Later in 1967, the Corona-Human virus was isolated from the organ farm and the subsequent transfer was in the brains of the baby rats.
The clinical features of the CORONA-OC43 virus appear to be similar to those caused by the CORONA-229E virus, which cannot be distinguished by symptoms from other respiratory viruses such as influenza A viruses and nose viruses.
Both the Corona human virus .229E and the Corona-OC43 human virus have spread globally, often tending to move through the winter season in the temperate climate.
In general, the time of custody of these two viruses is less than one week, followed by a sense of disease for approximately two weeks.
According to a human volunteer study, the infection of healthy individuals with the Corona human virus, 229E, has caused a mild cold.
Only a few HIV-positive patients showed severe lower respiratory infection.
SARS, also known as "Atypical Pneumonia", is the first pandemic of the human Corona virus to be well documented in the history of mankind and its causative agent is SARS-Koff, the third human krona virus to be detected.
The first case of SARS dates back to late 2002 in Guangdong Province, China.
The SARS epidemic has resulted in 8,096 confirmed casualties and 774 deaths, spread across many countries and continents.
Regardless of the superconductor, it has been estimated that a single case can lead to approximately two secondary cases, with a 4 to 7-day custody period showing the peak of the viral load on the 10th day of the disease.
Sars-Koff's symptoms begin to show muscle pain, headache, fever, sickness, chills, followed as late symptoms by difficulty breathing, coughing and respiratory distress.
The lack of lymphocytes, liver dysfunction, and the rise of creatine kinases are common laboratory disorders of SARS.
In SARS patients there is also widespread schizophrenic damage, apparent cell reproduction, and an increase in the number of balm cells.
About 20-30 percent of patients then need intensive care and artificial breathing.
In addition to the lower respiratory system, in severe cases, many organs can also be infected, including the digestive system, liver and kidney, usually accompanied by a cytokin storm, which can be particularly fatal in HIV patients.
The virus was first isolated from an open lung biopsy of a relative of the first case of infection who travelled from Guangzhou to Hong Kong.
Since then, considerable efforts have been devoted to research on the Corona human virus.
The Corona-NL63 human virus was isolated from a 7-month-old child from the Netherlands in late 2004.
Initially, it was found to be common in young children, older persons and HIV patients suffering from respiratory diseases.
The cold, convulsive inflammation, fever, and bronchitis are common symptoms of the disease caused by the Human Corona-NL63 virus.
Another independent study described the isolation of the same virus from a sample of the nose of an 8-month-old child suffering from pneumonia in the Netherlands.
Although discovered in the Netherlands, it's worldwide.
An estimated 4.7% of common respiratory diseases are responsible for the Corona-NL63 virus, which peaks in early summer, spring and winter.
The Human Corona-NL63 virus is associated with laryngitis, also known as strangulation.
In the same year, the HKU1-Krona virus was isolated from a 71-year-old man who was hospitalized for pneumonia and bronchitis in Hong Kong.
In addition to community-based pneumonia and bronchitis, HKU1 has been reported to be associated with the exacerbation of acute asthma attacks.
The HKU1-Krona human virus was found to be globally widespread, causing mild respiratory diseases, similar to the HK-NL63 virus, the HK229E virus and the HK43-Krona virus.
All four of these human Corona viruses acquired from society have adapted well to humans. In general, there is little likelihood that they could cause diseases with high prevalence rates, but the coincidence has occurred for unknown reasons, as in the rare case of the most vicious sub-type of the Human Corona-NL63 virus, which has recently been reported to cause severe infections to China’s lower respiratory system.
In general, when Corona viruses acquire the ability to move efficiently and maintain themselves continuously within humans, they also become less intense or pathogenic.
Mirs-Koff was first removed in 2012 from the lung of a 60-year-old patient with pneumonia and kidney failure in Saudi Arabia.
While most of the confirmed cases are laboratory-based from the Middle East, in many European countries and Tunisia cases have been reported from abroad and a rare secondary transfer of two mixtures in close personal contact.
Another secondary outbreak in South Korea in 2015 resulted in 186 confirmed cases.
The clinical symptoms caused by Mers are similar to those caused by Sars, and are characterized by increased acute pneumonia.
Unlike SARS, many people with Mirs have also suffered severe renal failure, which is what Mers has distinguished from other diseases caused by the Corona virus.
More than 30% of patients suffer from infectious intestinal symptoms, such as diarrhoea and vomiting.
On February 14, 2020, more than 2,500 laboratory confirmed cases were reported with a high mortality rate of 34.4%, making Mirs-Koff one of the most known destructive viruses in humans.
From mid-December to late 2019, groups of pneumonia patients were later identified as the result of SARS Cove-2 infection in Wuhan, Hubei Province, China.
The World Health Organization (WHO) has declared the current prevalence of lower respiratory infections due to the SARS Cove-2 virus to be a public health emergency of international importance, as it has been referred to as Koved-19.
On March 3, 2020, 90,053 cases were confirmed worldwide, with an initial mortality rate of 3.4 per cent.
It should be noted that the mortality rate in the province of Hobei, China, is 4.2 per cent, while it is 1.2 per cent outside.
Sarse Cove-2 causes severe respiratory infections such as Sars-Koff and Mirs-Koff, which appear in the form of fever, coughing and respiratory distress.
Diarrhea also appears in some of the injured.
Pneumonia is one of the most serious symptoms and can rapidly develop into acute respiratory stress syndrome.
Although Sars-Koff and Sars Cove-2 are very similar because of the 82% great homogeneity of the nucleotides sequence, they belong to different branches of the strain evolution tree.
Sarse Koff-2 appears to be less severe but more contagious than Saras-Koff and Mirs-Koff.
It has been reported that there are people who, despite being infected with SARS Cove II, may be contributing to its rapid spread around the world.
The comparison and variation between Sars Cove-2 and the six other human viruses of Corona revealed similarities and differences of great importance.
First, Corona's human viruses are similar during the pre-school and the time period of the disease.
In this regard, Sarse Cove-2 follows the general trend of the other six human viruses of Corona.
Second, the severity of the symptoms of the Coed-19 infection is between Sars-Koff and the four human viruses of Corona acquired from society (i.e., the Corona Human Virus 229E, the Corona Human virus-OC43, the Corona Human virus-HKU1 and the Corona Human virus-NL63).
On the one hand, SARS Cove-2 shows features that are more common in cases of human viruses acquired from society, including the appearance of unspecified or minor symptoms or even the absence of symptoms.
On the other hand, a small subset of severe cases with Coved-19 can also be seen, as in the case of SARS-Koff, although the ratio is slightly lower.
Third, SARS Cove-2’s transmission shows interesting patterns of both the human virus Corona acquired from society and SARS-Koff.
On the one hand, SARS Cove-2 is at least as high as the human virus transmission potential acquired from society.
On the other hand, verification of whether SARS Cove-2 transportability is reduced after human transport remains the case in SARS-Koff and Mirs-Koff cases.
Finally, Sarse Cove-2 can be detected in stool samples as in other Corona human viruses.
Further studies are still needed in the future to clarify whether Sarse Cove-2’s movement from the oral anal route plays an important role, at least in the case of Sars-Koff.
It is worth noting whether Sarse Cove-2 may show seasonal prevalence as in cases of human viruses acquired from society.
However, the features of Sarse Cove-2, including the possibility of transition, and the mechanism of morbidity and sustainable spread after human transition, will have an impact on the final fate of the current Koed-19 outbreak.
All four human corona viruses acquired from society and causing minor symptoms have adapted well to humans.
Another perspective, which may also be true, is that humans have adapted well to these four human Corona viruses.
In other words, they may both be survivors of the old Corona virus epidemics.
The human viruses of Corona, which afflict humans with severe diseases, as well as humans who have contracted the acute diseases of the Corona human virus, have been eliminated.
For this to happen, the human viruses of Corona must be replicated in humans enough to allow the accumulation of adaptive mutations that confront the limiting factors of the host.
And from this logic, the longer Sars Cove-2 spreads and the more infected, the more likely it is to be fully adapted to humans.
If it adapts well, it is difficult to stop human transmission through quarantine or other anti-infection measures.
The four koruna viruses acquired from society spread among human populations over many years, causing colds among people with good immunity.
These viruses don't need an animal warehouse.
On the contrary, Sars-Koff and Mirs-Koff, the cause of severe human morbidity, have not adapted well, and have not been able to continue the transition between humans.
They need to stay and reproduce in their animal reservoirs and then find the right opportunity to move to the most vulnerable human targets, perhaps through one or more intermediate and inflated hosts.
SARS COFF-2 has similar features to SARS-Koff/MERS-KOV and the four human viruses of Corona acquired from society.
It's as contagious as the human viruses of Corona acquired from society, at least for the time being.
However, it causes the disease more than the human viruses of Corona acquired from society and less than Sars-Koff or Mirs-Koff.
It is not yet clear whether they will be fully adapted to humans and spread among them without the need for a warehouse or an intermediate animal host.
Before discussing the animal origins of the Corona human viruses, it would be useful for us to review the definitions and characteristics of evolutionary, natural, reservoir, intermediate and amplified hosts of the Corona human viruses.
The animal acts as the evolutionary host of the human Corona virus if it harbours the virus of a closely related origin and shares a large similarity in the levels of neoclyotides.
The original virus is usually well-adapted and not pathogenic to this host.
Similarly, the repository hosts the Corona human virus on a continuous and long-term basis.
Either way, the hosts are naturally infected and the natural hosts of the Corona human virus or their father-in-law's virus.
On the contrary, if Corona's human virus enters a newly mediated host just before or near its attack on humans, it does not adapt well to the new host and often causes ill health.
This intermediate host can act as an animal source of human infection and also act as an inflated host by allowing the virus to be copied temporarily and thus transmitted to humans to expand the range of infection among humans.
The infection of the Corona human virus may be at an impasse if the virus fails to transmit from within the intermediate host.
On the contrary, Corona's human viruses can also adapt to the intermediate host and may even settle for a long time.
In this case, the intermediate host becomes the natural repository host.
Epidemiological data later revealed that the first case of SARS had a history of contact with the prey.
Subsequent seroprevalence surveys indicated that animal traders had a higher prevalence rate of Sars-Koff IgG than ordinary people.
For the first time, the masked palm yogurt (Pagama Larvata) and the raccoon dog in the live animal markets were identified as carrying SARS-Koff-like viruses that almost matched Sars-Koff.
This indirectly supported the fact that no other SARS case was reported after all the yogurt cats were killed in the market.
However, it was reported that the result of SARS-Koff ' s examination of masked palm yogurt living in the wild or on farms without exposure to the markets of living animals was largely negative, indicating that the masked palm yogurt may be only an inflated intermediate host, but it is not SARS-Koff ' s natural warehouse.
It should be noted that, since 80% of the different animals in the markets in Guanzu have anti-Sars-Koff objects, the possibility that multiple species of small mammals also serve as the inflated intermediate host of SARs-Koff is not ruled out.
Looks like all these guys are hosts who don't move Sars-Koff.
The subsequent search for Sars-Koff’s animal natural host led to the detection of the closely related krona bat virus, called the China’s red horse’s shoe bat virus associated with severe acute respiratory syndrome (HKU3) (the Chinese horse’s red horse’s shoe virus associated with severe acute respiratory syndrome (HKU3), which is found in the Chinese horse’s shoe bats.
The result of the examination of Sars-Koff antibodies in these bats and the sequence of the Chinese horse-temperature virus virus associated with severe acute respiratory syndrome (SARS) was positive.
This virus and the other krona bat viruses share a 88-92% symmetry of the nucleotides with Sars-Koff.
These studies have laid the foundation for the new concept that bats are host to emerging human pathogens.
Many of the Kuruna-like viruses (Korona-like severe acute respiratory syndrome (SARS)) were identified from bats, but none could be isolated as a living virus except for WIV1.
The human Angiotin 2 transformer enzyme is known as the receiver of SARS-KOV.
It was established that WIV1 from a bat stool sample was using an angiotin 2-transformed enzyme in a bat, yogurt cat, and humans as a receiver to enter the cell.
Interestingly, the serum recovered from severe acute respiratory syndrome had the ability to equalize WIV1.
So far, WIV1 is the most closely associated parent of SARS-Koff in bats, as they share 95% of the symmetry of the nucleotides.
Despite the high symmetry between these two viruses, it is generally believed that WIV1 is not SARS-Koff's direct father virus and that bats are not a direct repository for SARS-Koff.
The analysis of the evolution of the Mers-Koff strains of the Corona-HKU4 virus group is collected in bats and the Corona-HKU5 virus in the same bats.
The Corona-HKU4 virus is used in bats and Mers-Koff is the host's own receiver, a bi-petideal bi-pettedaz4 (di-peptideal peptidas 4), to enter the virus.
The reposy DNA sequences of Mirs-Koff are closer in terms of the evolution of strains to their counterparts than the Corona Beta viruses in the bats identified in Europe and Africa.
It has not yet been discovered that Mirs-Koff lives in wild bats.
Mirs-Koff and the Corona-HKU25 virus share in their nearest bats only 87% similarity to the nucleotides.
Thus, the host bats may not be the direct repository of Mirs-Koff.
On the other hand, studies in the Middle East have shown that the single centimetres are positive antibodies for Mirs-Koff, as well as those of Middle Eastern origin in many African countries.
Mirs-Koff, a human-compatible neighborhood, was isolated from single-sniffed nostalgia nasal scans, suggesting that the camels serve as the host of Mirs-Koff's original warehouse.
It should also be noted that minor symptoms have generally emerged in camels that have been experimentally infected with Mirs-Koff, but a massive viral dispersion has been observed.
The infected camels were spreading viruses noticeably not only through breathing but also through the oral anal route, which is the primary route for spreading the virus from bats.
However, questions remain because many confirmed cases of Mers do not have a history of contact with camels prior to symptoms, and these cases are logically attributed to human-to-human transmission or unknown modes of transmission involving unidentified species of animals sheltering Mirs-Koff.
Sars Cove-2 shares the Corona RTG13 virus in isolated bats from horseback bats in 96.2 percent neoclytide symmetry.
The sequence difference between SARS Cove-2 and RATG13 is too long to determine the relationship with the father, as in the SARs-Koff and Mirs-Koff cases.
This means that bats may not be the host(s) of SARS Cove-2's direct repository unless Corona's bat viruses are found almost identical in the future.
SARS Cove-2 intermediate hosts are assumed to be among the species of wild animals sold and killed at Wuhan Seafood Market, in which many of the initial cases of Coved-19 were associated, suggesting possible animal-to-human transmission.
Many recent studies based on the metagenomy sequence suggested that a group of endangered small mammals known as Manis javanica could also accommodate the original Corona Beta viruses associated with SARS Cove-2.
The genomes of the new Corona virus for these ants and SARS Cove-2 share the symmetry of the nucleotides by 85-92%.
However, they are closely related to RaTG13 with about 90% similar in the nucleotides sequences.
They are clustered in two sublines of SARS Cove-2-like viruses in the strain development tree, one of which shares a similar field of association of receivers (receiver area) with SARS Cove-2, with an amino acid sequence of 97.4%.
In stark contrast, SARS Cove-2's metabolites differ significantly from RaTG13, although the entire genome sequence is much higher.
A previous study of a sick ant eater also revealed the presence of viral organisms from lung samples, which were similarly found to be associated with SARS Cove-2.
This study adopted different methods of assembly and manual treatment to generate a partial genome sequence consisting of the entire viral genome of approximately 86.3% length.
We can't rule out the possibility that the ant eater is an intermediate host animal for SARS Cove-2.
However, there is currently no evidence to support the fact that the acupuncture is the direct origin of SARS Cove-2 due to the different sequences between SARS Cove-2 and the Corona Beta viruses associated with SARS Cove-2 in the acupuncture.
In addition, the distance between SARS Cove-2 and RATG13 is less than the distance between SARS Cove-2 and the Corona Beta viruses associated with SARS Cove-2 in anatomy.
The evolutionary path of Sars Koff-2 is still in bats, acupuncture and other mammals are under recruitment.
While the highest serial symmetry was found in the areas where the receivers are connected between SARS Cove-2 and AAA, the Corona Beta viruses associated with SARS Cove-2 and SARG13 share the highest symmetry of the complete genome sequence.
It is a dominant speculation that the high degree of similarity between SARS Cove-2 receivers' areas of interconnectivity in the uterine ant eater of Corona Beta and SARS Cove-2 viruses is led by selective approximation.
There is a counterproposal likely to be reconstructed between Sarse Cove-2 in the pharmacological ant eater of the Corona Beta virus and RaTG13 in the third terrestrial species.
Restructuring is widespread among the Corona Beta viruses as a driving force for development.
The direct animal origin of SARS Cove-2 has not yet been confirmed.
In addition to the highly pathogenic human viruses of Corona, the animal origin of the Corona human virus 229E, the Corona Human virus-OC43, the Corona Human virus-NL63 and the Corona Human virus-HKU1 has also been studied.
Evidence of the evolution of strains has indicated that both the human Corona-NL63 virus and the human Corona-229E virus may have originated from the Corona Bat virus, while the father's viruses of the human Corona-OC43 virus and the human Corona-HKU1 virus were found in rodents.
It has been reported that the Corona virus in bats called ARCov2 (Krona Ablache Highlands virus) discovered in three-coloured bats in North America is closely related to the Human Corona-NL63 virus.
On the other hand, the Corona human virus was found to be genetically linked to another krona virus in bats, called Hiposideros/GhanaKwam/19/2008, which was discovered in Ghana, and it was suspected that the ablazes were also its intermediate host.
To illustrate, the current information on animal assets of the Corona human viruses known in figure 1 and table 2 has been summarized.
An analysis of the evolution of strains has provided evidence of the transmission of the Corona human viruses between species throughout history.
When the Couruna-Human virus crossed species to infect humans with household livestock around 1890, a respiratory infection epidemic was recorded.
The history of HIV transmission among species is still less clear.
Corona Alpha viruses in bats were found to be closely related to the Corona human virus .229E.
There's an Alpha Corona virus in the Alpaca.
Many evidence supports the transmission of the virus from bats to humans directly.
First, humans, not alpaca, may have contact with bats in a common environmental home.
Humans have close contact with the Alabama.
Second, the Corona-H229E virus from the Corona Alpha viruses is in multiple bats and not pathogenic in bats, while the Corona-Alpaca virus causes respiratory diseases to spread among infected animals.
Finally, the Corona Alpha virus associated with the abaca has not been detected in wild animals.
Therefore, it cannot be ruled out that alpaca has been infected with the human virus Corona-229E of the Corona Alpha virus.
In fact, bats are the direct source of viruses that cause diseases to humans, including rabies, Ebola, Nebah and Hendra.
So it's not surprising that the bats may transmit the Corona human virus 229E directly to humans.
While the Corona Alpha viruses in bats act as a gene pool for the Corona human virus of 229E, alpaca and single camels may act as intermediate hosts that transmit viruses to humans, just as in Mirs-Koff.
Mirs-Koff provides an excellent example of interspecies transmission from bats to single camels and from single camels to humans.
Mirs-Koff's evolutionary origin from bats has been defined since the beginning of their identification and has also been enhanced through subsequent results.
Obviously, bats provide a rich pool of viruses to exchange genetic pieces within the same species and their transmission between species.
Bats are age-long, living in overcrowded colonies, close social interaction, and strong flying capacity, all of which are favorable conditions to make them an ideal “viral distributor”.
On the other hand, Mirs-Koff has moved to the single camels for decades.
You've adapted well to these camels until you've turned from an intermediate host into a normal, stable warehouse host.
Mirs-Koff causes a very minor disease and maintains a relatively low mutation rate in these animals.
His intermittent transmission to humans remains a coincidence and humans are an untransmitted host for Mirs-Koff, where his transport cannot continue.
In contrast to the role of camels in the transport of Mirs-Koff, the role of anatomy eater, if any, in the transport of Sarse Cove-2 is different.
In particular, the Corona Beta viruses associated with the acupuncture of abrasive ants make him very ill.
They may be non-carrying hosts for Sars Kauf-2 of the Corona Beta viruses, as in the case of Sars-Koff.
Future studies will resolve many possibilities for Sarse Cove-2 to move between species of animals to humans by either proving them or excluding them.
First of all, the bats may be hosting a repository of a virus associated with SARS Cove-2, which is mostly identical to SARS Cove-2.
Humans and bats may share their ecological habitat through slaughter or coal mining.
Second, an acupuncture can be one of the intermediate amplifiers of the virus associated with the recently discovered SARS Cove-2.
Humans are infected by the slaughter and consumption of prey's meat.
Many mammals, including pets, are likely to be exposed to SARS Cove-2.
A survey of antibodies in pets and wild animals is warranted.
Third, as mentioned above, SARS Cove-2 may have been re-assembled and adapted in a third species with links to bats and ant-eating.
The search for the animal origin of SARS Cove-2 is still ongoing.
Regardless of the different types of animal hosts, on the viral side there are three major factors that are also important in facilitating the infection of Corona viruses to overcome species barriers.
First of all, her mutation rates are relatively high in the doubling of reposi DNA.
The estimated rates of mutations of the Corona viruses, compared to the other mono-chained DNA viruses, can be considered to be “medium” or “high” with an average turnover rate of ~10.4 replacements each year for site 2, depending on how the Corona virus adapts to new hosts.
Corona viruses include an external recyclative enzyme, which results in very high mutagenicity or a lack of development.
Interestingly, the remedicifer is known for its ability to suppress the Corona virus through the inhibition of the external rebonoclias enzyme and the reposy acid polymerase based on reposi DNA.
Rimdicifer is one of the anti-Sars Cove factors to be tested in clinical trials.
However, Corona virus mutation rates are about a million times higher than host rates.
In addition, the mutation rate is often high when Corona viruses do not adapt appropriately to the host.
The rate of mutations for SARS Cove-2 is significantly low when compared to SARS-Koff with a high rate of mutation, which indicates a higher level of human adaptation.
Looks like he's already adapted to another human host.
In addition to Sarse Cove-2, this also applies to Mirs-Koff, who has adapted well to the one-sniffed camels.
In theory, genetic deviation is unlikely to help vaccines and antiretroviral drugs to resist Sarse Cove-2 by rapidly weakening its effectiveness.
Second, the massive DNA genome in the Corona viruses actively provides an additional node in mutation modification and reconstruction, thereby increasing the probability of interspecies evolution, which serves to create new Corona viruses when conditions become appropriate.
This is supported by unique, abundant open-reading templates and coded protein functions near the end of 3% genomics.
Third, the Corona viruses switch templates randomly and repeatedly during the replication of reposi DNA through the unique “selection of versions” mechanism.
In a host that's like a mixing vessel, the sequence is frequently replaced through the replicating of the reposi DNA of the Corona virus.
High-symmetry recommencing high-length and secondary genomic DNAs may reconstruct the generation of new Corona viruses.
A special evidence of the evolution of strains has been discovered for the natural reconstruction of the HKU1-HKU1 and the HOC43-KORONA-animal viruses, as well as the severe acute respiratory syndrome virus in bats and HKU9 in bats.
The interaction of the virus with the host associated with the transmission
In addition to the three viral factors mentioned above, viral interaction with the host receiver is another major factor influencing interspecies transmission.
In this regard, we take SARS-Koff's re-establishment as a typical example, which also showed evidence of positive selection during interspecies transport incidents.
Based on a comparative analysis of isolated samples of Sars-Koff in humans and yogurt cat, Sars-Koff was thought to be undergoing rapid adaptation in various hosts, particularly through mutations in the field of protein-survivor association.
In general, the field of association of the protein to the Corona virus interacts with the cellular receiver and is selected intensively through the anti-host response of the body.
In Sars-Koff, the area of attachment of the receivers occurs in amino acids from 318 to 510 in S1, which is associated with the angiotin 2 transformer enzyme, as well as with the proximal receivers to enter the virus.
SARS-KOV's field of association is capable of identifying the NGT2-transformed enzyme receivers in various animals, including bat, yogurt cat, mouse and raccoon dog, which allows HIV transmission between species.
In fact, only 6 amino acid residues were observed that were different from human insulated viral samples and yogurt cat in receiver association, and 4 of them were found in a future chain of association pattern to interact with the oxygen-transformed enzyme receiver 2.
K479N and S487T mutations are found in the field of SARS-Koff receiver association in the yogurt cat, which can increase the probability of the reaction of the Spike protein in the human 2 enzymotenuse transformer enzyme receiver.
In other words, these two types of amino acid alternatives may be critical to human viral adaptation.
It should be noted that Sarse Cove-2 shares the same cellular receiver as Sars-Koff.
There is a 30% difference between Sarse Cove-2 and Sars-Koff in the S-1 unit of the S-protein, which implies that the probability that the protein of the S-protein is associated with the human angiotensin 2 transformer enzyme has changed.
Indeed, an ultra-cold electronic microscope study indicated that there was a higher probability of 10 to 20 times this correlation compared to that between the human angiotensine 2 conversion enzyme and the S-protein in Sars-Koff.
It is also interesting to determine whether any other kind of auxiliary receiver might be necessary for Sarse Cove-2 to move.
It's also interesting that the Human Corona-NL63 virus is also associated with the angiotensine conversion enzyme 2 but in a different part of protein s.
There are many other human corona virus receivers, such as the protein analytics of the chlorohuman virus .229E, and the acetic acid 9-O of the oc43-Corona human virus.
They may also be responsible for the successful adaptation of these Corona viruses in humans after moving between species of their animal hosts.
In addition to cellular receivers, the result of inter-species transmission of the Corona human viruses is also controlled by other dependency factors and host constraints.
The flow of these host proteins between humans and natural repository hosts of Corona viruses, such as bats, single camels and rodents, may constitute a barrier to interspecies transmission.
The Corona human viruses need to control the host's dependencies and weaken their limitations to implement successful inter-species transmission.
In this regard, molecular determinants in this important area of HIV interaction with the host remain detectable and identifiable.
The extensive and unbiased examination of the genome can be used to examine the reliability and host restraints of SARS Cove-2 using the advanced Cresper technique.
The emergence of the emerging Corona human viruses: a return to the starting point
The diversity of Corona viruses in bats offers ample opportunities for emerging Corona human viruses.
From this logic, Corona viruses in bats are a genetic pool of Corona human viruses.
In addition, the rapid mutation and genetic reconstruction are also driving the development of the Corona human virus and are important points in this process.
For example, the acquisition or loss of emerging protein encryption genes has the potential to significantly modify viral apparent patterns.
Among Sars-Koff's organizational proteins, ORF8 was thought to be important for human adaptation, where SARS-Koff was isolated from viruses in bats but was found to encode different ORF8 proteins.
It was found that the 29 properties of the removal of the sars-koff nucleotide were found in isolated strains at the beginning of the human epidemic.
This deletion has led to the division of ORF8 into ORF8a and ORF8b, and is believed to be an adaptive mutation that enhances the replacement of hosts.
In addition, Sars-Koff has a history of possible reconstruction through the strains of the Corona Alpha and Jama viruses, where a large number of small re-establishment areas have been identified in the repository DNA polymerase.
Restructured sites have also been identified in nsp9, most nsp10, and parts of nsp14.
In a similar way, research has shown that the Mirs-Koff epidemic has seen recombination between different strains, which occurred in the single camels in Saudi Arabia.
In addition to Sars-Koff and Mirs-Koff, re-installations were also observed in other Corona human viruses, where the Corona human viruses were installed with other Corona animal viruses in their non-constructive genes.
It should be noted that artificial selection can also help unintended changes in the viral genome, most of which are likely to result from the release of viruses from selective pressures, such as those caused by the host's immune system.
The loss of an ORF4 protein in the bloodline of the phenotype of the Corona-H229E virus due to the deletion of two neoclytide is an example of these effects.
Although the proper ORF4 can be observed in camel and bat viruses associated with the corp9E human virus, the chloro-alpha virus that infects the alpaca is shown to be a single neoclytide stitch, leading to the mutation of the tyre.
Last but not least, the evolution of the new Corona viruses is also driven by selective pressure in their own storage hosts.
Unsurveillance or mild symptoms were detected only when bats were infected with Corona viruses, indicating mutual adaptation of Corona viruses to bats.
She showed that the bats were properly adapted to Corona's anatomical and physiological viruses.
For example, the weak activation of the pro-inflammation response in bats has been reduced by the efficacy of the pathogens triggered by the Corona viruses.
In addition, natural killer cellular activity in bats has been suppressed by the increased rate of inhibiting NKG2/CD94 cell receiver and the low level of expression of the main tissue compatibility compound type I.
Furthermore, the high level of interactive oxygen compound species (interactive oxygen compound species) resulting from high bat metabolic activity can lead to both inhibition of the Corona virus and the effect of correction by external reponocleus enzyme, thus providing selective pressure for the development of highly pathogenic strains of the virus when a new host is infected.
Additional pathogenic strains may arise from the Corona virus by recombination, resulting in the acquisition of new proteins or protein properties to adapt to the host.
Therefore, it is no coincidence that three new Corona viruses have emerged over the past two decades.
Corona viruses are not pathogenic or cause mild symptoms in stored hosts such as bats and camels.
They copy hard without triggering a strong immune response from the host.
Here are the secrets that explain why HIV-positive people do not show symptoms and why there are acute cases of human infection.
The acute symptoms are caused mainly by hyper-in immuno-response activity and cytokin storm, where the stronger the immune response, the more severe the lung damage.
In contrast, in the case of non-stereopathological carriers, the immune response is separated from the replication of the Corona virus.
A similar immune response separation strategy may have beneficial effects on SARS Cove-2 anti-treatment.
The interferon response is particularly strong in bats.
Thus, interferon type I can be used at least in the first stage of infection with SARS Cove-2 in humans.
In addition, the activation of the CNRP3 in bats is weak.
With this mental logic, the inhibition of the CCR3 particle using the MCC950 inhibitor is useful in the CHF-19 treatment.
The emergence of Sarse Koff-2 follows the general idea that Sars-Koff and Mirs-Koff originated.
At the time it was discovered that the Corona Beta virus in the bats shared 95% neoclytide homogeneity, there was also a Corona virus in the bats that shared 96% of the neoclytide homogeneity with Sarse Cove-2.
While it was discovered that yogurt cats and other animals on the market harbour similar viruses to SARS-Koff, they did not discover the intermediate direct hosts of SARS Cove-2.
Corona Beta viruses have been detected in anatomy, which is very much homogenous with SARS Cove-2, indicating that the anatomy animals may be intermediate hosts or that the Corona Beta viruses in an anatomy have contributed genetically, leading to the final release of SARs Cove-2.
Although questions remain, there is no evidence that Sarse Cove-2 is man-made, not intentionally or by accident.
Corona viruses have returned to focus because of the recent outbreak of SARS Cove-2.
The study of Corona viruses in bats and other animals has significantly changed our idea of the importance of the origins of animal-based diseases and the animal repositories of the Corona human viruses in human transmission.
The overwhelming evidence has shown that Sars-Koff, Mirs-Koff and Sars Koff-2 all originate from the bat and have moved to humans through intermediate hosts.
Based on the fact that SARS-KOV infection originated from contact between humans and butter cats on the market, the closure of fresh product markets and the killing of yogurt cats were supposed to effectively end SARS's epidemic.
In the same mental sense, the ant-eating animals should be disposed of from fresh product markets to prevent the transmission of animal-born disease, in the light of the discovery of multiple strains of the Corona Beta viruses in the ant-eater, which are very close to Sarse Cove-2.
However, whether or not Sarse Cove-2 has moved to man, as well as no matter how it is transmitted, through ant-eating animals and other mammals, its transmission remains a topic that needs to be clarified in future research.
On the other hand, Mirs-Koff was found in the lonely camels for a long time.
These camels are an important means of transport as well as a major source of meat, milk, leather and wool products for local citizens.
It is widespread throughout the Middle East and Africa region.
It is therefore impossible to sacrifice all camels to control Mirs, as officials in China's wildlife markets have done to prevent the spread of Sars-Koff and Sars Koff-2.
In order to stop the frequent outbreaks of Meres, a comprehensive approach should be taken to the development of effective anti-Meres-Koff vaccines for camels, as well as other anti-infection measures.
Because of our inability to eradicate these viruses once and for all, new genetic patterns can emerge and cause outbreaks.
There is a variety of Corona viruses associated with animal-born diseases in wildlife.
In particular, Corona viruses are very diverse in bats that have the potential to cause animal-based diseases.
There are many opportunities for the development and recombination of the Corona viruses associated with animal-based diseases, resulting in new, more transferable and/or deadly viruses in humans in the future.
The culture of eating wildlife in some places in China should be abandoned to reduce unnecessary contact between humans and animals.
In the light of the plight of mankind caused by Sars, Mers and Coved-19, an appropriate preparedness and response plan should be developed.
The truth is that many viruses have taken their place on the planet for a very long time.
They live in their own natural reservoirs until they have a chance to spread and spread.
Although bats carry many of the characteristics that favour the spread of viruses, human contact with bats and other species of wild animals can be reduced if humans adopt a culture that obliges them to move away from them.
The continuous monitoring of mammals is a necessary measure to gain a better understanding of the environment of the Corona viruses and their natural hosts, which proves to be useful in preventing their transmission from animals to humans and preventing future appearances.
In conclusion, the best way to prevent viral diseases of animal origin is to move humans away from the environmental location of natural repositories of viruses that cause diseases of animal origin.
The mystery of the origin of the animal disease of SARS Cove-2 is still surrounded by many questions that need to be answered.
First, if bats transmit SARS Cove-2's original virus to the ant eater, it is important to know what conditions are in place for the sharing of bats and ant eater animals with similar environmental location.
Second, if bats play a more direct role in the transmission of disease to humans, then the way in which people communicate with them should be determined.
Third, if a third type of mammals serves as the true intermediate host, then it should be explained how they interact with different species, including humans, bats and ant-eating.
Finally, since many mammals, including pets, may be suspected of carrying SARS Cove-2, both monitoring and experimental infection should be conducted.
Whether the host is a bat, an ant eater or other mammals, it is expected to identify Sarse Cove-2 or the parent viruses from which it is subdivided, which are almost identical in their future natural hosts.
Continued research in this area will reveal the evolutionary path of SARS Cove-2 in animals, with important actions to prevent and combat Koide-19 in humans.
Need to update the criterion of “suspect situation” and “certain case” in the diagnosis of Koed-19 disease
On February 6, 2020, our team published a rapid guidance on the diagnosis and treatment of the infection of the new 2019 Corona virus (the new 2019), which provided our experience and included appropriate reference information to combat the pandemic worldwide.
Although Corona 2019 (Coved-19) is a new disease, our awareness and knowledge are gradually increasing based on the results of ongoing research and clinical practice; diagnostic and treatment strategies are constantly updated.
In this speech, we responded to a comment on our guidance and presented the most recent diagnostic criteria, “suspected case” and “confirmed case”, which is in accordance with the latest Coed 19 Diagnostic and Treatment Directive (version VII) of the National Health Committee of the People's Republic of China.
In December 2019, the new Corona virus spreads 2019 (the new Corona virus 2019), now officially known as the Corona virus 2019 (Coved-19) and called the virus the Corona 2 virus associated with severe acute respiratory syndrome (SARS Cove-2).
On March 11, 2020, the World Health Organization (WHO) described Koed-19 as the pandemic.
To combat SARS Cove infection, our team drafted and published a quick guidance on the Internet in the Municipal Medical Research Journal on February 06, 2020.
He's had a lot of interest since his release.
Please note that, although Koed-19 is a new disease, our awareness and knowledge is gradually increasing based on the results of ongoing research and clinical practice experiences; diagnostic and treatment strategies are also constantly updated.
For example, the Coved-19 Diagnostic and Treatment Directives of the National Health Commission of the People’s Republic of China (http://www.nhc.gov.cn), between January 16, 2020 and March 3, 2020, produced seven overall issues with some contexts fundamentally changed.
Now our guidance has been answered by a comment from Cho and others, who have made a simple proposal for grade monitoring based on clinical experience.
Their efforts have added a new guidebook to our guidance and have become a valuable reference to this pandemic all over the world.
We support their great effort and express our appreciation.
However, their work also needs to be updated in accordance with the latest Koed-19 Diagnostic and Remedial Guidelines (Type Version 7) and recent studies.
According to Release 7 (3 March 2020), confirmation of a suspected case requires a combination of any of the characteristics of the epidemiological history and two clinical appearances in order to arrive at a comprehensive analysis, or three clinical appearances in the absence of a clear epidemiological history:
Epidemiological history: 1) includes a date of travel to Wuhan City and surrounding areas, or other communities reported to have been infected with Coved-19, or to be resident with it, during the last 14 days prior to the onset of symptoms; 2) a date of communication with SARS Cove-2 cases (with positive results of DNA testing); 3) a date of communication with patients with fever or respiratory symptoms from Wuhan City, surrounding areas or other communities reported to have been infected with Coved-19 during the last 14 days before the onset of symptoms; 4) a date of communication with a group of confirmed cases (2 or more cases of fever and/or respiratory symptoms that occurred in 2 weeks in small areas, such as the home, office, classroom, etc.).
Clinical features: (1) fever and/or respiratory symptoms; (2) with properties that are demonstrated by the photographic examination of Koed-19 infection; (3) showing the total number of white blood cells at a normal, low or low level of lymphoids in the early stage of onset of infection.
The confirmed case diagnosis must be based on the suspected case involving any of the elements of the evidence of pathogens or seroprevalence reactions: (1) positive as a result of the real-time BCR test of SAR Sars Cove-2; (2) the high homogeneity of the entire viral genome sequence with the properties of the known emerging Corona viruses; (3) positive results of the IgM antigen and IgG antibodies Cove-2 tests in the serum; or the change of the IgG antigen of SARs Cove-2 from negative to positive, or that the high calibration in the recovery phase is equal to or more than four times that level in the acute phase.
In our view, the real-time PV test for DNA in the respiratory tract or blood samples was added to version II (18 January 2020) and version III (22 January 2020).
The detection of pathogens in the blood sample was added to version 4 (27 January 2020) and fifth (8 February 2020); then the blood serum reaction manual was added to version 7.
These adjustments have relied on the continuing work of researchers to arrive at the design of an ideal tool kit for rapid diagnostic DNA detection, as well as samples of respiratory behaviour, including blood samples, which has increased the availability of different samples, and supported the transfer of the positive result of the anti-genic body to confirmed case standards.
Besides, there is growing evidence to be cautious when dealing with patients with unusual symptoms and unsuspecting conditions.
The content of Cho and others' flow chart should therefore be updated, as they classified a person without clinical symptoms at a “low risk” level.
The grade monitoring system also needs to be validated in practice and additional clinical studies.
In conclusion, we hope to find more direct evidence and invite readers to provide us with their comments.
To diagnose the “suspect situation” and the “confirmed situation”, we call for tracking and adherence to the latest instructions issued by home countries.
Our team will also update our guidance in time to provide assistance.
Bangladesh has five new deaths due to Koed-19 disease, the highest daily rate
Yesterday, Bangladesh confirmed five new deaths due to Koed-19 on that day.
This is the highest number of deaths in one day due to the virus.
The Institute of Epidemiology, Disease Control and Research (IEDCR) in Bangladesh reported that, as of yesterday, 114 registered cases of infection were active and 33 were home-based.
17 deaths were recorded.
In an online press conference, the Director of the Institute of Epidemiology, Disease Control and Research, Dr. Mirjadi Sabrina Flora, stated that deaths involved four males and one females.
According to Dr. Mirjadi, there were two cases aged over 60, two cases aged between 51 and 60, and one case aged between 41 and 50.
She also said that two deaths were from Dhaka.
On March 11, the World Health Organization (WHO) declared Koed-19 a pandemic.
An official of the Anatolia Agency Hospital, a local news agency, said that one of the deceased was Jalal Saif Rahman, director of the Bengali Anti-Corruption Commission, who was being cared for at the Kuwait Mytry Hospital.
The Minister of Road Transport and Bridges of Bangladesh, Obaid Qader, said in an online video statement on Saturday that public transportation would stop longer than originally planned, until next Saturday.
The disruption of public transport began on March 26 and was scheduled to end on Saturday, April 4.
The transport of commodities, namely, medical products, fuel and food, is still permitted.
The first cases of Koed-19 disease were recorded in Bangladesh on 8 March, for two people who returned from Italy, as well as for one of their wives.
All three have already recovered by March 19th.
The number of SARS Cove-2 virus infections has exceeded 2 million worldwide.
Data from Johns Hopkins University on Thursday indicated that the total number of cases of the Corona virus causing acute acute respiratory syndrome (SARS Cove II) had exceeded 1 million cases worldwide.
Koed-19's disease from the Corona virus caused at least 52,000 deaths.
This dangerous development came on the same day that Malawi confirmed the first cases of the Corona virus, and the first associated death was recorded in Zambia.
North Korea claimed that, as of Thursday, it was one of the few countries still free from the Corona virus.
The World Health Organization (WHO) reported 1051635 confirmed cases, as of yesterday, of which 79332 were in the 24 hours preceding 10 a.m. Central European time (800 hours UTC) on April 4.
More than 244,000 cases of the Corona virus were recorded in the United States of America, with at least 5,900 deaths.
CBS News, according to Johns Hopkins University data, reported more than 1,000 deaths in the United States on Wednesday caused by the Corona virus infection.
States around the world have announced stricter measures to prevent the spread of the disease.
On Thursday, Mr. Sergei Sobianin, Mayor of Moscow, announced that the closure of the city would be extended until 1 May.
At the national level, President Vladimir Putin announced that he would continue to pay salaries to Russians without going to work until April 30.
The Portuguese Parliament voted to extend the state of national emergency for 15 days; the vote was approved by 215 votes, with 10 abstentions, and one vote was opposed.
Saudi Arabia extended the curfew in the cities of Makkah al-Mukarramah and Al-Munwar to all day; it was from 3 p.m. to 6 a.m. only.
Thailand plans to impose a curfew from 10 p.m. to 4 a.m.
The Governor of Ohio, Mr. Mike de Wayne, announced that the state extended the stay at home until 1 May.
Australia ' s stores reduce the purchase limit for toilet paper per transaction
The Australian Store Series Wallworths and Collins on Saturday and Sunday evenings emphasized the restrictions on buying toilet paper to reduce it to two rolls of Wallworth and one roll of Coles for each transaction in all branches nationwide.
I also identified Aldi's stores for one roll, on Monday.
These purchase restrictions have been published as messages at the pay-as-you-go points in the supermarket chains and on their Facebook pages.
It has been reported that buyers stored them because of concerns about Koed-19 disease in case people need self-segregation.
Wallworths approved restrictions on the delivery of toilet paper to homes on Wednesday to become one roll per purchase order.
These changes followed previous restrictions adopted by Wallworths on March 4 and Coles on March 5 by allowing the purchase of only four rolls per transaction.
In its press release of March 8, Coles reported that despite the application of the four-roll restrictions, “many stores still sell all their belongings within one hour of receipt”, the application was described as “unprecedented”, as did Aldi's stores in a Facebook publication on Tuesday as “unexpected.”
Sales increased "big" last week, according to the spokesman for Wallworth.
The Costco store in Canberra last week also determined that the amount allowed to be purchased was two rolls.
In order to alleviate the shortage, Coles stores asked suppliers for larger rolls and increased delivery frequency, and Wallworth stores asked for additional stock, while Aldi stores made available their stock for special offers scheduled for Wednesday early.
Russell Zimmerman, Executive Director of the Australian Retailer Association, said that retailers were trying to increase inventory, but local council restrictions on the timing of delivery of trucks made it difficult.
Production costs are expected to rise, as suppliers try to meet demand, with few private offers.
On Tuesday, Aldi's stores announced that as a result of the early availability of stock, some stores would not be able to provide a special Wednesday offer.
According to Dr. Gary Mortimer, retailer at Queensland Technical University, in a report on News.com.au, stores are filled every night.
He pointed out that toilet paper was a large commodity, resulting in a reduction in stock in numbers, and when sold in full, large empty spaces were left on the shelves, reinforcing the feeling of shortages.
According to ABC News, Russell Zimmerman stated: “Coles and Wallworth stores have a view that if there are many goods on the shelves and if products such as latrine rolls and sterilizers can be [purchased] and supplied in large quantities, it may reduce panic.”
Last Wednesday, Wu Gives a Crab, which produces recycled toilet paper, reported that its stock was depleted.
According to the News.com.au report, Kimberly-Clark, which produces Klinx toilet paper, and Solaris Pepper, which produces Sorbent napkins, confirmed that they are working 24/7 to continue providing their products.
Domain.com, a real estate site, indicated that some real estate sellers provided free toilet paper to the first bidder at auctions in Melbourne, while fewer auctions were held because buyers stopped working on the long weekend of Labor Day.
The Thursday edition of NT News, a daily publication in Darwin City, featured eight-page advertisements that could be cut and used as toilet paper.
Stores initially hesitated about imposing restrictions, according to a report released by ABC Australia on March 3, where they stated that they had no plans to impose restrictions on purchases.
Russell Zimmerman added that there was also a great demand for other products, including muzzles, sterilizers, dried goods, handwashing and flour.
Similarly, outside Australia, it was observed on Sunday evening that a British online store named Okado identified the purchases of toilet paper by Andrés with two canisters of 12 rolls.
The World Health Organization (WHO) announces that Koed-19 is a pandemic.
On Wednesday, the World Health Organization (WHO) announced that the constant outbreak of Coffid-19 - a disease caused by the Corona virus associated with severe acute respiratory syndrome (SARS) and known in short as SARS Cove-2 - reached the epidemic level.
Although the word “emergence” refers only to the extent of the disease, and not to the seriousness of specific situations, the World Health Organization (WHO) has noted the need for Governments to take the necessary measures:
“All countries can still change the course of the epidemic.
The Director-General of the World Health Organization (WHO), Tidros Adham Gebresus, said: “If countries discover, test, treat, isolate, track and mobilize people to confront.”
"We are all very concerned by the alarming levels of proliferation and danger as well as alarming levels of inaction."
According to Dr. Tom Frieden, the Director of the Centers for Disease Control and Prevention in the United States, this pandemic is “unprecedented”.
In statements published by CNN in February, it was stated, "No other respiratory virus has been traced from the beginning of its appearance to the ongoing global spread, other than influenza."
Gebresus expressed a similar view: “We have never been exposed to an epidemic caused by a Corona virus”.
Keep going: "We've never seen a pandemic that can be controlled at the same time."
The new situation is described as a pandemic following the decision of the World Health Organization (WHO) in January to declare the outbreak a public health emergency of international concern.
The director of the National Institute of Sensitivity and Infectious Diseases of the United States, Dr. Anthony Fawchi, said about the outbreak: “The bottom line is that things are going to get worse.”
The Associated Press reported that there were at least 126,000 Koped-19 cases worldwide on Thursday, and more than 4,600 deaths.
The Corona 2019-20 virus pandemic is an ongoing pandemic for the Corona 2019 virus (covid-19), caused by the Corona 2 virus associated with severe acute respiratory syndrome (SARS Cove-2).
The outbreak was identified in Wuhan, China, in December 2019, and declared a public health emergency of international concern on January 30, 2020, recognized as a pandemic on March 11, 2020.
As of April 10, 2020, approximately 1.61 million cases of Coved-19 were reported in 210 countries and territories, resulting in approximately 97,000 deaths.
About 364,000 people recovered.
The mortality rate in China was estimated at 4%, while worldwide it ranged from 13.04% in Algeria to 0.08% in New Zealand.
Common symptoms include fever, cough and respiratory distress.
Symptoms may include pneumonia and acute respiratory stress syndrome.
The period between exposure and symptoms is usually about five days, but may range from two to fourteen days.
There's no known vaccine or specific anti-virus treatment.
Essential treatment is supportive and symptomatic. Recommended preventive measures include handwashing, oral coughing, maintenance of interpersonal spacing, monitoring and self-insulation of suspected injured persons.
Authorities around the world respond to this threat by imposing travel restrictions, quarantine, curfews, workplace hazard controls and closure of installations.
This pandemic has led to severe global social and economic disruption, postponement or cancellation of sporting, religious, political and cultural events, and a large-scale shortage of supplies exacerbated by the panic of procurement.
Schools and universities were closed either nationally or locally in 193 countries, affecting about 99.4 percent of the world’s students.
Misinformation about HIV has spread on the Internet, and there have been incidents of xenophobia and discrimination against Chinese, other people of East and South-East Asian origin and appearance, and other regions where significant HIV infections have occurred.
As a result of reduced travel and closure rates for heavy industries, there has been a reduction in air pollution and carbon emissions.
The health authorities of Wuhan city (the capital of Hobei Province) in China reported a series of cases of pneumonia for an unknown reason on 31 December 2019, and the investigation began in early January 2020.
Cases are often associated with the Wuhan Seafood Market for wholesale sale, so the virus is believed to have an animal origin.
The virus that caused the outbreak is known as SARS Cove-2, a newly detected virus closely associated with the Corona viruses in bats, the Corona viruses in the abrasions of ants, and SARS-Koff. It was later discovered that the first person with symptoms was infected on December 1, 2019, and this person had no clear contact with the humid market group that was later discovered.
Of the early caseload reported in December 2019, two thirds were found to be market-related.
On March 13, 2020, an unverified report published by the morning newspaper South China indicated that a case dating back to November 17, 2019, 55 years old from Hobei County, was probably the first. On February 26, 2020, the World Health Organization (WHO) reported that, although new cases in China had decreased, they had suddenly risen in Italy, Iran, and South Korea, with new cases outside China exceeding new ones for the first time.
There may be a significant underreporting of cases, especially among those with mild symptoms.
By February 26, relatively few cases were reported among young people, with 19-year-olds and under-ages accounting for 2.4% of cases worldwide. The UK’s chief scientific adviser, Patrick Valance, estimated that 60% of British people needed to be infected before effective herd resistance could be performed.
Cases indicate the number of people who have been tested for Koed-19, and their injuries have been confirmed in accordance with official protocols.
As of March 23, no country had tested for more than 3% of its population, and many countries had formal policies not to test only for those with mild symptoms, such as Italy, the Netherlands, Spain and Switzerland.
A study published on March 16 found that, as of January 23, an estimated 86% of the cases of Coved-19 had not been detected in China, and that these unrecorded injuries were the source of infection for 79% of the recorded cases.
A statistical analysis published on 30 March estimated that the number of casualties in Italy was much higher than recorded cases.
Preliminary estimates of the basic reproduction number (R0) of the C4-19 ranged from 1.4 to 2.4.
A study published by the Center for Disease Control and Prevention in the United States concluded that it could be 5.7.
Most people with code 19 are recovering.
For those who do not recover, the period from deteriorating symptoms to death takes between 6 and 41 days, the most common being 14 days.
As of April 10, 2020, Coved-19 caused about 97,000 deaths.
As of February 5, around 80% of deaths in China were concentrated in those over 60 years of age, and 75% had pre-existing illnesses, including cardiovascular diseases and diabetes. Official statistics on deaths due to the Koed-19 pandemic generally refer to those who have been found to have been affected by a code of ethics.
The real number of deaths from Koped-19 may be much higher, because it may not include people who die without testing - for example, at home, in nursing homes, etc.
Partial data in Italy revealed that the number of excess deaths during the pandemic exceeded the official number of Koved deaths recorded by a factor of 4.5x.
The spokesman for CDC in the United States admitted that “we know that [the number of reported deaths] reflects a lower estimate than reality,” a statement supported by narrative reports indicating inaccuracy in the United States. Such underestimation occurs in pandemics; such as the H1N1 influenza pandemic in 2009, was the first confirmed death in Wuhan on January 9, 2020.
The first death out of mainland China was on February 1 in the Philippines, and the first death out of Asia was in France on February 14.
By February 28, more than a dozen deaths were recorded outside mainland China in Iran, South Korea and Italy.
By March 13, more than 40 countries and territories reported deaths, on all continents except Antarctica. Many measures are commonly used to determine mortality.
These figures vary by region and over time, and are influenced by the scale of the tests, the quality of the health-care system, treatment options and time taken from the onset of the outbreak, and population characteristics such as age, sex, and public health. The mortality/injury ratio reflects the number of deaths divided by the number of cases diagnosed over a given period of time.
Based on Johns Hopkins University statistics, the global mortality to injury ratio is 6.0% (97,039/1,617,204), as of April 10, 2020.
The number varies by region.
In China, estimates of mortality from injuries have fallen from 17.3% (for those with symptoms from 1 to 10 January 2020) to 0.7% (for those with symptoms after 1 February 2020). Other measures indicate the CFR mortality rate, which reflects the percentage of people who died from disease, and the IFR mortality rate, which reflects the percentage of those who were infected (and those who were not) who died from disease.
These statistics do not have a time frame and follow a specific population from injury to fate.
A number of academics have tried to calculate these numbers for certain population groups.
The Oxford University Evidence-based Medicine Centre estimates that the overall pandemic mortality rate is between 0.1% and 0.39%.
The higher estimate of this range is consistent with the results of the first random Koved-19 test in Germany, and with a statistical study analysing the impact of the test on the estimates of the mortality rate.
WHO is emphasizing the possibility of controlling the pandemic.
The peak of the outbreak and its maximum duration are uncertain and may vary according to location.
Massage Bonnie of Pennsylvania State University stated: “The outbreak of infectious diseases that are left uncontrollable usually peaks and then begins to decline when the disease does not find available hosts.
But it's almost impossible to arrive at any logical expectation now about the timing of that.”
China's chief medical adviser Chong Nanshan stated that “it could end by June” if all countries could be motivated to follow WHO advice on measures to stop the spread of the virus.
On March 17, Adam Kocharsky of the London School of Hygiene and Heat Medicine stated that Sarse Cove-2 would be “perhaps deployed for a year or two”.
According to a study carried out by the Imperial College of London under the supervision of the world, Neil Ferguson, we will need to rely on physical spacing and other measures “to make a vaccine available (perhaps 18 months or more).
William Shafner from Vanderbilt University said, "I think this Corona virus is unlikely to disappear completely -- because it can be easily transmitted," and it may turn into a seasonal disease -- so that it returns every year."
The fierceness of return will depend on collective immunity and the extent of transformation.
Coed-19's symptoms may be relatively undefined and may not show symptoms for the infected.
The two most common displays are fever (88%) and dry cough (68%).
The less common symptoms include fatigue, respiratory pygmies, loss of smell, shortness of breath, muscle and joint pain, throat inflammation, headaches, chills, vomiting, blood blowing, diarrhoea, or glaucoma. The World Health Organization (WHO) asserts that approximately one in six people is severely ill and has difficulty breathing.
The CDC in the US has limited the emergency symptoms to respiratory difficulties, persistent chest pain or pressure, sudden disarray, difficulty waking up, and facial or lip glaucoma. Immediate medical attention is advised if these symptoms appear.
Some of the infected, who do not have clinical symptoms but whose injuries are confirmed by the results of the tests, may not show symptoms, so specialists have advised that mixed persons must be closely monitored and examined to eliminate the injury.
Chinese estimates of the proportion of cases without symptoms range from a few to 44%.
The usual period of custody (the period between injury and symptoms) ranges from 1 to 14 days; it is often 5 days. As an example of confusion, it was estimated that 30% of those who initially lost a sense of smell and then recently fell to 15%.
Some details of how the disease spread are still under consideration.
It is believed that the disease spreads mainly during mixing or through spatter at coughing, sneezing or speaking; when mixing at a distance of 1 to 2 metres (3 to 6 feet).
Studies have shown that coughing without mouth cover may result in spraying scattered from 4.5 metres (15 feet) to 8.2 metres (27 feet).
Some believe that the virus may also be transmitted by long-term air spray, which may be produced in the course of speech. It may also produce respiratory spray during exhalation, including when speaking, although the virus is not generally airborne.
Sprays may fall on the mouths or noses of persons close to them or be inhaled into the lungs.
Some medical procedures, such as CBR intubation and CPR, may cause respiratory discharges to be released in the form of spray and thus cause spread by air.
It may also spread when a person touches a contaminated surface, including skin, and then touches his eyes, nose, or mouth.
Although there are concerns about the possibility of spreading from faeces to mouth, that risk is thought to be limited.
China’s government denied the possibility of Sarse Koff-2’s transmission from faeces to mouth. The virus is more infected during the first three days of symptoms, although it may spread before any symptoms appear and during later stages of the disease.
People were diagnosed with the disease up to three days prior to the onset of the symptoms, indicating the possibility of transmission prior to the onset of severe symptoms.
There are few reports of cases without laboratory confirmed symptoms, but no symptoms were identified by some countries during Mixture Tracking Surveys.
The European Center for Disease Control and Prevention (ECCDC) asserts that although there is some ambiguity about how easily the disease spreads, one person can be infected from two to three people in general. The virus stays on the surface from hours to days.
Specifically, the virus was found to be detectable for up to three days on plastic (polyproplin) and stainless steel type 304, one day on cardboard and up to four hours on copper.
However, this is different based on humidity and temperature.
There is no evidence that animals can transmit the virus to humans, yet British authorities recommend washing hands after mixing animals, as is the case with other surfaces that may have been touched by an injured person.
The Corona 2 virus associated with severe acute respiratory syndrome (SARS Cove 2) is an emerging virus, with three people suffering from pneumonia being first isolated from a combination of cases of acute respiratory disease in Wuhan.
Outside the human body, home soap kills the virus, where its protective membrane is melted. SARS Cove-2 is closely linked to the original SARS Cove virus.
It's believed to have animal origin.
Genetic analysis revealed that the Corona virus is genetically associated with the Corona Beta virus race, and is sub-gendered by the Corona Sarby virus (b strain) in addition to two strains of bats.
96% of the entire genome matches other samples of Corona viruses in bats.
In February 2020, Chinese researchers discovered only one difference in amino acids in certain parts of genome sequences between the viruses originating from the ant eater and the viruses originating from humans.
A comparison of the entire genome to date has resulted in the discovery of at most 92% of genetic material sharing between the Corona virus for the ant-eating reagent and the SARS Cove-2 virus, a percentage that is insufficient to prove that the ant-eating agent is the intermediate provider of the virus.
HIV infection can be diagnosed temporarily on the basis of symptoms, although the confirmation is ultimately made by the reaction of the PVT-BCR to the infected aberrations or computerized CAT scans.
A study in the city of Wuhan comparing the reaction of polymoraz with the computerized CT showed that computational CT was more sensitive than the reaction of polymorphisms, although less accurate, with many of its imaging properties interfering with cases of pneumonia and other pathological stages.
As of March 2020, the American Radiogram College recommends that "no computerized C.O.T. can be used to detect C.O.D.19 or considered as a preliminary diagnosis test."
The World Health Organization (WHO) published several protocols for testing the SARS Cove-2 DNA for the first time on January 17.
The test uses the reaction of the RRT-PCR in real time.
Tests can be performed on respiratory or blood samples.
Results are generally available within a few hours to days.
This test is generally carried out by a nasal float, and can also be used by a socket of throat. A number of laboratories and companies develop serum tests that detect antibodies.
As of April 6, 2020, none of them proved sufficiently accurate to be widely used.
A serum test developed by Célix obtained a credit for emergency use in the United States only in certified laboratories.
The characteristics of radiophotograms and CT for people with symptoms of disease include an asymmetric endocrine such as a classified glass mist and a disoriented crystal leachate.
The Italian Radiation Society collects an international online database of confirmed case imaging results.
Radiography without a PV reaction is a limited procedure for the detection of Koed-19; it overlaps with other diseases such as gland virus infection.
A major study in China compared the results of the computerized chest C.T. with the chain reaction of polymoraz and demonstrated that although the C.T. is less accurate in terms of evidence of injury, it is faster and more sensitive, suggesting that it be considered a screening tool in endemic areas.
Artificial I.I.-based aberrant neuronets have been developed to detect the properties of HIV imaging in both radiophotograms and computerized CAT scans.
Strategies to prevent transmission include maintaining good hygiene in general, washing hands, avoiding eye, nose or mouth contact with unwashed hands, and using a napkin at cough or sneeze and then disposing of it by throwing it directly into the trash.
Those already infected were advised to wear a medical mask in public.
Physical separation is also recommended to prevent transmission. Several governments have banned unnecessary travel to and from countries and regions affected by the outbreak or advised against travel.
However, HIV has reached the stage of spreading throughout society in large parts of the world.
This means that the virus is spreading within communities, and some individuals do not know where or how they have been infected. Health-care providers, who care for a potentially infected person, are advised to use reasonable measures, precautions for mixing and eye protection.
The use by Governments of GPS data for tracking raised privacy concerns, with Amnesty International and more than 100 other organizations issuing a statement demanding that such surveillance be restricted.
Many mobile phone applications were designed or launched for voluntary use. As of April 7, 2020, more than a dozen specialized groups worked to find privacy solutions, such as the use of Bluetooth to record user proximity to other mobile phones.
Users then receive a message if they approach a person who has been proven to have been infected with code 19. Misperceptions about how to prevent infection are promoted; for example, the washing of nose and gargoyles with mouthwash is not a viable solution.
There is as yet no vaccine for code 19, although many organizations have been working on the production of a vaccine.
Handwashing is recommended to prevent the spread of the disease.
The Center for Disease Control and Prevention recommends that people wash their hands repeatedly with soap and water for at least 20 seconds, especially after going to the toilet or when the dirtyness appears on the hands, before eating, and after emptying the nose, cough or sneeze.
That's because home soap kills the virus outside the body; it destroys its protective membrane.
The CDC also recommended using a hand sterilizer containing at least 60% alcohol when water and soap are not available.
WHO advises people to avoid touching eyes, nose or mouth with unwashed hands.
The surfaces can be disinfected using several disinfectants (within one minute of putting disinfectant on the stainless steel surface), including ethanol 62–71%, isopropanol 50–100%, sodium hypochlorite 0.1%, hydrogen peroxide 0.5%, and iodopovidone 0.2–7.5%.
There are other disinfectants, such as benzalconium chloride and chlorhexane glucon, with less efficacy.
The Center for Disease Control and Prevention recommends that if a person is suspected or confirmed to have been injured in an office or care centre, all places such as offices, bathrooms, common spaces and common electronic devices such as tablets, touch screens, keyboards, remote control devices and ATMs used by the patient must be sterilized.
Health organizations have recommended that people cover their mouths and noses when coughing or sneezing either by bending the elbow and putting it in front of the mouth and nose or by using paper towels and immediately disposing of any napkins.
It is recommended that those likely to be injured should use medical masks, as wearing the mask reduces the size of the respiratory spray and the distance it travels when dispersed due to speech, sneeze and cough.
WHO issued instructions on when and how to use masks.
According to Stephen Griffin, a virus scientist at Leeds University, “the mask of [persons'] desire to touch their faces can be reduced, which is a major source of infection if the hands are not properly cleaned.” Those who take care of potentially infected people are recommended with masks.
The World Health Organization (WHO) recommended that healthy people wear masks only if they are exposed to high risk of infection, such as those who take care of people with code 19, although it also recognizes that wearing masks may help people avoid touching their faces.
Several countries have begun to encourage ordinary people to wear face masks.
The U.S. Center for Disease Control and Prevention recommends wearing a non-medical face mask made of cloth. China specifically recommended the use of disposable medical masks, especially in the case of persons mixed (1 m (3 feet) or less) directly.
Hong Kong recommends wearing a medical mask when using public transport or staying in crowded places.
Thai health officials encourage individuals to make fabric masks at home and wash them daily.
The Czech Republic and Slovakia prohibited going out to public places without wearing a mask or covering the nose and mouth.
On March 16, Vietnam asked everyone to wear masks when going to public places to protect themselves and others.
The Austrian government has required anyone entering a grocery store to wear a mask.
Israel asked the entire population to wear masks in public places.
Taiwan, which produces 10 million masks a day since mid-March, demanded that passengers on trains and inter-city buses wear masks on April 1.
Panama made it necessary to wear a face mask when exiting, while also recommending the manufacture of face masks at home for those who cannot buy face masks.
Face masks are also widely used in Japan, South Korea, Malaysia and Singapore.
Social separation (also known as physical separation) includes infection control measures aimed at slowing the spread of the disease by minimizing individual mixing.
Roads include quarantine; travel restrictions; closure of schools, workplaces, playgrounds, theatres or shopping malls.
Individuals can apply social separation methods by staying at home, limiting travel, avoiding crowded areas, exchanging greetings without contact, and physically separating from others.
Many governments currently impose or recommend social spacing in areas affected by the outbreak.
The maximum size of assemblies recommended by U.S. government bodies and health organizations has been reduced rapidly from 250 persons (if there is no outbreak of code 19 in the region) to 50 people, and 10 people later.
Older persons and those suffering from chronic diseases such as diabetes, heart disease, respiratory diseases, hypertension, and weak immune systems are at increased risk of serious illness and complications and have been advised by CDC to stay at home as much as possible in areas of inter-community disease. In late March 2020, WHO and other health agencies began replacing the term “social distance” with “physical distance,” to show that the goal is to reduce physical contact while maintaining social connections, either hypothetically or at a distance.
The use of the term “social distance” has led to the suggestion that people should be in complete social isolation, rather than encouraging them to communicate with others through alternative means. Some authorities have issued sexual health directives for use during the pandemic.
This includes recommendations to only have sex with a person with whom she lives who is not HIV-positive or suffering from symptoms.
Self-segregation is recommended at home for those affected by Coved-19 and those suspected of being infected.
Health agencies have issued detailed instructions for proper self-segregation, which have been imposed or recommended by several governments for all people living in affected areas.
The strongest self-immolation instructions have been issued to those most at risk.
Those who have dealt with a person with a code 19 and those who have recently travelled to a country or area where the infection is widely transmitted are advised to be quarantined for 14 days from another time are likely to be exposed.
The strategies for controlling the spread of the disease are containment or inhibition and reduction of proliferation.
Containment is applied in the early stages of the outbreak and is aimed at tracking and isolating the infected as well as introducing other infection control measures and vaccines to prevent the disease from spreading to the rest of the population.
When the spread of the disease is no longer possible, efforts are then directed to the mitigation phase: measures are taken to slow the spread and mitigate its effects on the health-care system and society.
A combination of both containment and mitigation measures can be undertaken at the same time.
Restriction requires more stringent measures to reverse the pandemic by reducing the number of essential reproductions to less than 1. Part of the management of the spread of infectious diseases is trying to reduce the peak of the epidemic, as the epidemic curve is known.
This reduces the risk of straining health services and saves more time for the development of vaccines and treatments.
Non-pharmacological interventions that could address the outbreak include personal protective measures, such as hand-cleaning, wearing masks, and self-censorship; community actions aimed at physical separation such as closing schools and cancelling major gatherings; community solidarity to encourage acceptance and participation in such interventions; as well as environmental measures such as cleaning roofs. More stringent measures have been taken to contain the outbreak in China as soon as the severity of the outbreak becomes apparent, such as the introduction of quarantine to entire cities and a strict travel ban.
Other countries have also taken a variety of measures aimed at reducing the spread of the virus.
South Korea introduced group tests and local quarantine and issued casualty movement alerts.
Singapore provided financial support to self-insolved patients and imposed substantial fines on those who did not.
Taiwan has increased the production of masks and criminalized the acquisition of medical supplies. Simulations by the United Kingdom and the United States show that mitigating (not halting the spread of the epidemic) and curbing (reverse the growth of the epidemic) face significant challenges.
Optimal mitigation policies may reduce the peak demand for health care by 2/3 and mortality by half, but still lead to hundreds of thousands of deaths and strain on health systems.
Restriction may be preferable but it must be maintained as long as the virus spreads to humans (or until the vaccine becomes available, if first, because on the other hand the transition is rapidly reversed when the measures are relaxed.
Long-term intervention to curb the pandemic causes social and economic costs.
There are no specific anti-viral drugs approved for code 19, but development efforts are ongoing, including testing of existing medicines.
The use of treatment medications for unprescribed colds, fluids and rest may help to alleviate symptoms.
Depending on the severity, oxygen, intravenous fluids and respiratory support may be required.
The use of stimulants may exacerbate the results.
Many pre-approved compounds are subject to testing for the CF-19 treatment.
The World Health Organization (WHO) also stated that some “traditional and home-based treatments” could provide mitigation of the symptoms caused by Sars Coved-19.
Increased capacity and adaptation of health-care centres to provide for the needs of Koed-19 patients have been described by WHO as essential measures to respond to the outbreak.
The European Center for Disease Control and Prevention and the WHO European Regional Office have issued guidelines for hospitals and primary health-care services for the transfer of resources at multiple levels, including the concentration of laboratory services on the Coffid-19 test, the elimination of optional procedures where possible, the separation and isolation of persons with Cuvide-19, increased intensive care capacities through staff training and the increase in the number of artificial respirators and beds available.
There are multiple theories about where the first case arose (so-called patient 0).
The first known case of the new Corona virus may date back to December 1, 2019 in Wuhan, Hobei, China.
Within a month, the number of cases of the Corona virus in Hobei has gradually increased.
This was often linked to Wuhan’s wholesale seafood market, which also sells live animals, and one theory is that the virus came from one of these species of animals; in other words, it has animal origin. A group with pneumonia was observed for an unknown reason on December 26, and was handled by Dr. Zhang Jishian at Hobei County Hospital, which reported to Jianghan Bohan Center for Disease Control on December 27.
On December 30, a group of doctors at Wuhan Central Hospital warned their colleagues of the Corona-like SARS virus.
Police alerted eight of these doctors, including Lee Win Liang, to spread false rumours, and another female doctor, Iven, was reprimanded by her superiors to trigger the alarm.
The Wuhan Municipal Health Committee subsequently issued a public notice on 31 December and informed the World Health Organization.
Sufficient cases of unknown pneumonia were reported to Wuhan’s health authorities, prompting the investigation to begin in early January. During the early stages of the outbreak, the number of cases doubled almost every seven and a half days.
In early and mid-January 2020, the virus was transmitted to other Chinese provinces, with the help of movements during China’s New Year’s New Year and as a transport hub and the intersection point of the main railway lines.
On January 20, China reported approximately 140 new cases in one day, including two in Beijing and one in Schengen.
As of March 26, the US exceeded China and Italy with the highest number of confirmed cases in the world. As of April 9, 2020, more than 1.61 million cases were reported worldwide, with more than 97,000 people dead and more than 364,000 recovered.
About 200 countries and territories registered at least one case.
Owing to the pandemic in Europe, many countries in the Schengen region have restricted freedom of movement and imposed border controls.
National responses included containment measures, such as quarantine (known as house orders, shelter orders, or closure) and curfews. As of April 2, nearly 300 million people, or about 90% of the population, have been subjected to a form of closure in the US, more than 50 million have been closed in the Philippines, 59 million have been closed in South Africa, and 1.3 billion have been closed in India.
On March 26, 1.7 billion people around the world were subjected to one form of closure, which rose to 2.6 billion two days later - about one third of the world's population.
The first confirmed case of Coved-19 dates back to December 1, 2019 in Wuhan; an unconfirmed report indicates that the first case was on November 17.
Dr. Zhang Jishian observed a series of unknown cases of pneumonia on 26 December, and subsequently reported to her hospital at Jianghan Bohan Center for Disease Control on 27 December.
An initial genetic test of patients' samples on December 27, 2019 indicated the presence of a Corona virus resembling SARS.
On December 31, the Wuhan Municipal Health Commission issued a public notice.
Reported to the World Health Organization on the same day.
With these notices, the doctors in Wuhan were warned by the police about “dissemination of rumours” about the outbreak.
The China National Health Commission initially claimed that there was no “clear evidence” of a person-to-person move.
In late January, the Chinese government launched a radical campaign that Chinese Communist Party Secretary-General Xi Jinping later described as a “people's war” to contain the spread of the virus.
In what was described as the “largest quarantine in human history”, a health cordon was declared on 23 January to stop travel to and from Wuhan, extending to a total of 15 cities in Hobei, affecting some 57 million people.
Private vehicles were banned in the city.
New Chinese New Year celebrations (25 January) were cancelled in several places.
Authorities have also announced the construction of a temporary hospital, Houshinchan Hospital, which was completed within 10 days.
Another hospital was built after that, Leishchinshan Hospital, to deal with the additional patients.
In addition to newly established hospitals, China has also transformed 14 other facilities in Wuhan, such as conference centres and playgrounds, into temporary hospitals. On January 26, the government took other measures to contain the Koped-19 outbreak, including health announcements for travellers and the extension of spring holiday.
Universities and schools have also been closed throughout the country.
The Hong Kong and Macao regions have taken several measures, particularly with regard to schools and universities.
Remote action measures have been taken in several Chinese regions.
Travel restrictions were imposed both inside and outside Hoby.
Public transportation has been modified, and museums have been temporarily closed throughout China.
Public movement has been controlled in several cities, and it is estimated that 760 million people (more than half of the population) have been subjected to one form of exit restriction. After the outbreak became global in March, Chinese authorities took firm action to prevent the virus from being “bringed” from other countries.
For example, Beijing imposed a 14-day mandatory quarantine on all those returning to the city from other countries. On March 23, one case was transferred locally to mainland China over the past five days, by a passenger returning to Guanzu from Istanbul.
On March 24, 2020, Chinese State Council President Li Qi Chiang announced that the prevalence of locally transmitted infections and control of outbreaks in China had declined.
Travel restrictions in Hobei were eased on the same day, with the exception of Wuhan, two months after the closure was imposed. On March 26, 2020, the Chinese Ministry of Foreign Affairs announced that visa or residence permit holders would be suspended from March 28 onwards, with no specific details as to when this policy would end.
Those wishing to enter China will have to apply for visas at Chinese embassies or consulates.
The Chinese government urged companies and factories to resume work on March 30, and introduced a corporate monetary stimulus package. The State Council announced a three-minute day of silence on April 4 at 10:00, in conjunction with the Qing Ming Festival, although the central government demanded that families show respect online for physical distance to avoid the Coffid-19 outbreak again.
Koffid-19 was confirmed to have moved from China to South Korea on January 20, 2020.
The National Health Agency announced a significant increase in confirmed cases on February 20, largely due to a gathering in Daeju of a new religious movement known as the Shinchiungi Church of Jesus.
Shinchiungi's followers visiting Daeju from Wuhan were suspected of being the source of the outbreak.
As of February 22, 1,261 people, or about 13% of the 9.336 church followers, reported symptoms. South Korea declared the highest level of preparedness on February 23, 2020.
On February 28, more than 2,000 confirmed cases were reported in Korea, where they rose to 3,150 on February 29.
All South Korean military bases were quarantined after tests confirmed that three soldiers were infected with the virus.
South Korea applied a program that was considered the largest and best organized in the world to screen people for the virus, isolate any infected person, and track and quarantine them.
The screening methods included mandatory personal reporting of symptoms by new international arrivals via mobile phone application, HIV testing of people in their cars, with test results available the following day, and increased testing capabilities to 20,000 people per day.
South Korea’s program represents a success in controlling the outbreak despite not applying quarantine to entire cities. South Korea’s society was initially divided around President Moon Jae In’s response to the crisis.
Many Koreans have signed petitions either demanding the isolation of Mon, claiming the Government ' s ill-treatment of the outbreak, or applauding its response.
On March 23, it was announced that South Korea had the lowest total cases in one day in four weeks.
On March 29, it was reported that, as of April 1, all new arrivals from abroad would be quarantined for two weeks.
According to media reports on April 1, South Korea received requests from 121 different countries to help test the virus.
Iran reported the first confirmed case of SARS-KOV-2 virus on February 19, in Qom, where two people died later that same day, according to the Ministry of Health and Medical Education.
Early actions announced by the Government included the cancellation of concerts and other cultural and sports events, Friday prayers, and the closure of universities, institutes of higher education and schools.
Iran has allocated five trillion rials to fight the virus.
President Hassan Rouhani stated on February 26, 2020 that there was no plan to quarantine areas affected by the outbreak, and only individuals would be isolated.
Plans to limit inter-city travel were announced in March, although heavy inter-city traffic continued before the Persian New Year of Noroz.
Shia shrines remained open to pilgrims until March 16, 2020. During February, Iran became the centre of the spread of the virus after China.
In the midst of allegations of Iran’s cover-up of the extent of the outbreak, more than a dozen countries tracked Iran’s returns from February 28, suggesting that the extent of the outbreak might exceed the 388 reported by the Iranian government to date.
The Iranian Parliament was closed, and 23 of its 290 members were reported HIV positive on March 3.
On March 12, Human Rights Watch demanded the unconditional release of human rights defenders detained for peaceful opposition, as well as the provisional release of qualified prisoners.
She stated that there was a high risk of HIV spreading in closed settings such as detention centres, which also lacked adequate medical care.
On March 15, the Iranian government announced 100 deaths in one day, the highest number recorded in the country since the outbreak began.
At least 12 Iranian politicians and current and former government officials died of the disease by 17 March.
By March 23, Iran was recording 50 new infections per hour, and one death every ten minutes due to the Corona virus.
According to a WHO official, the number of cases in Iran may be five times higher than that reported.
It is also believed that US sanctions against Iran may affect the financial capacity of the state to respond to the spread of the virus.
The Office of the United Nations High Commissioner for Human Rights (OHCHR) has called for the alleviation of economic sanctions against the States most affected by this pandemic, including Iran.
The outbreak in Italy was confirmed on January 31, when the tests of Sars-Koff-2 Chinese tourists in Rome were positive.
The situation has begun to increase sharply, prompting the Italian Government to suspend all flights to and from China and declare a state of emergency.
An unrelated set of Koed-19 cases was subsequently discovered, starting with 16 confirmed cases in Lombardia on February 21. On February 22, the cabinet announced a new decree-law to contain the outbreak, including quarantine for more than 50,000 people from 11 different municipalities in northern Italy.
Prime Minister Giuseppe Conté said, "There will be no access to or exit from the outbreak areas.
On March 4, the Italian government ordered the complete closure of all schools and universities throughout the country, where deaths in Italy amounted to 100.
All major sports events, including first-class football tournaments, were scheduled to be held behind closed doors until April, but on March 9, all sports events were suspended for at least one month.
On March 11, Prime Minister Conté ordered the suspension of almost all business activities, with the exception of supermarkets and pharmacies. On March 6, the Italian College of Anesthesiology, Resuscitation, Recovery, and Intensive Care (SIARTI) published medical ethics recommendations regarding screening protocols that could be used.
On March 19, Italy surpassed China as the country with the highest number of deaths associated with the Corona virus in the world after 3,405 deaths were reported.
On March 22, Russia sent nine military aircraft carrying medical equipment to Italy.
As of 5 April, confirmed cases amounted to 128,948, 15,887 deaths and 21,815 cases recovered in Italy, most of which were in the Lombardia region.
The CNN report noted that a combination of a large number of older persons and the inability to test all people living with HIV to date in Italy may have contributed to high mortality.
The UK's response to the virus first emerged as the most lax among the affected countries, and as of March 18, 2020, the British government did not impose any form of social separation or comprehensive quarantine measures on its citizens.
As a result, the government has been criticized for its perceived lack of speed and intensity in responding to public fears. On March 16, Prime Minister Boris Johnson issued a statement advising that unnecessary travel or social mixage should be avoided, suggesting that people should work from home as much as possible and avoid a number of places, such as bars, restaurants, and theatres.
On March 20, the government announced that it would shut down all recreational facilities such as bars and gymnasiums as soon as possible, and promised to pay up to 80% of workers’ wages up to £2,500 a month to reduce unemployment at a time of crisis. On March 23, the prime minister announced stricter social-diversion measures, prohibiting gatherings for more than two people and restricting travel and activity outside the home except as strictly necessary.
In contrast to previous measures, these restrictions have been implemented by the police through the issuance of fines and the separation of assemblies.
Most companies have been ordered to close, with the exception of “necessary” businesses, including supermarkets, pharmacies, banks, hardware stores, petrol stations and garages.
On January 20, the first known case of the Coffide-19 virus was confirmed in Washington, D.C., for a returning man from Wuhan on January 15.
The White House task force to combat the Corona virus was set up on January 29.
On January 31, Trump announced a public health emergency and imposed entry restrictions on passengers from China.
On January 28, 2020, the Center for Disease Control - the leading public health institute of the U.S. government - announced that it had developed its own test set.
Although this was done, the United States slowed down the test, blocking the real extent of the outbreak at the time.
The test was marred by a flawed test group produced by the federal government in February, the lack of federal government approval of non-governmental test groups (by academia, companies, hospitals) until the end of February, and the restrictive criteria for people to qualify for the test until early March (the doctor’s order was subsequently required).
By February 27, Washington Post reported that less than 4,000 tests had been conducted in the United States.
By March 13th, the Atlantic reported that less than 14,000 tests had been conducted.
On March 22, Associated Press stated: “Many people who suffered symptoms and had a doctor’s order waited hours or days to be tested.”
Schools in Seattle cancelled on March 3, and by mid-March, schools were closed across the country. On March 6, 2020, the US was informed of the forecast of the impact of the new Corona virus on the country by epidemiologists at Imperial College London University.
On the same day, President Trump signed the Corona HIV Preparedness and Response Supplemental Funds Act, which provided emergency funding to federal agencies in the amount of $8.3 billion to respond to the outbreak.
Companies have imposed travel restrictions on employees, cancelled conferences, and urged employees to work from home.
Sports activities and seasons were cancelled. On March 11, Trump announced travel restrictions for most of Europe, except the United Kingdom, for 30 days, starting from March 13.
The following day, restrictions were extended to the United Kingdom and Ireland.
On March 13, he declared a national emergency, which allowed federal funds to be used to respond to the crisis.
As of March 15, many companies have closed down or reduced their working hours across the United States in an effort to reduce the spread of the virus.
By March 17, the epidemic was confirmed in all 50 states and in Columbia County. On March 23, 10,700 cases of the Corona virus were reported in New York City, more than the total number of cases in South Korea.
On March 25, the governor said that social spacing seemed to have been a success, with estimates showing a deceleration from 2.0 days to 4.7 days.
As of March 28, 32,308 confirmed cases were in New York City, and 672 people died of the virus. On March 26, more confirmed cases of the Corona virus were reported in the United States than in any other country in the world, including China and Italy.
According to media reports on March 30, US President Trump decided to extend the social separation directives until April 30.
On the same day, USNS Comfort, a hospital ship with about 1,000 beds, docked in New York.
On April 3, the United States recorded 884 deaths due to the Corona virus within 24 hours.
The White House was criticized for underestimating the threat and controlling the circulation of news by directing health officials and scientists to coordinate public statements and publications on HIV with Vice President Mike Pence's office.
Trump's management of the crisis has not been universally welcomed as it has created widespread polarization among the parties.
Some U.S. officials and commentators criticized the U.S. reliance on importing essential materials, including essential medical supplies, from China.
Analysis of air travel patterns was used to map and forecast patterns of proliferation and was published in the Journal of Travel Medicine in mid-January 2020.
Based on information from the International Air Transport Association 2018, Bangkok, Hong Kong, Tokyo and Taipei had the largest number of passengers from Wuhan.
Dubai, Sydney and Melbourne were also reported as famous destinations for travelers from Wuhan.
Bali was reported to be the least able of more than 20 popular destinations in terms of preparedness, while cities in Australia were considered to be the most capable. Australia released its Emergency Response Plan for the emerging Corona virus (Coved-19) on February 7.
Much remained to be discovered about the Coffid-19 virus, and Australia would place emphasis on border control and communications in its response to the pandemic.
On March 21, a biosecurity emergency was declared in Australia.
Given the impact of effective quarantine on Wuhan and Hobei, several countries planned to evacuate their nationals and diplomatic personnel from the region, primarily through charter flights from their home countries, with permits provided by the Chinese authorities.
Canada, the United States, Japan, India, Sri Lanka, Australia, France, Argentina, Germany and Thailand were among the first countries to plan the evacuation of their nationals.
Pakistan has announced that none of its citizens will be released from China.
On February 7, Brazil evacuated 34 Brazilians or family members in addition to four Poles, one Chinese person, and an Indian citizen.
Polish, Chinese and Indian citizens landed from the plane in Poland, where the Brazilian aircraft stopped before resuming its route to Brazil.
Brazilian citizens who went to Wuhan were isolated at a military base near Brasilia.
On the same day, 215 Canadians (176 from the first plane and 39 from a second aircraft chartered by the U.S. government) were evacuated from Wuhan to Canadian Forces Base Trenton to be isolated for two weeks.
On February 11, another plane carrying 185 Canadians landed from Wuhan at Canadian Forces Base Trenton.
Australian authorities evacuated 277 citizens on 3 and 4 February to the Christmas Island Detention Centre, which was reused as a quarantine facility, where they stayed for 14 days.
A New Zealand evacuation flight arrived in Auckland on February 5, and its passengers (including people from Australia and the Pacific) were isolated at a naval base in Wangbarawa, Northern Auckland.
On February 15, the United States announced that it would clear the Americans on board the cruise ship Diamond Prince.
On February 21, a plane landed in Trenton, Ontario, carrying 129 Canadian passengers evacuated from the Diamond Prince.
In early March, the Indian government began to evacuate its citizens from Iran. On March 14, a South African airliner aircraft chartered by the South African government returned 112 South Africans.
A pre-departure medical examination was conducted, and four southern Africans with signs of the Corona virus were left to mitigate risks.
South Africans whose test results were only negative were returned.
The results of the test proved that South Africans, including flight crews, pilots, hotel staff, police and soldiers involved in the humanitarian mission, all of whom, as a precautionary measure, had been under surveillance and quarantine at Ranch Resort for 14 days, were not infected.
On March 20, the United States began to partially withdraw its troops from Iraq due to the pandemic.
On February 5, the Chinese Foreign Ministry reported that 21 countries (including White Russia, Pakistan, Trinidad and Tobago, Egypt and Iran) had sent assistance to China.
Some Chinese students at American universities joined forces to send assistance to China’s HIV-infected areas, and a joint group in the greater Chicago region reportedly sent 50,000 N95 masks to hospitals in Hoby County on January 30. The Humanitarian Aid Organization, in coordination with FedEx, sent 200,000 face masks with other personal protective equipment, including gloves and hospital workers’ clothing, via the Air Emergency Bridge, to Wuhan Union Hospital by January 30.
On February 5, Bill and Melinda Gates pledged $100 million to the World Health Organization (WHO) to fund vaccine research and treatment efforts, along with the protection of “at-risk populations in Africa and South Asia.”
Interaction reported that the Chinese government donated 200,000 masks to the Philippines on February 6, after Senator Richard Gordon shipped 3.16 million masks to Wuhan.
On February 19, the Singapore Red Cross announced that it would send $2.26 million in aid to China.
Japan donated 1 million face masks, Turkey sent medical equipment, Russia sent more than 13 tons of medical supplies to Wuhan, Malaysia pledged 18 million medical gloves to China, Germany delivered several medical supplies, including 10,000 protective suits, and the United States donated 17.8 tons of medical supplies to China, and promised further financial support of $100 million to affected countries. After the cases settled in China, the country was sending assistance to various countries affected by the pandemic.
In March, China, Cuba and Russia sent medical supplies and experts to help Italy deal with the Corona virus outbreak.
Businessman Jack Ma sent 1.1 million test kits to Addis Ababa, Ethiopia, 6 million face masks, and 60,000 protective suits distributed by the African Union.
Later, 5,000 test kits, 100,000 face masks and five respirators were sent to Panama.
The Netherlands, Spain, Turkey, Georgia, and the Czech Republic expressed concern about masks and test kits manufactured in China.
For example, Spain withdrew 58,000 test kits for China’s Corona virus, which was only 30% accurate, and in the meantime, the Netherlands returned 600,000 face masks made in China that were defective.
Belgium returned 100,000 unusable facial masks thought to be from China, but they were actually from Colombia.
On the other hand, parts of Latin America and Africa welcomed Chinese aid well. On April 2, the World Bank launched emergency support operations for developing countries.
WHO commended the efforts of the Chinese authorities in managing and containing the epidemic.
The World Health Organization (WHO) noted the difference between the SARS outbreak between 2002 and 2004, where Chinese authorities were accused of being blinded by prevention and containment efforts, and the current crisis, where the central government provided “systematic updates to avoid panic before the New Year's lunar holiday”.
On 23 January, in response to the central authorities’ decision to implement a transport ban in Wuhan, the representative of the World Health Organization (WHO) observed that while that was “not certainly a recommendation from WHO”, it was “a very important indicator of the commitment to contain the epidemic in its highly concentrated place” and described it as “unprecedented in the history of public health.” On 30 January, after confirming the transition from one person to another outside China, and the increase in the number of cases in other countries, WHO declared the outbreak as a public health emergency of international concern (BHIAC), the sixth public health emergency of international concern since this action was first introduced during the 2009 pig flu pandemic.
The Director-General of the World Health Organization (WHO) said that considering the outbreak as a public health emergency of international concern was due to “the global risk of proliferation, especially in low- and middle-income countries that do not have strong health systems.
In response to the implementation of the travel restrictions, Tedrus stated that “there is no reason to take measures that unduly interfere with international travel and trade” and that “WHO does not recommend a reduction in trade and mobility”.
On February 5, WHO appealed to the international community to contribute $675 million to strategic funds in low-income countries, noting the urgent need to support those countries that “do not have systems to detect people living with HIV, even if they appear”.
Tedrus also made statements declaring that “our strength is measured by the power of our weakest person” and urging the international community to “invest today or pay a large price later.” On February 11, the World Health Organization (WHO) called the disease, at a press conference, Coved-19.
On the same day, Tedus stated that the Secretary-General of the United Nations, Antonio Guterres, had agreed to provide “the full response potential of the United Nations system”.
As a result, a United Nations crisis management team has been set up, allowing for the coordination of the United Nations response as a whole, and WHO will allow it to “focus on the health response while the experience of other agencies can be used to learn about the social, economic and broader development impacts of the outbreak”.
On 14 February, a WHO-led joint mission team was prepared with China to provide international and WHO experts on the ground in China to assist in local governance and to assess “the severity and the mobility of the disease” by hosting workshops and meetings with key national institutions, and conducting field visits to assess “the impact of response activities at the provincial and city levels, including in urban and rural areas.” On 25 February, WHO announced that “the world needs to do more to prepare for the potential Corona virus pandemic,” noting that it was too early to describe it as a pandemic, but that countries should be “in a state of preparedness.”
In response to the outbreak in Iran, WHO sent a joint mission team there to assess the situation. On February 28, WHO officials said that the global assessment of the Corona virus threat would rise from “high” to “very high,” its highest level of warning and risk assessment.
Mike Ryan, Executive Director of the WHO Health Emergency Programme, warned in a statement that "This is a real test for every government on Earth: so we have to be prepared.
This virus may be on its way and you must prepare for it, and urge that the right response measures be taken that can help the world avoid “worst”.
Ryan also stated that current data do not justify public health officials declaring the disease as a global pandemic, saying that such a declaration means that “we basically accept that every human being on this planet will be exposed to this virus.”
On March 11, the World Health Organization (WHO) announced the outbreak of a virus by Corona as a pandemic.
The Director-General said that “WHO is deeply concerned about alarming levels of prevalence and severity, and alarming levels of inaction.” WHO faced severe criticism of what is perceived to be an inadequate treatment of the pandemic, including delays in declaring a public health emergency, and classifying the virus as a pandemic.
The violent reactions included a petition for resignation from WHO Director-General Tedros Adham, signed by 733,000 people as of April 6.
On March 26, 2020, dozens of United Nations human rights experts affirmed respect for the rights of everyone during the Koved-19 pandemic.
The Group of Experts stated that everyone has the right to life-saving interventions and that the Government has this responsibility.
The group stressed that lack of resources or health insurance should not justify discrimination against a particular group.
Experts emphasized that everyone has the right to health, including persons with disabilities, persons belonging to minorities, older persons, internally displaced persons, homeless persons, those living in extremely poor conditions, detainees, as well as refugees and other non-specific groups requiring government support.
Intergovernmental organizations are addressing the economic and social impacts of the Koed-19 crisis.
OECD has launched a platform to provide comprehensive and timely information on policy responses in countries around the world, as well as views and advice.
A policy to strengthen health systems and the global economy to address the effects of closures and travel restrictions includes a digital hub that tracks State policy and aims to help countries learn from each other and facilitate a coordinated global response to the Corona virus.
The Chinese government was criticized by the United States, British Cabinet Secretary Michael Goff, and Edward Paulonaro, the son of Brazil's President Geir Paulonaro, for her handling of the pandemic, which began in Hobei Province of China.
A number of CCP directors were dismissed at a cross-sectoral level for dealing with quarantine efforts in central China, indicating dissatisfaction with the political institution ' s response to the outbreak in those areas.
Some commentators believe that this move was aimed at protecting the Secretary General of the Chinese Communist Party Xi Jinping from public resentment over the spread of the Corona virus.
Some Chinese officials, for example Chow Lijian, rejected an earlier admission that the Corona virus outbreak had begun in Wuhan, in favour of the conspiracy theories claimed by the United States or Italy with regard to the Coffid-19 virus.
The US administration Donald Trump described the Corona virus as “a Chinese virus” or “the Wuhan virus”, saying that China “has imposed a blackout on the news that has exacerbated the virus, which is now a global pandemic”, which has been criticized by some critics for being racist and dissociated from its management’s failure to contain the disease.”
Dili Best obtained a U.S. government telegram reviewing the communication scheme with clear sources in the NSC, with a strategy stating that "everything is about China.
We were asked to seek out and disseminate these messages in any way possible, including press conferences and television appearances. “News sources such as Politico, Vorin Polisi and Bloomberg claimed that China’s efforts to send assistance to HIV-affected countries were part of my advocacy for global impact.
European Union foreign policy official Josep Burrell warned of a “geographic political component that includes a struggle for influence through the practice of circumvention and policies of generosity”.
Burrell also said, “China is strongly pushing the message that, unlike the United States, it is a responsible and reliable partner.”
China also called on the United States to lift its sanctions against Syria, Venezuela and Iran, while reportedly sending aid to the last two countries.
U.S. sanctions banned Jack's donation of 100,000 masks to Cuba on April 3.
The U.S. authorities were also accused of transferring aid to other countries to their countries.
There were mask disputes reported between other States, such as Germany, Austria, Switzerland, the Czech Republic and Italy.
In addition, Turkey has seized hundreds of respirators destined for Spain.
In early March, the Italian government criticized the EU's lack of solidarity with Italy affected by the Corona virus.
Mauritsu Masari, Ambassador of Italy to the European Union, said that “China has responded only bilaterally.
Sure, that's not a good sign of European solidarity."
On March 22, following a telephone call to Italian Prime Minister Giuseppe Conté, Russian President Vladimir Putin prepared the Russian army to send military paramedics, special clearance vehicles and other medical equipment to Italy.
The Italian newspaper La Stampa reported a "high-level political source" that 80 percent of Russia's aid was "nil or low-interest to Italy."
The source accused Russia of initiating a remarkable “geographical and diplomatic” attack.
The President of Lombardy, Atilio Fontana, and the Italian Minister for Foreign Affairs, Luigi de Mayo, denied the press reports and expressed their gratitude.
Russia also sent a cargo plane carrying medical aid to the United States.
The spokesman for the Kremlin, Dmitry Piskov, said that when he helped his American colleagues, Putin assumed that when American manufacturers of medical equipment and materials were activated again, they would also be able to repay the favor if necessary.
NATO's planned military exercises “Guns 2020” will take place in Germany, Poland, and the Baltic States, the largest NATO military exercise since the end of the Cold War on a small scale.
“In the current public-health crisis, training endangers not only the lives of troops from the US and many participating European countries, but also the populations of the countries in which they are to be conducted.” The Iranian government has been severely affected by the virus, with about 20 MPs and 15 other former or current political figures infected.
Iranian President Hassan Rouhani wrote a public letter to world leaders on March 14, 2020 requesting help, saying that his country was struggling to fight the spread of the disease because of the lack of access to international markets as a result of US sanctions against Iran. The outbreak triggered calls for the US to adopt common social policies in other rich countries, including comprehensive health care, comprehensive childcare, paid family leave, and higher levels of public health funding.
Political analysts predicted that this could negatively affect Donald Trump’s chances of re-election in the 2020 presidential election. Diplomatic relations between Japan and South Korea deteriorated because of the pandemic.
South Korea criticized Japan's “mysterious and negative quarantine efforts” after Japan announced that anyone from South Korea would be quarantined at certain government sites for two weeks.
South Korean society was initially polarized by President Moon Jae In’s response to the crisis.
Many Koreans signed petitions calling for the isolation of Mon because they claimed that the Government had misaddressed the outbreak or praised its response. The pandemic allowed States to pass emergency legislation in response.
Some commentators have expressed concerns that this might allow Governments to tighten their control over power.
In Hungary, Parliament voted to allow Prime Minister Victor Urban to rule by decree indefinitely, to suspend Parliament as well as elections and to punish those who disseminated false information about the virus and the Government's handling of the crisis.
The outbreak of the Corona virus has been blamed, which has led to numerous shortages of supplies due to the increasing global use of equipment to combat outbreaks, panic procurement and the disruption of plant and logistics operations.
The U.S. Food and Drug Administration issued warnings about the shortage of medicines and medical equipment due to increased consumer demand and the interruption of suppliers.
Many areas have also seen panic purchasing, which has resulted in shelves being free of basic groceries such as food, toilet paper and water bottles, causing shortages of supplies.
In particular, the technology industry warned against delays in shipments of electronic goods.
According to WHO Director-General Tedros Adham, the demand for personal protection tools has increased 100 times.
This demand caused prices to rise by up to 20 times the normal price and also caused medical supplies to be delayed by four to six months.
It also caused a shortage of personal protection tools worldwide, warning WHO that this would put health workers at risk.
In Australia, the pandemic provided a new opportunity for Diego shoppers to sell Australian products in China.
The activity led to a shortage of infant milk in some supermarkets and was subsequently banned by the Australian government. Despite the widespread occurrence of Koed-19 cases in northern Italy and the Wuhan region, followed by high demand for food products, the two regions survived severe food shortages.
The actions taken by China and Italy to combat the stockpiling and illicit trade of vital products have successfully avoided the severe food shortage expected in Europe as well as in North America.
Northern Italy has not experienced a significant decline in its large agricultural production, but prices may rise according to the expectations of industry representatives.
Food shelves were temporarily empty, even in Wuhan City, while Chinese government officials released stocks of pork to ensure adequate nutrition for the population.
Similar laws exist in Italy that require food producers to keep stocks for such emergencies.
China felt the damage to the global economy: according to a media report on March 16, China’s economy was severely affected in the first two months of 2020 by government actions to reduce the spread of the virus, and retail sales fell by 20.5%.
Given that mainland China is a major economic and industrial centre, the spread of the virus has been observed as a major destabilizing threat to the stability of the global economy.
Agatha Demares expected the economic intelligence unit to keep the markets volatile until a clearer picture of the potential results was seen.
In January 2020, some analysts estimated that the economic implications of the epidemic for global growth could exceed those of the SARS outbreak between 2002 and 2004.
An expert at Washington University in St. Louis estimated that the global supply chain was affected by over $300 billion, which could last until two years.
The Organization of the Petroleum Exporting Countries (OPEC) has reportedly experienced “disorder” after a sharp drop in oil prices due to falling demand from China.
The global stock markets declined on February 24 due to a significant rise in the number of Koed-19 cases outside mainland China.
On February 27, because of growing concerns about the spread of the Corona virus, several United States equity indicators, including NASDAK-100, Standard and Poor's 500, recorded the largest decline since 2008, with Dow Jones' industrial average falling 1.191 points, the largest decline in a single day since the 2007–08 financial crisis.
The three indicators ended the week with a drop of more than 10%.
On February 28, Scoob Rattings GMBH confirmed China's sovereign credit rating, but maintained negative expectations.
The stocks retreated again due to fears of the Corona virus, the largest decline on March 16.
Many believe that economic stagnation is possible.
Economist Mohamed Al-Erian commended the timely emergency measures taken by central banks and States.
Central banks respond faster than they did with the 2008 financial collapse.
Tourism is one of the sectors most affected by the travel ban, the closure of public places, including tourist attractions, and the warning of governments to travel around the world.
As a result, many airlines cancelled their flights because of low demand, including British Airlines, East China Airlines, and Kantis, while the British Regional Air Company, Flype.
The impact on the airline industry was at an unprecedented level.
Many train stations and ferry ports have been closed as well.
The epidemic coincided with the spring season known as Chunyun, the main season of travel associated with the New Chinese New Year's holiday.
National and regional governments have cancelled a number of large crowds, including New Year’s celebrations, while private companies have also closed their shops independently and tourist attractions such as Disneyland Hong Kong and Disneyland Shanghai.
Many events of the new lunar year and tourist attractions have been closed to prevent large gatherings, including the forbidden city of Beijing and traditional temple exhibitions.
In 24 of the 31 provinces, and in municipalities and regions of China, the authorities extended New Year’s holiday until February 10, and instructed most workplaces not to reopen until that date.
These regions account for 80% of the country’s gross domestic product (GDP) and 90% of exports.
Hong Kong has raised the response to infectious diseases to the highest level and declared a state of emergency, closing schools until March and cancelling New Year’s celebrations. The global retail sector has been affected by reduced shop hours or temporary closures.
Visits to retailers in Europe and Latin America decreased by 40%.
North American and Middle East retailers have seen a decline between 50% and 60%.
This also led to a 33% to 43% drop in pedestrian traffic to shopping malls in March compared to February.
Market-centre operators around the world have imposed additional measures, such as increased hygiene, the installation of thermal scanners to check shoppers’ temperature, and the elimination of efficiencies. According to ECLAC, the recession caused by the pandemic could leave 14 to 22 million people in extreme poverty in Latin America more than they would have experienced without the pandemic.
In January and February 2020, during the peak of the epidemic in Wuhan, about 5 million people in China lost their jobs.
Many of China’s 300 million rural migrant workers were trapped in their homes in the interior, or in Hoby County. In March 2020, more than 10 million Americans lost their jobs and applied for government assistance.
India’s closure has left tens of millions of Indian migrant workers (paid through daily wages) unemployed. The Angus Red Institute survey found that 44% of Canadian households have suffered from unemployment.
During the second half of March, 4 million French workers applied for temporary unemployment benefits and 1 million British workers applied for a comprehensive credit scheme. Nearly half a million companies in Germany sent their workers on government-supported short-term business plans known as Korzarbet.
France and Britain have adopted a German short-term employment compensation scheme.
The theatre arts and cultural heritage sectors have been deeply affected by the pandemic, affecting the operations of organizations as well as individuals - workers and independents - globally.
Institutions in the arts and culture sector have sought to support their mission (mostly funded by the government) to provide access to the cultural heritage of society, to preserve the safety of their employees and the public, and to support artists as much as possible.
By March 2020, in varying degrees worldwide, museums, libraries, performance places and other cultural institutions were closed indefinitely with their exhibitions, events and presentations cancelled or postponed.
In response, there have been intensive efforts to provide alternative services through digital platforms. Among other recent accelerating consequences of the disease, religious services, major sports events, and other social events, such as concerts, concerts, technology conferences, and fashion shows, have been abolished.
The Vatican announced the cancellation of the Holy Week celebrations in Rome, which take place during the last week of Christian repentance in Grand fast.
Many congregations have recommended that older Christians stay at home instead of attending Mass on Sundays; some churches have made church services available on radio, on-line or on television, while others worship without leaving their cars.
With the closure of the Roman Catholic diocese in Rome of its churches and church churches, and the evacuation of St. Peter’s Square from Christian pilgrims, other religious bodies have also abolished limited public services and gatherings in churches, mosques, synagogues, temples and gordwara.
The Iranian Ministry of Health announced the cancellation of Friday prayers in the areas affected by the outbreak, after which the shrines were closed, while Saudi Arabia banned the entry of foreign pilgrims as well as their inhabitants into the Holy Places in Mecca and the city.
This pandemic has caused the biggest disruption in the world's sports calendar since World War II.
Most major sporting events have been cancelled or postponed, including the European Champions League 2019-20, the Super League 2019-20, the European League 2020, the American Professional Basketball League season 2019-20, and the National Hockey League 2019-20.
The outbreak disrupted plans for the 2020 Summer Olympics, which were scheduled to begin at the end of July, and the International Olympic Committee announced on March 24 that the event “will be rescheduled beyond 2020 but no later than the summer of 2021.” Gambling clubs and other playgrounds around the world were closed and direct gambling tournaments postponed or cancelled.
This has led many gamblers to move to play online, with many online gambling sites reporting significant increases in new subscription rates. The entertainment industry has also been affected, with different musical groups suspended or concert tours cancelled.
A lot of big theaters like those on Broadway hung up on all the shows, too.
Some artists have discovered ways to continue to produce and participate online as an alternative to traditional direct performances, such as live broadcasts or the creation of online “celebrations” for artists to perform, distribute and disseminate their work.
On the Internet, many Internet features of the Corona virus have spread, with many turning into humor and entertainment under uncertainty.
Since the Coved-19 outbreak, extreme prejudice, xenophobia and racism have been observed against persons of Chinese origin and East Asians, and against persons from hot spots in Europe, the United States and other countries.
Incidents of fear, suspicion and hostility have been observed in many countries, particularly in Europe, East Asia, North America and the Asia-Pacific region.
Reports released in February (when the majority of cases were still confined to China) documented racist sentiments expressed by various groups around the world towards the Chinese that they deserved the virus or received what was allegedly justified punishment.
Anti-China sentiment has also risen in some African countries.
Many residents of Wuhan and Hobei reported discrimination on the basis of their territorial origin.
There was support for Chinese both online and offline, and for those living in HIV-affected areas.
After the outbreak in new hot spots, people from Italy, the first country in Europe to experience a severe outbreak of Coved-19, may be skeptical and xenophobic. Citizens in countries including Malaysia, New Zealand, Singapore, and South Korea initially signed petitions for pressure to prevent Chinese from entering their country in an effort to stop the disease.
In Japan, Hashtag ChinseDuntComtoJapan #Twitter.
Chinese as well as other Asians in the United Kingdom and the United States reported increasing levels of racial violations, as well as attacks.
American President Donald Trump faced criticism of the reference to the Corona virus as a “Chinese virus”, a term that critics considered racist and hostile to Chinese.
Protesters in Ukraine attacked buses carrying Ukrainians and foreigners evacuated from Wuhan to Novi Sanzari.
Students from north-east India, which shares the border with China, and who study in major Indian cities, have been harassed by the outbreak of the Corona virus.
The head of BJP unit in West Bengal state, Dileep Ghosh, stated that the Chinese had destroyed nature and “that is why God avenged them.”
The Chinese consulate in Kolkata subsequently condemned these statements, calling them “wrong.” In China, the pandemic led to increased xenophobia and racism against non-Chinese residents, where foreigners were described as “foreign garbage” and targeted for “disposal.”
Many newspapers have removed co-payed pages of some or all of their coverage of the Corona virus.
Many scientific publishers made available scientific papers on the outbreak for open access.
Some scientists chose to share their results quickly on pre-print servers such as BioRxiv.
Emerging infectious diseases – infectious diseases are often the causes of emerging diseases, emerging in terms of their scale of spread or mode of transmission.
Globalization and disease — an overview of globalization and disease transmission
List of Epidemics and Pandemics — List of Deaths from Infectious Diseases
Wildlife smuggling and zoo-based diseases — health risks associated with trade in exotic wildlife
The laboratory test of 2019 (Coved-19) and the associated SARS-Koff-2 virus includes methods of detecting the presence of the virus, where antibodies produced in response to infection are identified.
RTPR confirms the presence of viruses in the samples, where the reposi DNA of the Corona virus is detected.
This test is accurate and designed only for the detection of the SARS-K-2 DNA.
It is used to confirm very recent or active infections.
Antibodies detection is used for diagnosis and population control.
Antibody tests show the number of people infected, including those whose symptoms were too simple to report or who did not show symptoms.
The precise mortality rate of the disease and the level of collective immunity among the population can be determined based on the results of this test.
Due to limited testing, no country had reliable data on HIV prevalence in its population in March 2020.
On March 23, no country examined more than 3% of its population, and there is a significant variation in the number of tests conducted by different countries.
This discrepancy is also likely to have a significant impact on reported mortality rates, which are likely to be significantly overstated in some countries.
With the use of the instant ulomerase reaction (RTT-PCR), respiratory samples obtained in various ways, including nasal bulimia or phlegm samples, can be tested.
Results are generally available within a few hours to two days.
RTBC, which is performed using throat scans, is used only in the first week of the disease.
The virus may disappear from the throat afterwards while continuing to reproduce in the lungs.
For injured persons who are examined in the second week, a sample of deep airways can be taken instead by catheter or coughing (pistol).
One of the early PCR tests was created in Chartette in Berlin in January 2020 using the instant polymerase reaction (RRT-PCR) and formed the basis for 250,000 test kits distributed by the World Health Organization (WHO).
The UK also developed a test on January 23, 2020. The South Korean company Kogenebiotech developed a PowerChek Coronavirus detection set for SARS-2 suitable for safe clinical use and based on PCR on January 28, 2020.
In China, BGI Group was one of the first companies to obtain emergency use approval from China's National Department of Medical Products for a SARS-2 detection crew based on BCR. In the United States, CDCs distribute their own diagnostic plate of the new 2019 Corona virus (the new 2019) based on the instant RTCR public health laboratories.
One of the three genetic tests in the old versions of the test kits produced inconclusive results due to defective detectors, and one of the testing stages was delayed in the CDC in Atlanta; this led to the completion of an average of less than 100 samples per day successfully throughout February 2020.
Tests using two components were not trusted until February 28, 2020, and government and local laboratories were not allowed to start testing until then.
The Department of Food and Medicine approved the testing under the emergency authorization for use. Commercial laboratories in the United States began testing in early March 2020.
On March 5, 2020, Lab Corp announced the availability of the Koped-19 test across the country based on RTPR.
Similarly, Quest Diagenostex made the Koed-19 test available across the country as of March 9, 2020.
No quantitative restrictions have been announced; the sampling and processing process must be conducted in accordance with the requirements of the CDC.
In Russia, the State Research Centre for Virus Science and Biotechnology (CSRB) created and produced Victor's Koved-19 test.
On February 11, 2020, the Federal Health-Care Surveillance Service registered the test. On March 12, 2020, Mayo Clinek reportedly developed a Koped-19 infection test.
On March 19, 2020, the Food and Drug Administration granted emergency use permission (EUA) to Abbott Laboratories to conduct a test on the M2000 Abbott system; previously, the Food and Drug Administration granted a similar permit to Lab Corp and Thermo Fisher Scientific.
On March 21, 2020, Sieph received a similar emergency permission from the Food and Drug Administration for a test that takes about 45 minutes.
The FDA has agreed to a test using the technique of amplification of equal-temperature DNA instead of PCR.
Since this does not require a series of consecutive temperature cycles, this method can show positive results in less than five minutes and negative results in 13 minutes.
There are currently about 18,000 of these machines in the US and Taiwan expects to increase manufacturing to conduct 50,000 tests a day. Taiwan is also developing a test using a single-fertile antibody linked specifically to the new Corona virus protein, hoping to achieve results within 15 to 20 minutes, such as a rapid flu test.
A review of studies in March 2020 concluded that “breast X-rays of low diagnostic value in early stages, while results of CT [computed CT] may be clear even before symptoms appear”.
The usual properties that appear in the computerized C.T. include binary, polyclaminated glass floats with an oceanic, asymmetric and backward distribution.
Underside prevalence is developing, showing irregular patches and intensifying as the disease develops.
A study in the city of Wuhan comparing PCR to computerized CT with respect to the origin of the current pandemic indicated that CT was more sensitive than PCR, although less accurate, with many of its photographic properties interfering with cases of pneumonia and other pathological stages.
In March 2020, the American Radiography College recommends “no use of computerized C.T. to detect C.O.D.19 or consider it a preliminary diagnosis test.” In March 2020, C.C.C. recommends the use of P.C.R. for the initial examination.
Part of the immune response to infection involves the production of antibodies, including IgM and IgG.
They can be used to detect individual injuries during a period starting from 7 days or after symptoms have emerged, to determine immune potential, and in the case of population surveillance, analyses can be performed at CLT or by testing the clinical care point (BCT).
The highly functional automated systems in many clinical laboratories will be able to perform these analyses, but their availability will depend on the production rate of each system.
For central laboratories, a single sample of ambient blood cells is usually used, although successive samples can be used to follow up on the immune response.
For the clinical care point test, a single blood sample is usually withdrawn by perforating the skin.
Unlike PCR, the extraction step does not need to be taken before testing. On March 26, 2020, the Food and Drug Administration identified 29 entities that gave notice to the agency in accordance with the requirements and thus were able to distribute their antibody tests.
On April 7, 2020, the Food and Drug Department adopted only one test under its emergency authorization. In late March 2020, Euroimmun Medical Laboratory Diagnastics and Epitope Diagnastics obtained European credits for their test crews, which can detect IgG and IgA antibodies in blood samples.
The test completes several hundred samples within hours and is therefore much faster than the conventional PCR analysis of viral reposi DNA.
The antibodies can often be detected 14 days after the infection began. In April, the UK discovered that the antibody test crews it purchased were not good enough to use.
Hong Kong has developed a plan whereby patients suspected of being infected can stay at home, “give the emergency department a sample tube to patients,” spit in the tube, and repeat it to get the test results after a simple period of time. The British National Health Services has announced that it is experimenting with a plan to test suspected cases at home, thereby excluding the risk of infection from the injured when they come to hospital or the need to sterilize the used ambulance.
In Germany, on 2 March, the National Association of Legal Health Insurance Physicians stated that it had been able to conduct about 12,000 out-patient tests per day and 10,700 people had been tested last week.
The costs are borne by the health insurance if the test is ordered by a doctor.
According to the head of the Robert Coch Institute, Germany has a total capacity of about 160,000 tests per week.
On March 19, HIV tests were made available inside the car in several major cities.
On March 26, 2020, the total number of tests conducted in Germany was unknown, as only positive case results were reported.
A preliminary laboratory study revealed that from the 12/2020 calendar week, at least 483,295 samples had been tested by the end of the 12/2020 week, with 33,491 samples (6.9%) positive for SARS-2. In Israel, researchers at the Rembam Hospital developed a method for testing samples taken from 64 patients at the same time, by collecting samples and conducting further tests only when the sample was found to be positive.
With Wang Jian, the founder of BGI, supervising construction work and taking five days in it, modelling exercises showed that the cases in Hobei would have increased by 47% and the associated costs of quarantine would have doubled if that testing capacity had not been achieved.
The Wu-Yan Laboratory was immediately followed by the establishment of Huo-Yan Laboratories in Shenjin, Tianjin, Beijing and Shanghai and in a total of 12 cities throughout China.
By March 4, 2020, total daily productivity was 50,000 tests per day. Origami Assays produced open-source and multi-spread designs that can test up to 1122 patient samples to detect Koped-19 using only 93 tests.
In March, the shortage and inadequacy of reagents caused trouble when a large number of tests were conducted in the European Union, the United Kingdom and the United States.
This led some specialists to explore sampling protocols that include the heating of samples at 98 degrees Celsius (208 degrees Fahrenheit) for five minutes to free the reposi DNA genome for further testing. On 31 March, it was announced that the United Arab Emirates was at the top of the world’s population’s krona virus test rate, and was on its way to raising the test level to most of the population.
This was through a combination of activation of in-car testing capacity, and the purchase of a high-productivity laboratory with a range suitable for the population from Group 42 and BGI (based on their emergency detection laboratories Huo-Yan in China).
The laboratory was established within 14 days, allowing tens of thousands of tests of RTBCR daily, the world's first laboratory of this size to operate outside China.
Various testing methods targeting different parts of the genetic characteristics of the Corona virus were developed in China, France, Germany, Hong Kong, Japan and the United States.
The World Health Organization (WHO) has adopted the German crew industry plan, which is sent to low-income countries that do not have the resources to devise their own crews.
The German plan was announced on January 17, 2020; the protocol developed by the U.S. Centers for Disease Control and Prevention was not available until January 28, delaying the tests available in the US. China and the US faced problems regarding the reliability of test kits early in the outbreak, and these countries and Australia were unable to provide adequate kits to meet demand and follow the test recommendations of health experts.
In contrast, experts have stated that the abundance of tests in South Korea has helped to reduce the spread of the new Corona virus.
The South Korean government has significantly enhanced testing capacity in private sector laboratories over several years.
On March 16, the World Health Organization (WHO) called for the intensification of testing programmes as the best solution to curb the progress of the Koped-19 pandemic. The increased demand for testing caused hundreds of thousands of tests to accumulate in private American laboratories, and the supply of scans and chemical detectors was scarce.
In March 2020, China reported problems with the accuracy of its test crews.
In the United States, “deficits” were found in the testing crews created by the CDC; thus, the government removed the bureaucratic barriers that prevented the test in particular. Spain purchased test sets from Shinzhen Bioacy Biotechnology Limited, but found that the results were inaccurate.
KOTC explained that the incorrect results could be due to failure to collect samples or to improper use of crews.
The Spanish Ministry stated that it would withdraw from buying the kits that gave incorrect results, and replace them with other test kits from Shenzhen Bioacy. 80% of the test kits purchased by the Czech Republic from China gave the wrong results.
According to Professor H. Kara of the Turkish Ministry of Health, the test kits purchased by Turkey from China had a “high error rate” and “prevented their use.” The UK also purchased 3.5 million test kits from China but in early April 2020 declared them unserviceable.
The tests, followed by a quarantine for those found injured and the tracking of those involved with SARS-KOV-2, yielded positive results.
Researchers working in the Italian city of Fu, which witnessed the first death of Coved-19 in Italy, tested the entire population of about 3,400 twice, taking about 10 days at a time.
Nearly half of the people tested positive did not show symptoms, and all detected cases were isolated.
As a result of the ban on movement between towns, new injuries were completely eliminated.
Singapore’s Corona 2020 HIV pandemic has seen a significant decrease in prevalence compared to other developed countries, but without severe restrictions such as forced closure of restaurants and retail facilities; through rigorous tracking of mixtures and restrictions on internal travel, tests, and quarantine.
Many events have been cancelled, and Singapore has already begun to urge residents to stay at home on March 28, but schools were reopened on March 23rd on time after the break.
Several other States have also taken control of the pandemic through strict tracking of mixtures and restrictions on internal travel, testing and quarantine, but with less stringent closure decisions, such as in Iceland and South Korea.
A statistical study has revealed that countries that have conducted more tests than deaths have much lower mortality rates, perhaps because these countries are better able to identify only those with mild symptoms or no symptoms.
WHO recommends that countries that do not have the capacity to conduct tests or have local laboratories with limited experience of Koide-19 send the first five positive samples and the first ten negative samples of Coved-19 to one of the 16 WHO-approved laboratories to confirm testing.
Of the 16 certified laboratories, 7 are located in Asia, 5 in Europe, 2 in Africa, 1 in North America and 1 in Australia.
In the next graph, the column “positive % of the tests” is influenced by the policy of the state in conducting the test.
The State that only tests people transferred to the hospital will have a higher positive rate of testing than the country that is tested for all its population, whether or not they show symptoms, taking into account the equality of other factors.
Hand washing (or hand washing), also known as hand cleaning, is the process of cleaning hands for the purpose of removing dirt, grease, microorganisms or other unwanted substances.
The continuous washing of hands with soap at certain “necessary times” during the day prevents the spread of many diseases, such as diarrhoea and cholera, which are transmitted through the oral anal route.
People can also be infected with respiratory diseases such as flu or cold, for example, if they do not wash their hands before touching their eyes, noses or mouths (i.e. mucous membranes).
The five necessary moments during the day when washing hands with soap is important: before and after defecation, after cleaning the baby's ass or changing diapers, before feeding the child, before eating, before preparing food or dealing with meat or raw fish or poultry.
If water and soap are not available, the hands can be cleaned with ash. The World Health Organization recommends that the hands be washed:
Before the food is prepared, during, and after.
Before and after taking care of a sick person.
After changing a baby's diapers or cleaning it after using it for the toilet.
After you clean your nose, or cough, or sneeze.
After touching animals, their feeds, or their waste.
The medical hygiene of the hands refers to hygiene practices associated with medical procedures.
Handwashing before medication or medical care can prevent or limit the spread of the disease.
The main medical purpose of handwashing is to cleanse hands of pathogens (bacteria, viruses or other microorganisms that can cause disease) and chemicals that can cause damage or disease.
This is particularly important for people who deal with food or work in the medical field, but it is also an important measure for the general public.
Handwashing has many health benefits, including reducing the spread of influenza, the Corona virus and other infectious diseases, preventing diarrhoeal infectious diseases and reducing respiratory infections.
Reduced infant mortality rates at home.
A 2013 study showed that improved hand-washing practices may lead to minor improvements in height growth in children under five years of age.
In developing countries, child mortality rates for respiratory diseases and diarrhoea can be reduced through simple behavioural changes, such as hand washing with soap.
This simple measure can reduce the mortality rate from these diseases by almost 50%.
Measures that encourage hand washing from diarrhoea can be reduced by approximately one third, similar to the provision of clean water in low-income areas.
The only more effective and less expensive way to prevent diarrhoea and acute respiratory infections (ARE) when applying spontaneous behaviour in homes, schools, and communities around the world is to wash hands with soap.
Pneumonia, one of the major acute respiratory infections, is the leading cause of death among children under five years of age, killing about 1.8 million children annually.
Diarrhoea and pneumonia together cause about 3.5 million deaths a year.
According to UNICEF, turning handwashing with soap before eating and after using the toilet into an inherent habit can save more lives than any vaccine or medical intervention, reducing deaths from diarrhoea by almost half, and deaths from acute respiratory infections by about a quarter.
Handwashing is usually combined with other hygiene measures as part of water, sanitation and hygiene (water, sanitation and hygiene) programmes.
It also protects handwashing from herpes transmitted through direct physical contact.
The simple harmful effect of handwashing is that repeated handwashing can result in skin damage due to its drought.
A Danish study in 2012 revealed that excessive handwashing can lead to a skin condition of peeling and itching known as eczema or inflammation of the hand, which is particularly common among health-care workers.
Too much handwashing is also often seen as a symptom of OCD.
There are five moments during the day when washing hands with soap is important for reducing the transmission of diseases through the oral anal route: after using the bathroom (pee, poop), after cleaning the baby's ass (retardation), before feeding the baby, before eating, before/after preparing food or dealing with meat, fish or raw poultry.
The correct hand-washing method should be exercised in other cases in order to prevent the transmission of the disease, including before or after the treatment of a cut or wound, after sneezing, coughing or cleaning of the nose, after touching or dealing with animal waste, and after touching garbage.
In many countries, the rate of handwashing with soap is low.
A study on hand-washing in 54 countries in 2015 found that, on average, 38.7% of households wash their hands with soap. A 2014 study showed that Saudi Arabia has the highest rate of 97 percent, the US is approaching the middle by 77 percent, and China by 23 percent.
The “Basic Health Care Programme” implemented by the Department of Education of the Philippines is an example of widespread action to promote children's health and education.
The treatment of worms twice a year, as well as the daily washing of hands with soap, and the daily cleaning of teeth, is at the heart of this national program.
It was also successfully implemented in Indonesia.
The addition of soap or detergents to water enhances the removal of microorganisms from the skin.
The main effect of soap and detergents is to reduce decomposition barriers and increase solubility.
Water alone is an ineffective skin disinfectant because fat and proteins, which are organic soil components, do not readily degrade in water.
However, the flow of an appropriate amount of water helps to disinfect.
Because of its reusable nature, solid soap may carry bacteria from previous uses.
A few studies that have observed bacterial transport from contaminated solid soap have concluded that transport is unlikely because bacteria are washed with foam.
The Centers for Disease Control and Prevention continue to provide that “liquid soap is preferred from devices that operate without touching to pump soap”.
Antibacterial soap has been widely promoted to healthy consumers.
So far, there is no evidence that the use of recommended disinfectants or sterilizers is chosen to eliminate antibiotic-resistant organisms in nature.
However, antibacterial soap contains common antibacterial agents such as Triklosan, which does not affect a large number of strains of living organisms.
So, if antibacterial soap does not affect antibiotic strains, it may not be as effective as it is being marketed.
Apart from the surface stress reduction and the skin protection factor, advanced formulations may contain acids (Acetec acid, Ascorbic acid, Lactic acid) as a regulator of acid, active anti-microbial benzoic acid and other skin moisturizers (solids, vitamins, manthols, plant extracts). A comprehensive analysis by the University of Oregon School of Public Health indicated that ordinary soaps are as effective as antibacterial soap in the consumer category, which contains triclosan in preventing diseases and removing bacteria from the hands.
Hot water to wash hands isn't hot enough to kill bacteria.
Bacteria grow much faster at body temperature (37°C).
However, warm water and soap are more effective than cold water and soap in the removal of natural soil and bacterial oils.
Contrary to popular belief, scientific studies have shown that the use of warm water has no effect in reducing microbial loads on the hands.
Purgatory or hand sterilizer is a non-water-based material for cleaning hands.
In the late 1990s and early 21st century, non-water-based alcohol hand-cleaners sterilized through rubs (also known as handwash with alcohol composition, purified handwash or hand sterilizers) began to gain popularity.
Most of them rely on isopropyl alcohol or compound ethanol with a thickening agent such as carbomer (acrylic acid polymer) in gel, or a moisturizer such as glycerine in liquid, or foam for ease of use and reduction of the impact of alcohol-induced dehydration.
Adding diluted hydrogen peroxide increases antimicrobial activity. Hand sterilizers containing alcohol are effectively considered to be at least 60% to 95% steroids.
Merchandise alcohol sterilizers eliminate bacteria, drug-resistant multibacteria (golden cluster coils resistant to methicillin and phencomysin), tuberculosis, some viruses (including HIV, Herpes, respiratory-free virus, nasal viruses, sepsis, influenza, hepatitis) and fungi.
Alcohol sterilizers containing 70% of alcohol through the rubs consume 99.97% (a 3.5 decrease in logarithmic, similar to a 35-minute reduction in decibel) of the bacteria on the hands 30 seconds after they have been placed and 99.99% to 99.999% (a 4-5 reduction in logarithmic) of the bacteria on the hands 1 minute after they have been placed. Hands sterilizers are more effective against bacteria and less effective against some viruses.
Alcoholic hand sterilizers are almost completely ineffective against NOV viruses, the most common cause of infection-induced gastroinflammation and intestinal intestines. Enough manual purgatory or alcohol scrubbing must be used to wet or fully cover both hands.
The front and back are rubbed between the hands and all the fingers and limbs for approximately 30 seconds until the liquid, foam, or gel is dried.
The U.S. Center for Disease Control and Prevention recommends washing hands with hand sterilizers, especially when hands are clearly dirty.
The increasing use of these detergents is due to their ease of use and rapid activity in the elimination of microorganisms; however, they should be an alternative to washing the right hands only if water and soap are not available.
The repeated use of alcohol sterilizers can cause the skin to dry unless rain or skin refreshments or both are added to the formulation.
The effect of alcohol on the dryness of the skin can be reduced or eliminated by adding glycerin or other rain or both to the formulation.
Clinical experiments have shown that alcohol sterilizers containing rain can cause less skin irritation and dehydration than soap or antimicrobial detergents.
Sensitivity skin inflammation, coronary arthritis, alcohol hypersensitization or additives in alcoholic handwashes are rare.
The low incidence of irritant pyrositis has become a factor of attraction compared to the washing of hands with water and soap.
Despite the effectiveness of non-water-based detergents, they do not cleanse hands of organic matter, but simply sterilize it.
For this reason, hand sterilizers such as soap and water are not effective in preventing the spread of many pathogens, where pathogens remain on the hands.
The efficacy of the alcohol-free hand sterilizer depends heavily on the ingredients and composition, and historically the effect has been significantly lower than that of alcohol-containing and alcohol-singling.
Recently, formulations using benzalconium chloride have been shown to have a cumulative and continuing effect as an antimicrobial after-use, unlike alcohol, which has been shown to be less effective after repeated use, probably due to progressive reverse dermal reactions.
Many people in low-income communities cannot afford to buy soap and use ash or dirt instead.
Ash or dirt may be more effective than water alone, but it may be less effective than soap.
One concern is that if dust or ash are contaminated with microorganisms, they may increase the spread of the disease rather than reduce it.
Ashes are also, like soap, a disinfectant because they form a alkali solution when they touch water.
WHO recommended using ash or sand as an alternative to soap when it is not available.
The method of washing the right hands recommended by the United States Centers for Disease Control to prevent transmission includes the following steps:
Wet hands with warm or cold running water.
The use of running water is recommended because existing basins may be contaminated, while water temperature does not seem to make a difference.
Make foam on the hands by rubbing them with a plentiful amount of soap, including the back of the hands and between the fingers and under the nails.
Soap removes germs from the skin, and studies show that people tend to wash their hands well when using soap instead of just water.
Rub for at least 20 seconds.
Rubping creates friction, which helps remove germs from the skin, and removes rubs for longer periods of more germs.
Rinse well under the running water.
Rinsing the hands inside the tub could lead to repollution.
Dry with a clean towel or leave it dry in the air.
Wet and wet hands are easily contaminated again. The most common parts that are overlooked are thumbs, wrists, areas between fingers, and under nails.
Artificial nails and cracked nail paints may contain microorganisms.
Lushen is often recommended for use as a moisturizer to prevent dry hands, and dry skin can damage it, thereby increasing the risk of infection.
Various low-cost options can be made available to facilitate handwashing in developing countries, where tap water and/or soap are not available, such as pouring water from a hanging vessel or slinging appropriate holes and/or using ash if necessary. In places with limited water supply (e.g. schools or rural areas in developing countries), there are solutions to rationalize water consumption, such as “Tippe Hanafe” and other low-cost options.
Tibby's tap is a simple technique that uses a needle hanging from a rope, and a foot-to-foot control arm to pour a small amount of water on the hands and a piece of soap.
Effective hand drying is an essential part of the hand-cleaning process, but there is some debate about the most effective form of drying in public toilets.
A growing number of research indicates that paper towels are healthier than electric hand dryers found in many toilets.
In 2008, the University of Westminster in London conducted a study, sponsored by the European tissue symposium on paper towels, to compare the levels of cleaning provided by paper towels, warm air hand dryers and fresher air hand dryers.
After washing hands and drying them with the warm air dryer, the total number of bacteria was found to increase on average on the inside of the fingers by 194 percent and on the palm of the hand by 254%.
The drying using the jet air dryer increased the average total number of bacteria on the inside of the fingers by 42% and on the palm of the hand by 15%.
After washing hands and drying them with a paper towel, the total number of bacteria decreased on average on the inside of the fingers by as much as 76% and on the palm of the hand by 77%, and scientists also conducted tests to determine whether there was a risk of infection for other toilet users and the toilet environment as a result of each type of drying method.
The jet air dryer, which pushes the air out of the unit at speeds of up to 180 m/s (650 km/h; 400 miles per hour), is capable of inflating microorganisms from the hands and the device, and may be infected to other users of the toilet and the restroom environment up to 2 metres away.
The use of a warm air dryer spreads microorganisms about 0.25 metres from the dryer.
Paper towels showed no significant prevalence of microorganisms. In 2005, a study conducted by TÜV Produkt und Umwilt assessed the different drying methods of the hands.
The following changes were observed in the numbers of bacteria after the drying of hands:
There are many manufacturers of different hand dryers, and I compared hand dryers to paper towels.
Washing hands with hand sterilizer napkins is an alternative while travelling due to lack of soap and water.
Alcoholic hand sterilizer must contain at least 60% of alcohol.
Medical handwashing became mandatory for a long time after the Hungarian doctor discovered its effectiveness (1846) in preventing diseases in the hospital environment.
There are electronic devices that provide notes to remind hospital staff to wash their hands as soon as they're forgotten.
One study found low rates of infection.
Medical handwashing is for at least 15 seconds, using abundant amounts of soap, water or gel to make foam and rub each part of the hand.
The hands must be rubbed together and the fingers tangled.
If there's crap under the fingernails, you can use a rough-haired brush to remove it.
Since germs may still be in the water on the hands, it's important to rinse them well and dry them with a clean towel.
After drying, the paper towel should be used to close the water (and open any exit door if necessary).
This avoids the contamination of the hands again from those surfaces.
The purpose of washing hands in a health-care setting is to remove pathogenic microorganisms ("bes") and avoid their transfer.
According to New England Journal of Medicine, not washing hands is still at unacceptable levels in most medical settings, with large numbers of doctors forgetting to wash their hands routinely before touching patients, thus moving microorganisms.
One study showed that proper handwashing and other simple procedures could reduce catheter-related blood flow infections by 66 per cent, and the World Health Organization published a newspaper explaining how to wash and rub hands in the health-care sectors.
The draft guidance document for the organization’s clean hands can also be found on its website for public comment.
Wetby et al. conducted a related review.
Commercial devices can measure and verify the cleanness of hands, if required to demonstrate compliance with regulations.
The World Health Organization (WHO) has five moments to wash hands:
After exposure to blood/body fluids
Before a sterilisation mission,
Adding disinfectant chemicals to soap ("medicine" or "antimicrobial") adds an exterminator to the handwasher.
This element of extermination may be desirable before surgery or in places where antibiotic-resistant organisms are most prevalent. When “flicking” someone’s hands for surgery, a tap that can be activated and stopped without contact with the hands, some chlorhexane or iodine washing, sterile hand drying towels after washing, a sterile scrubbing brush, and another sterile nail cleaning tool are required.
All jewels must be removed.
This procedure requires washing hands and forearms to elbows, usually from 2 to 6 minutes.
Long scrubbers (10 minutes) are not necessary.
When rinsing, the water must be prevented from recoiling from the hand-to-hand.
After washing hands, the hands dry off a sterile cloth and wear a surgical dress.
To limit the spread of germs, it's best to wash hands or use a disinfectant before and after taking care of a sick person.
To control the infection of cluster diaphragms in hospitals, the greatest benefit of manual cleansing was found to have come from the first 20% of laundry, and it gained a very small additional benefit when the frequency of hand-cleaning increased to over 35%.
Regular soap washing results in more than three times the rate of food-borne infectious diseases compared to anti-bacterial soap washing. Compared with alcoholic solution and handwashing with antibacterial soap for an average of 30 seconds, alcohol scrubbing has been found to reduce bacterial contamination by 26% more than antibacterial soap.
But water and soap are more effective than handwashing to reduce the H1N1 influenza virus and hard-to-hand spores. Measures to improve the cleanliness of hands in health-care settings may include educating employees about handwashing, increasing the availability of handwashing, and written and oral reminders for employees.
Further research is needed to determine which of these measures is most effective in different health care settings.
In developing countries, hand-washing with soap is recognized as an essential and affordable tool for achieving good health, as well as good nutrition.
However, the lack of reliable water supply, soap or hand-washing facilities in homes, schools and workplaces makes it difficult to find general hand-washing behaviours.
For example, in most rural areas of Africa, hand-washing taps are rarely found near each private or public toilet, although there are cheap options for building hand-washing stations.
However, low hand-washing rates can be the result of ingrained habits rather than lack of soap or water.
Promoting and advocating hand-washing with soap can influence political decisions, increase awareness of the benefits of hand-washing and change the long-term behaviour of the population.
For this to work effectively, monitoring and evaluation are essential.
A systematic review of 70 studies found that community-based approaches are effective in increasing hand-washing in lower-middle-income countries, while social marketing campaigns are less effective. One example of promoting hand-washing in schools is the “three-star approach” designed by UNICEF to encourage schools to take simple and inexpensive steps to ensure that students wash their hands with soap, among other health requirements.
When minimum standards are met, schools can move from one star until they eventually reach three stars.
Building hand-washing stations can be part of hand-washing promotion campaigns to reduce morbidity and child mortality.
World Handwashing Day is another example of awareness-raising campaigns that are trying to bring about behavioural change. Because of the Corona virus pandemic 2019-20, UNICEF has encouraged the adoption of an expression symbol for handwashing.
A few studies have considered the overall cost-effectiveness of handwashing in developing countries and its relationship to disability-adjusted years of life.
However, one audit suggests that promoting hand-washing with soap is significantly more cost-effective than other water and sanitation procedures.
The importance of hand-washing for human health - especially for people in critical circumstances such as mothers who have just been born or wounded in hospitals - was recognized for the first time in the mid-19th century by two clean hands: Hungarian doctor Agnes Similves, who worked in Vienna, Austria, and English-speaking Florence Nightingale, “Modern Nursing Founder”.
Most people at the time still believed that the infection was caused by the stench of the so-called meazaz.
In the 1980s, food-borne outbreaks and health-care infections led the United States Centers for Disease Control and Prevention to promote cleaner hands more effectively as an important way to prevent the spread of infection.
The outbreak of pig flu in 2009 and the Coved-19 pandemic in 2020 have raised awareness in many countries of the importance of washing hands with soap to protect themselves from these infectious diseases.
For example, posters containing “right ways of washing hands” were suspended next to handwashing pools in public toilets and in the toilets of office buildings and airports in Germany.
The term "washing hands from" means something that is declared unwilling to take responsibility for something or to participate in complicity in it.
It stems from a passage in the Bible in Matthew, where Pilate washed his hands of the decision of the crucifixion of Jesus Christ, but it has become a much wider use in some English societies.
In the Macbeth Shakespeare play, Ms. Macbeth begins to wash her hands too often in an attempt to purify a place of fiction that represents her guilt for the crimes she committed and the crimes she urged her husband to commit.
It was also found that people, after referring to or thinking about immoral acts, tended to wash hands more often than others, and tended to appreciate handwashing tools more.
Moreover, those who are allowed to wash their hands after this study are less likely to participate in other “cleaning” compensatory actions, such as volunteering.
The symbolic hand-washing, using water without hand-washing soap, is part of the hand-washing rituals that have emerged in many religions, including the Baha’i, Hindu, and Tivilah faiths, the hand-washing in Judaism, the washing of Christianity, and the display of Islam. Religions also impose the washing of healthy hands, especially after certain actions.
Hinduism, Judaism and Islam require the washing of hands after using the toilet.
Hinduism, Buddhism, Sikhism, Judaism and Islam require the washing of hands before and after each meal.
Koffid-19 Risk Controls in the Workplace
The workplace risk control controls of Koed-19 are the application of occupational safety and health methodologies for risk control controls to prevent the 2019 Corona virus disease (Coved-19).
Proper controls of workplace risk control depend on the workplace and the job function, based on an assessment of the risk of exposure sources, the risk of disease in society, and the risk factors that threaten individual workers who may be exposed to CFO-19.
According to the U.S. Department of Occupational Safety and Health (OSHA), low-risk work involves minimal communication with the public and other co-workers, a situation in which it is recommended that basic measures be applied to prevent infection, including hand washing and encouraging workers to stay at home if they are ill, taking into account coughing and sneezing ethics, and maintaining normal practices for cleaning and cleaning the working environment.
Jobs with moderate exposure risks include those requiring frequent or close communication with unknown or suspected individuals with code 19, but may be infected by continuous transmission in society or international travel.
This includes workers who have reached out to the public as in schools, high labour-intensive work environments, and some large retail outlets.
Risk control controls for this group include, in addition to basic infection prevention measures, ventilation using high-efficiency air filters, sneezing barriers and the use of personal protective equipment available in the event of dealing with a person with code 19.
The Department of Occupational Safety and Health considers health-care workers and the mortuary of dead persons who are exposed to a person known to be exposed to or suspected of being exposed to high levels of exposure, which increases the risk of exposure to the extreme if the workers carry out aerosol procedures, or collect or deal with samples from a known or suspected person affected by code 19.
Appropriate risk control controls for these personnel include engineering controls such as passive pressure ventilation rooms and personal protective equipment suitable for the function.
Coved-19 outbreaks can have multiple effects in the workplace.
Workers may be absent from work due to illness, the need to care for others, or fear of potential exposure.
Patterns of trade may change, both in terms of the quality of the goods required and the ways in which they are obtained (e.g., shopping in non-peak hours or through delivery or shopping services without leaving the car).
Finally, shipments of goods from geographical areas severely affected by Coved-19 may cease. The preparedness and response plan for infectious diseases can be used to guide preventive action.
The plans address risk levels associated with different workplaces and functions, including exposure sources, risk factors from home and community settings, and risk factors for individual workers such as old age or chronic medical conditions.
It also establishes controls to address these risks, and contingency plans for situations that may arise as a result of the outbreak.
Preparedness and response plans for infectious diseases may be subject to national and subnational recommendations.
The objectives of the outbreak response include reducing staff transmission, protecting those most at risk of negative health complications, maintaining business processes and reducing negative impacts on other entities in their supply chains.
The severity of the disease in the society in which the business takes place affects the responses taken.
The hierarchy of risk control controls is a widely used occupational safety and health framework for effectively classifying risk control controls.
Due to the fact that the risks of Koed-19 cannot be eliminated, the most effective controls are engineering controls, followed by administrative controls, and finally personal protective equipment.
Engineering controls include separating staff from work-related risks without relying on the behaviour of workers, and can be the most cost-effective solution for implementation.
Administrative controls are changes in labour policy or procedures that require action by the worker or employer.
Personal protective equipment (PBE) is less effective than engineering and administrative controls, but can help prevent certain exposures.
All types of personal protective equipment must be selected based on the worker ' s risk, appropriate suitability as appropriate (e.g. respirators), continuous and proper wear, regular inspection, maintenance and replacement, as necessary, removal, cleaning and storage, or proper disposal to avoid contamination.
According to the U.S. Department of Occupational Safety and Health (OHSHA), jobs involving lower exposure to risk involve minimal communication with the public and other co-workers.
Basic measures to prevent recommended infections in all workplaces include repeatedly and fully washing hands, encouraging workers to stay at home if they are ill, taking into account coughing and sneezed manners, including mouth and nose coverage at coughing and sneeze, providing paper towels and garbage containers, preparing to work remotely or organizing successive shifts if necessary, discouraging workers from using tools and equipment of others, and maintaining routine cleaning and cleaning of the working environment.
The immediate identification of individuals likely to be infected and isolated is a critical step in protecting workers, clients, visitors and others in the workplace.
The United States Centers for Disease Control and Prevention (CDC) recommend that staff with acute respiratory diseases remain at home until the fever, signs of fever and any other symptoms cease to exist for at least 24 hours without the use of fever relief medications or other medications that improve symptoms, that sick leave policies be flexible, that staff members be allowed to stay at home to care for a sick family member, and that staff be aware of these policies.
According to the Occupational Safety and Health Department, jobs with an average exposure risk include those requiring frequent or close communication within a distance of six feet (1.8 m) of unknown or suspected individuals with a code 19, but may be infected with SARS-K-2 due to continuous transmission in the community around the workplace, or recent international travel to a location where transmission is widespread.
Engineering controls include the installation of high-quality air filters, increased ventilation rates, the installation of physical barriers such as transparent plastic sneezes, the installation of windows to serve customers who shop without leaving the car. Management controls and high-risk groups include encouraging sick workers to stay at home, replacing face-to-face meetings with virtual communications, establishing consecutive structured work shifts, stopping unnecessary travel to sites where there is a constant outbreak of 19, developing emergency communication plans including a forum to respond to workers ' fears, providing workers with updated education and training on risk factors and preventive behaviour related to 19 delegations, training workers who need to use clothing and protective equipment on how to use them, providing resources and a working environment that encourage personal hygiene, requiring regular hand washing, limiting the arrival of customers and the public at the workplace, disseminating signs on hand-washing and other protective measures related to the 19th delegation. Based on the task of work, workers who are at risk of being exposed to personal hygiene, requiring regular handwashing, limiting the arrival of customers and the public to the workplace, disseminating signs on hand-washing and other protective measures related to the 19th delegation.
Workers in this risk group rarely need to use respirators.
If a person becomes ill while on an aircraft, appropriate protective controls to protect workers and other passengers include keeping the sick passenger 6 feet away from others, assigning one member of the aircraft team to serve the sick person, providing the sick person with a face mask or requiring the sick person to cover his mouth and nose with handkerchiefs when coughing or sneezing.
The crew of the aircraft must wear medical gloves that can be disposed of when dealing with a sick passenger or touching contaminated body fluids or surfaces, and possibly use additional personal protective equipment if the sick passenger suffers from fever, constant cough or difficulty breathing.
Contaminated surfaces must be cleaned and then sterilized. For commercial shipping, including cruise ships and other passenger ships, risk controls include a stay of travel in the event of illness, self-segregation and immediate notification to the medical centre on board if a person is infected with fever or other symptoms while on board.
For schools and childcare facilities, the CDC recommends a short-term shutdown for cleaning or cleaning if the infected person is in the school building regardless of the prevalence in society.
When there is a limited-to-average transmission limit in society, strategies of social spacing such as cancellation of field trips, gatherings and other large gatherings such as physical education classes, band classes or meals in the cafeteria, increased distances between offices, frequent attendance and departure times, reduction of unnecessary visitors, and the use of a separate health office for children with flu-like symptoms can be implemented.
When there is a major transmission of infection in the community, in addition to social-diversity strategies, the extension of school discharges can be taken into account. For law enforcement officials who carry out routine daily activities, direct health risks are considered low by the CDC.
Law enforcement officials who must communicate with individuals who have been confirmed or suspected of having been exposed to code 19 are advised to follow the same instructions as medical emergency professionals, including appropriate personal protection equipment.
In the event of direct contact during arrest, workers should clean and clean up work belts and tools before reuse using a household cleaning spray or mop, and follow standard operating procedures to deal with contamination and disposal of personal protective equipment used and to collect and wash clothes.
According to the Department of Occupational Safety and Health, some health-care workers and the mortuary fall into categories with high or very high levels of risk exposure.
Jobs with a high risk exposure include health-care workers, support, laboratory and medical transport who are exposed to known or suspected patients with code 19.
These become very high risk exposures if workers perform aerosol generation procedures, as well as collect or deal with samples from confirmed or suspected patients.
The procedures for the generation of aerosols include intubation, coughing procedures, retorts, certain dental procedures and tests, or the collection of invasive samples.
The functions of the high-risk mortuary include personnel involved in the preparation of the bodies of confirmed or suspected persons with code 19 at the time of death; those with a very high level of exposure if they perform an autopsy; additional engineering controls for these risk groups include isolation rooms for known or suspected patients with code 19, including in the implementation of aerosol generation procedures.
Specialized passive pressure ventilation may be appropriate in some health-care settings and the preservation of dead bodies.
Samples should be handled using Level 3 biosafety precautions.
The World Health Organization (WHO) recommends that incoming patients be isolated in separate waiting areas on the basis of whether they are suspected of having been exposed to Coffide-19 or not. In addition to other personal protective equipment, the Occupational Safety and Health Department recommends the use of respirators for those working within 6 feet of known or suspected patients with SARS-KOV-2 and those conducting aerosol procedures.
In the United States, N95-type N95 masked respirators, approved by the National Institute for Occupational Safety and Health, or better instruments, must be used in the context of the comprehensive written respiratory protection programme, which includes installation and suitability testing, training and medical examinations.
Other types of respirators can provide greater protection and improve worker comfort. The World Health Organization (WHO) does not recommend the use of aprons, because Coved-19 is a respiratory disease instead of being transmitted through body fluids.
WHO only recommends the use of a surgical mask for testing staff at the entry point.
For those who collect respiratory samples from Koped-19 patients, or take care of them, or transport them without any procedures for the generation of aerosols, WHO recommends the use of surgical mask, goggles, facial protection, squadrons and gloves.
If an aerosol procedure is implemented, the face mask will be replaced by a respiration mask N95 or FFP2.
Given that the global supply of personal protection equipment is inadequate, WHO recommends reducing the need for personal protective equipment through telemedicine, physical barriers such as transparent windows, allowing only those involved in direct care to enter a room with a patient with code 19, using only the personal protective equipment necessary for the specific task, continuing to use the same breathing mask without removing it while caring for many patients with the same diagnosis, monitoring and coordinating the supply chain of personal protective equipment, and discouraging the use of masks for individuals without symptoms.
From: Catherine Maher, Executive Director, Wikimedia Foundation
To: All employees of the Wikimedia Foundation
Subject line: [Coved 19] Relieving the burden and preparing for the future
Date/time of transmission: March 14, 2020, Global Standard Time
Licensing: CC0: No rights reserved
We've found ourselves in the midst of extraordinary circumstances this month.
The Coffid 19 epidemic has become a clear manifestation of global human interdependence and of our responsibilities to others.
Our history has never seen similar challenges, but we know for sure that the best response depends on a kind of global compassion, cooperation and community-building, which are at the heart of this institution.
The great friendship and care we have witnessed among all our colleagues through e-mails, calls, and conversations is an amazing demonstration of the amazing human feelings surrounding, fortunately, the way we work.
I am very grateful and deeply proud that you are real colleagues.
Last week, someone sent me a letter expressing appreciation for our work.
They reminded me of the critical importance of the world's ability to move towards Wikipedia right now, and of the powerful symbolism that this critical resource continues to be available online and accessible to all individuals.
Your efforts have made it possible, whether it be through the continued operation of sites, our colleagues getting paid, or the safety of our communities.
The world is in dire need of the information available in Wikipedia more than ever before.
It's a moment when the positive impact in the world is not only on our efforts, but also on the way they are made.
Because of the importance of this mission and your role in it, we will make major adjustments in how we work together starting next week.
Adjustments to the modus operandi and timetables
As Rubin mentioned earlier, Team J met yesterday to discuss our way and schedule for the days and months to come.
In that debate, we considered what we thought could be an appropriate response to what we are facing, and the ideal way to maintain the sustainability of the work of the institution during this period.
We wanted to get rid of stress and stress, and to support our mission in the long run.
If you want to reduce burdens and tasks, that's fine.
All employees, contractors and contract workers:
The expected daily working time is 4 hours per day, or 20 hours per week until further notice.
We're not about to announce a vacation, and if you can work longer than normal working hours, you might add your efforts to the mission.
However, the world is now unpredictable, and whether you want to take care of your loved ones, get groceries or go to a doctor, your safety is our top priority.
We don't track your times.
If you're sick, don't work.
It should be understood to allow this without expressing it, but we do remember it.
No sick leave or paid leave is required. You simply inform your manager and help your team review calendars and schedules to ensure that key areas of work are covered.
(If the doctor diagnosed you with Koed-19 positive diagnosis, please inform Brian at the Department of Training and Certificates so that the Department of Training and Certificates can help by providing support and ensuring that your case receives appropriate care from the Department.
Hourly colleagues receive their full wages.
We have already mentioned that, and we renew this commitment to our contractors and fellow hourly workers.
Each employee will be paid on the basis of normal working hours during normal conditions.
This includes whether the employee is ill or unable to work.
If you want to work, we support you.
Many people are using work to overcome the pressures that are spreading around the world.
What we can do will be amazingly productive, especially during difficult times like this.
Once again, it's about caring for oneself.
We only ask you to communicate with your manager so that he can know what to expect and adjust the procedures accordingly.
Some actions are necessary.
There are also some things that we must keep going.
Site reliability engineering teams, human resources operations, trust, trust and fund-raising (and others) are doing very important work, which may require further support.
We will start a process in cooperation with all departments to assess current objectives and shift our focus to supporting the elements necessary to achieve our mission.
There's a lot of work we all need to do, and we'll just focus on the most important projects.
Go slower now. It won't hurt us later.
We're not planning to "double the time to work" after the pandemic's over.
We're not expected to work extra hours to meet the unrealistic deadlines that are now.
We accept the fact that those circumstances have changed, and we will work to set new targets and timetables as soon as it becomes appropriate.
What's going on with the annual APP?
To adapt to the new reality and the expectations of daily working hours, we intend to adjust the delivery schedule for our annual planning for 2020-2021.
We intend to propose an extension of our 2019-2020 plan to allow more time to design the budget to allow staff to prioritize critical work, self-care and the care of loved ones while reconciling those who need or want to work within a reduced working schedule within the next few weeks.
This extension of the timetable reduces the current planning workload and pressure across the entire institution.
We will submit our proposal to the Governing Council next week and will update delegates and teams on the next steps as soon as confirmation is obtained.
We thank the annual planning team for its leading role in this matter.
Office status, exposure and clean-up
Last week we learned that one of our colleagues working in San Francisco might have been infected with the Coffid-19 virus.
However, starting with extreme caution and interdiction, we have hired a viral clean-up team to clear all surfaces in the San Francisco office.
The team has used the level-of-virus resistance solution used in hospitals to clear all surfaces, as well as the lobby and elevator units that lead to our own floor.
The building has implemented its own duty-of-care protocol using products that support the safety of tenants.
We're relieved that the office is properly equipped until we decide to get back to work.
Our office in Washington, D.C., is located in a WWWWRK building, which shared its Coffid-19 protocol with all the members of our Washington D.C. team.
Starting last week, our office in Washington, D.C., moved to a completely remote location according to joint guidance with our office in San Francisco.
As some of our colleagues at our headquarters in New York City know, we had a discussion about renting a place in Brooklyn.
Those discussions are continuing but may be delayed for some time.
Some of our colleagues work remotely for the first time.
Our long-term teleworking colleagues know it may be an adjustment, and they wanted to give you some advice:
Meetings should be limited to a maximum of one hour or a gradual increase of up to two hours.
If longer sessions are required, consideration should be given to how to divide them over several days.
The meeting should be clearly defined, an agenda should be prepared, and reading materials should be sent in advance.
Video should be made the default solution, and tools such as Google Docs and ZOM should be used to facilitate cooperation and direct communication.
Each meeting should be facilitated by one person to observe the conversation for questions and track the list of speakers, and another to help take notes (or implement the collaborative process of taking notes).
An e-mail should be sent to technical support when comfortable headphones are required.
The health and safety compensation programme can be used to obtain the cost of snacks.
You can join #remoties chanel in the Slack application to talk to colleagues about the distributed work
The Human Resources Operations Team is looking for user-friendly, web-based guidance to support the increase in business distributed across our institution.
Over the past week, we have asked all community grantees to cancel all public events funded by Wikimedia, such as those of web editors, to editathon until the World Health Organization (WHO) declares the pandemic over.
We told them that we understand that our request for cancellations and other restrictions may make completion of agreed grant activities impossible, and that no one will be fined for having to delay or modify these targets.
Next week, we will issue additional follow-up guidance on Boekemidia and other regional and thematic community conferences.
The general sentiment of the world community is mixed between the grief of the turmoil, the satisfaction of clarity and the ability to focus on their communities, Wikipedia and others.
In light of the progress of these actions, the Crisis Response Team is designing a page in Meta Wiki to provide space for society to monitor impact and follow up on all contacts with it.
Keeping up to date on topics related to Coved-19
We will send an invitation to your calendars next Thursday, 14:00 UTC, 07:00 Pacific Time for the meeting of the Working Group.
We'll use this time to share additional updates, answer questions and spend time communicating with us.
We're going through this together and we're always willing to help as much as possible.
In the meantime, we can continue to obtain information from this e-mail, and all other necessary information concerning the 19-Covide available in Oves Wiki.
The Crisis Response Team will keep these pages up to date and keep all information in one place.
We are also working to maintain regular contacts with workers residing in highly affected States.
If you have any questions about travel, events, key areas of work, coverage challenges or anything else you need help with, please do not hesitate to inform us and cooperate with the Crisis Response Team.
We're always ready to provide support and communication as necessary.
If you have a confidential or sensitive matter, please send an e-mail to Brian Gooden, Director of International Human Resources Operations.
None of these changes should be regarded as a renunciation of our work or of our obligations.
Instead, it is a realization at this moment, that our work and our commitments are likely to need to adapt to situations in a way that we have not in the past.
We believe that these steps are necessary to support each other, so that we can continue to work, provide our workers with the support they need, and provide the world with the service on which they depend.
The work that we have planned to achieve will be waiting for us when it comes to its completion.
Now, it is time for everyone to help each other and to create space for the important work that comes in the coming weeks and months.
We need you all to make this happen, so we need you all to take care of yourselves and your families to be at your best when the time comes for your efforts.
Now please wash your hands and don't touch the face!
Catherine, Director of the Crisis Response Team (Amanda K., Amy V, Brian J., Dorin D., Gregory V, Jimmy V, Joel L., Lynette L., Ryan M. and Tony S.) and other members of the leadership team (Grant Aye, Heather W., Jimmy V., Janine U., Lisa S., Robin A., Ryan M. and Toby N.).
An Angiotin 2 conversion enzyme (ACE2) is associated with the outer surface (cellular membranes) of cells in the lung, arteries, the heart, and kidney, as well as intestines.
An Angiotin 2-transformed enzyme counters the work of the Angiotensin transgenic enzyme (ACE) by reducing the amount of angiotencin 2 and increasing angiotencin (1-7); making it a promising drug in the treatment of cardiovascular diseases. It is also an entry for some types of coronary viruses into cells.
The human version of the enzyme is often referred to as a huece2.
An angiotin 2 transformer enzyme is defined as a metallic enzyme containing the zinc element located on the surface of the blanket cells and other cells.
The Angiotensine 2-converted enzyme protein has an amino limb, and the chropicicillic amino acid transporter colictrin series.
An Angiotin 2 transformer enzyme is a type 1 single-stroke membrane protein, with active enzyme receptors found on the surface of lung cells and other tissues.
The external part of the cell is separated from the cell range of the angiotensine 2-transformed enzyme by an enzyme called chidaz, which results in the release of a soluble protein into the bloodstream and then exits through the urine.
An Angiotin 2 transformer enzyme is found in most organs of the body: it is associated with the cellular membrane of type 2 skeletal cells in the lung, in the intestinal cells of the microintestinal, and in the blanket cells of the arterial artery and veins, as well as in muscle cells that are coated with arterial wall in most organs.
The reposi DNA sent by the Angiotin 2 transformer enzyme is found in the cerebral cortex, the blueprint, an area below the tranquilizer, and the brain stem.
The primary function of the Angiotin-2 enzyme is to act as a counterbalance to the Angiotin converter enzyme.
The angiotensin-transforming enzyme stimulates the transformation of angiotencin 1 to angiotencin 2 holding blood vessels.
In contrast, the angiotensine conversion enzyme 2 separates the amine acid-containing carboxyl vinyl from the angiogenine 2 (aspartite-argenine-valen-tairosine-isulosene-hestine-prolene-phenyl-lanin) and analyses it into angiotencin (1-7), (hestydine-aspartite-argene-valin-tairosin-isulosene-hesden-prolene-vinyl-lanin).
The angiotin 2 conversion enzyme is separated into a number of other peptides, including [Des-Argenine9]-Pradrikin, Ablin, Nerotinsen, Dynorvin A and Greline.
The Angiotin 2 transformer enzyme also regulates the membrane passage of a neutral carrier of SLC6A19 amino acids and has a role in Hartenpe disease.
As a protein via my membrane, an Angiotin 2 transformer enzyme is the main entry point to cells for some coronary viruses, which include the human virus NL63, SARS Cove (the virus that causes SARS), and SARS Cove-2 (the virus that causes Koped-19 disease).
In particular, the association of the S1 Spike protein with the SARS Cove and SARS Cove-2 virus with the enzyme scale of the Angiotensine 2 transformer enzyme on the surface of the cells leads to cellular insulation and the transmission of the virus and the enzyme to the internal particles that are located in the cells.
This input process needs to be configured with a protein S via the membrane, the host's serin2, whose inhibitor is still being tested as a possible cure. This makes some assume that lowering levels of the enzyme converted to neotensin 2 in cells may help to resist infection.
In any case, many specialized associations and self-regulatory bodies recommend the continued use of standard angiotensin-transformed enzyme inhibitors and engiotensin receiver blockades as treatment.
A methodological and percussion study published on July 11, 2012 showed that “the use of the angiotensin-transformed enzyme inhibitors was accompanied by a clear reduction in the risk of pneumonia by 34% compared to the reference set.”
In addition, “the risk of pneumonia has decreased among those infected with the Angiotensin-convertive enzyme inhibitors, who were more at risk of pneumonia, especially those suffering from stroke or heart failure.
The use of endocrine-transformed enzyme inhibitors has led to a decrease in deaths due to pneumonia, although the results have been less robust than the overall risk of pneumonia.”
It is believed that the transgenic rehACE2 enzyme will be a new treatment for acute lung injury, which has been found to improve the distribution of pulmonary blood, as well as oxygen saturation in pigs suffering from acute respiratory distress syndrome induced by several fatty sugars.
The half-life of the recombinant Angiotin 2 enzyme is approximately 10 hours, while it starts in 30 minutes, in addition to continuing to be effective (time period) until 24 hours.
There are several indications that the combined angiotensin-2 conversion enzyme may be a promising cure for those suffering from the unsustainability of the traditional angiogencin system inhibitors (RAS) and for diseases associated with an increase in angiotensin 2 in blood. Clinical trials are under way, on the impact of anaerotensin-2 conversion on the treatment of acute respiratory distress syndrome.
Coved-19 applications are software applications for mobile devices specifically designed to help track people mixed in response to the Corona HIV pandemic 2019-20, meaning the process of identifying people (“mixers”) who may have mixed a person with infection.
Many applications have been designed or proposed with official government support in some regions and jurisdictions.
Several frameworks have been developed to design applications to track mixtures.
Many have expressed concerns about privacy, especially about systems that rely on tracking the geographical location of users.
Less intrusive alternatives include the use of Bluetooth signals to record the user’s proximity to other cell phones.
On April 10, 2020, Google and Apple jointly announced that they might integrate a function that supports these Bluetooth-based applications, directly into their Android and IOS operating systems.
In China, the Chinese government, in cooperation with Alibay, published an application that allows citizens to check whether or not they have mixed people with code 19.
It is an application used by individuals in more than 200 Chinese cities. In Singapore, individuals use an application called TraceTogether.
The application was designed by a local information technology association, which issued it as an open-source application to be handed over to the government. Northern Macedonia launched the “StopKorona” application, a Bluetooth-based application to track exposure to potential infected individuals and provide rapid response to health-care authorities.
The application has been designed by the Ministry of Communications and Technology in cooperation with the Ministry of Health.
On April 14, 2020, the app was still waiting to adopt Google Play and App Store of Apple.
On April 12, the Government stated that the Mixture Tracking application was in the advanced stage of development, and might become available for distribution within weeks. Ireland and France are planning to launch a similar application, “StopCovid”.
Both Australia and New Zealand are considering designing applications based on the TraceTogether application launched by Singapore, as well as the BlueTres Protocol. Russia intends to introduce an application that uses the apparent geographic perimeter of patients diagnosed by doctors with 19 coved residents in Moscow, and is designed to ensure that they do not leave the home.
Ross Anderson, Professor of Security Engineering at Cambridge University, mentioned a number of potential practical problems surrounding application-based systems, including false positive cases and a possible lack of effectiveness if applications were used only by a small segment of the population.
To deal with concerns about the proliferation of misleading or harmful applications of the Corona virus, Apple imposed restrictions on the types of organizations that could add their Corona-related applications to its application shop; this was limited to “official” or other organizations of good repute only.
Google and Amazon have implemented similar restrictions.
The privacy advocates have expressed concerns about the consequences of mass surveillance resulting from the use of the Corona virus, particularly as to whether the surveillance infrastructure designed to deal with the Corona virus pandemic will disappear as soon as the threat has passed.
Amnesty International and more than 100 other organizations have issued a statement calling for restrictions on this type of surveillance.
The organizations also announced eight conditions for government projects:
Control should be “legal, necessary and proportionate”;
Extensions of monitoring and control should include clauses regarding the timing of their suspension;
The use of data should be limited to the purposes of code 19;
Data security and identity confidentiality should be protected and evidenced on the basis of evidence;
Digital surveillance should avoid increasing discrimination and marginalization;
Any sharing of data with external parties to the law should be specified;
Protect against abuse and protect citizens ' rights to address abuses;
“Effective participation” is required from all “stakeholders involved,” including public health experts and marginalized groups. The Chaos Computer Club (CCC) of Germany and Reporters Without Borders (RSF) have also issued checklists.
The proposed Google/Apple plan aims to address the ongoing control problem by removing the tracking mechanism from the hardware operating systems as soon as they are no longer needed.
Some countries have used network-based tracking rather than applications, eliminating both the need to download the application and the possibility of avoiding tracking.
In Israel, officials have adopted network-based tracking.
However, network-based solutions that have access to primary site data have significant potential privacy problems.
However, not all centralized server systems require access to personal location data; a number of privacy systems have been established that use only central servers for interfaces (see section below).
In South Korea, officials used a non-application-based system to carry out Mixture Tracking.
Instead of using an ad hoc application, the system collects tracking information from various sources, including mobile tracking data and card transaction data, and integrates these data to send notices via text messages to individuals with potential infection.
In addition to using this information to alert potential mixers, the government has also made site information publicly available, which has been allowed by extensive changes in information privacy laws following the outbreak of the Corona virus causing the Middle East Respiratory Syndrome in that country.
This information is available to the public through a number of applications and websites. Countries, including Germany, have considered using both centralized and privacy systems.
On April 6, 2020, the details of this matter have not yet been released.
On April 7, 2020, more than a dozen groups of experts worked to find privacy-friendly solutions, such as low-energy Bluetooth (BLA) to record user proximity to other cell phones.
However, the BBC-PT has been a coordinating effort that contains both centralized and decentralized approaches, not an individual protocol. Decentralized protocols include the tracking of decentralized approaches to privacy (DP-PPT/DP3T), interim contact numbers (TCN, previously known as CEN), privacy-sensitive protocols, and mechanisms for tracking mobile devices (BCT) and others.
In these protocols, personal identification data do not leave the device, and all matching processes occur on the device.
MIT Media Lab's privacy group was developing SafePaths, a platform for using privacy-based techniques to collect and use site or cross-track data to track the spread of Koved-19.
The SafeTrace platform of Enigma MPC, a company that develops privacy technologies that also originated in MIT Media Lab, is another similar effort.
SafeTrace techniques are used to allow users to share sensitive site and health data with other users and officials without compromising the privacy of the data.
On April 5, 2020, a Global Contact Number Tracking Coalition was established by groups focused on what was essentially a similar approach and highly overlapping protocols, with the aim of reducing dispersion and enabling global interoperability between tracking and alert applications, a key feature of widespread use.
On April 9, 2020, the Singapore government announced that it had made the Blue Trace Protocol, which is used by the official government application, open-source.
On April 10, 2020, Google and Apple, the companies that control the mobile systems Android and IOS, announced an initiative to track mixtures; they claimed that they would maintain privacy by combining low-energy Bluetooth technology and privacy encryption.
They also published the specifications of the main technologies used in the system.
According to Apple and Google, the goal is to project the system in three stages:
Tools to enable governments to develop formal, privacy-based applications to track the Corona virus
This function is integrated directly into the Android and IOS system and Google and Apple plan to solve ongoing use and control problems by distributing systems first through operating system upgrades and then by removing them in the same way as the threat ends.
The recycling of the drug (also known as reuse, reassignment, change of target or therapeutic transformation of the drug) is a redefinition of the use of a drug approved for treatment of a different disease or medical condition than was originally designed for treatment.
This is one of the methods of scientific research currently being used by researchers to develop safe and effective remedies for code 19.
Other research trends include the development of the Coffide-19 vaccine and the transfer of pure plasma. The SARS Cove-2 virus contains approximately 66 drug-treated proteins, each containing multiple-arbital sites.
The analysis of these interconnected sites provides the reasonable plan for the development of an effective antiviral drug that eliminates Koped-19 proteins.
Among the most important proteins targeted for SARS Cove-2 are the two-door proteazoids, the reposy DNA polymerase, the helicaz, the protenes and the repotazes of diphosphosphate.
Hüseyin A.A. and others studied several candidate compounds that were subsequently improved and analysed for the similarity of their structure to approved drugs with the highest resemblance, with a view to accelerating the development of a strong SARS Cove-2 antiretroviral drug in his pre-clinical study for recommendation in the design of a clinical study.
Chloroquin is a drug that doctors also use to treat certain autoimmune diseases.
On March 18, a World Health Organization (WHO) announced that chloroquine and its associated hydrochloroquine could be among the four drugs studied as part of the clinical solidarity experiment.
The Governor of New York, Andrew Como, announced that New York State experiments on chloroquine and hydroxychloroquine might begin on March 24. On March 28, the Food and Drug Administration authorized the use of hydroxychloroquine sulfate and chloroquine phosphate under an emergency use permit (EUA).
Clinical trial treatment was not approved by the Department of Food and Medicine and was licensed under an emergency employment permit only as a trial treatment for emergency use for patients who have been hospitalized but cannot receive treatment in clinical trial.
CDC has declared that it has not yet been determined “the use of hydroxychloroquine to prevent or treat SARS Cove-2 virus infection, doses or duration”.
Doctors say they use the drug when there's no other choice.
A Turkish research team in Istanbul is currently conducting a small study on the use of chloroquine in addition to zinc, vitamin A, vitamin C and vitamin D.
Major studies are conducted at Duke University and Oxford University.
The University of New York Langon Medical School is conducting an experiment on the safety and effectiveness of the preventive use of hydrogen chloroquine.
Chinese clinical trials in Wuhan and Schengen claimed that Favibiravir was “obviously active”.
Of 35 patients in Schengen, the test results were negative for an average of 4 days, while the period of illness was 11 days in 45 patients who did not receive it.
In a study conducted in Wuhan on 240 patients with pneumonia, half of them were given Favibiravir and the other half received Omivinover.
The Italian Drug Agency has alerted people to the fact that the existing evidence supporting the drug is incomplete and preliminary.
On April 2, Germany announced that it would buy the drug from Japan to include it in its reserve stock, and would use the army to deliver the drug to university hospitals, where the drug would be used to treat Koped-19 patients.
According to the morning newspaper of South China, Shinzo Abe had preliminary talks with the Trump administration about buying the drug. The drug may be less effective in treating the most severe cases where the virus has already doubled.
It may not be safe for pregnant women or women who wish to get pregnant.
One study that used Lubinavir/Ritunavir (Kalitra), a combination of the antivirals of Lubinavir and Ritunavir, stated that the results “did not detect any benefit”.
Drugs were designed to discourage HIV in order to prevent replication by linking it to protein.
A team of researchers at the University of Colorado is trying to modify drugs to access a compound associated with the Sars Cove-2 protein. The scientific community is witnessing criticism about channelling resources to redefine drug purposes specifically designed to treat HIV/AIDS.
The World Health Organization (WHO) has added Lubinavir/Retunavir to the international solidarity experiment.
Gelid Science has developed Rimdicivir as a cure for Ebola and Marburg virus infection. Geilaid Sciences has since discovered that Remdicevir is an antiviral activity in the laboratory against many filamentary viruses, mucus viruses, and Corona viruses.
One of the problems related to antiretroviral therapy is the development of resistance through transformations that can lead to more serious diseases and their transmission.
Some early pre-clinical studies suggest that Rimdecifer may have a high genetic barrier to resistance. There are many current clinical trials, including two conducted by Cleveland University hospitals; one is about patients with moderate disease and the other is intended for patients with the most severe disease.
There are three clinical trials of antiretroviral vitamin C on patients who have been hospitalized and suffer from severe disease due to Koed-19, as well as two controlled trials of the use of imaginary medicine (China, Canada) and one uncontrollable experiment (Italy).
The state of New York began experiments on the antibiotic effect of Azethromycin on March 24, 2020.
The Japanese National Centre for Public Health and Medicine (NCGM) is planning to carry out a clinical trial on the use of Telejin, an inhaling corticosteroid for the treatment of patients with the new Corona virus prior to symptoms.
A second-stage experiment is currently being conducted using a form of an Angiotensin transformer enzyme of 2 to 200 patients who are required to join the experiment from acute cases that have entered the hospital in Denmark, Germany and Austria to determine the efficacy of the treatment.
Researchers from the Montreal Heart Institute in Canada are currently studying the role of Kolchisen in reducing pneumonia and pneumonia in patients suffering from mild symptoms of the 19-acofide infection.
The study, by the name of Kolkoruna, includes 6,000 adults aged 40 and over who were diagnosed with a code 19 and suffered mild symptoms without having to be hospitalized.
Pregnant women, breastfed women or women who do not have an effective contraceptive method are not considered eligible.
Many anticoagulants are also tested in Italy.
Currently, low molecular weight heparin is widely used to treat patients, which requires the Italian Pharmaceutical Agency to publish instructions on its use.
A multi-centre study of 300 patients was announced in Italy to research the use of sodium ionoxabarin with disease prevention and treatment doses on April 14.
Since SARS Cove-2 has devoted considerable scientific attention to the reuse of antiretroviral drugs designed to deal with past outbreaks such as the Mars virus, SARS and the West Nile virus.
Repaverine: Specialists recommended the use of Repaverine to treat Coffid-19 in accordance with the 7th edition of the Chinese Directive.
Omphinovir: Specialists recommended the use of Omphinovir to treat Koved-19 in accordance with the 7th edition of the Chinese Directive.
Some antibiotics identified by specialists include the possibility of reusability as remedies for code 19:
Tusilisumab (received anti-interlocene 6): certified by China.
Experiences in Italy and China, too.
Coved-19 is an assumed vaccine against the 2019 Corona virus (Coved-19) disease.
Although no vaccines have been completed for clinical trials, many attempts are under way to develop this vaccine.
In late February 2020, the World Health Organization (WHO) (WH-O) said that it did not expect a vaccine against Sars-Koff-2, the virus causing the virus, to be available in less than 18 months.
There were five candidate vaccines in the first phase of safety studies in April.
Coved-19 was identified in December 2019.
A major outbreak spread around the world in 2020, resulting in significant investments and research activity to develop a vaccine.
Several published genome organizations are using to develop possible vaccines against SARS-KOV-2.
The requirements of the Alliance for Epidemiological Preparedness Innovations for Vaccine Development, announced in April, are speed, manufacturing capacity, widespread deployment and global access.
In April, scientists of the Pandemic Preparedness Innovations Coalition reported that 10 different technical platforms were under research and development in early 2020 to create an effective vaccine against Koped-19.
The main objectives of the platform advanced to the first phase of safety studies include:
DNA (deoxygenic DNA and repository DNA) (phase I developer and candidate vaccine: Moderna, MRNA-1273)
Vector (phase I developer, candidate vaccine: Moderna, type 5 vector)
According to scientists from the Epidemiology Alliance in April, 115 total vaccine candidates are in the early stages of development, with 78 active projects confirmed (79, according to the Melkin Institute) and 37 more have been announced, but with little public information available (presumably at the planning stage or in the process of design).
Phase I and phase II experiments perform a preliminary safety and immune test, usually random, controlled by oblique, and in multiple locations, with more accurate and effective doses determined.
Phase III experiments typically involve more participants, including the reference group, and a vaccine effectiveness test for disease prevention, with control of the negative effects of the optimal dose.
Of the 79 candidate vaccines under active development (confirmed as early April 2020), 74 were not yet under human evaluation (still under research “precedural”).
On January 24, 2020, in Australia, the University of Queensland announced that it was investigating the possibility of a molecular clamp vaccine that would genetically modify viral proteins to stimulate an immune reaction.
On January 24, 2020, in Canada, the International Vaccine Centre (VIDO-InterVac) at the University of Saskatchewan announced that work on a vaccine had begun, with the goal of starting testing in humans in 2021.
Vaccine development projects were announced at the China Center for Disease Control and Prevention on 26 January 2020 and at the University of Hong Kong on 28 January.
On approximately January 29, 2020, Jansen pharmaceutical companies, led by Hannicki Schweitmaker, announced that they had begun work on developing a vaccine.
Janssen is involved in the development of an oral vaccine with her biotechnology partner, Vaxart.
On March 18, 2020, Emergent BioSults announced a manufacturing partnership with Vaxart to develop the vaccine.
On February 8, 2020, the Oncogen Laboratory in Romania published a study on the design of a vaccine with technology similar to that used to treat cancer with the new antigen vaccine.
On March 25, the head of the Research Institute announced that they had completed the vaccine and that they had begun testing.
On February 27, 2020, Nugenerex Immuno-Oncology, a subsidiary of Generex, announced that it had started a vaccine project to create the Ii-Key Piptide vaccine against Koved-19.
They wanted to produce a candidate vaccine that could be tested in humans in 90 days.
On 5 March 2020, Washington University in St. Louis announced its vaccine development projects.
On 5 March 2020, the U.S. Army Medical Research and Equipment Command in Fort Derek and the Walter Reed Military Research Institute in Silver Spring, both in West Maryland, announced that they were working on a vaccine.
On March 10, 2020, Emergent Biosolutes announced that she had formed a team with Novax Inc.
In developing a vaccine and manufacturing it.
Partners also announced plans for pre-clinical tests and a first-stage clinical trial by July 2020.
On March 12, 2020, the Indian Ministry of Health announced that it was working with 11 isolated cases, and that even as the pace of work accelerated it would take at least a year and a half to nearly two years to develop a vaccine.
On March 12, 2020, Medico, a biotechnology company in Quebec City, reported that it was a significant development similar to the Corona virus with partial funding from Canadian health research institutes.
The candidate vaccine is subject to laboratory research, with human testing plans in July or August 2020.
Earlier that week, the Guardian stated that US President Donald Trump had offered CoreVac “large sums of money” for exclusive access to the Koed-19 vaccine, which the German government needed.
On March 17, 2020, the American pharmaceutical company Pfizer announced a partnership with the German company Biotech to jointly develop a DNA-based vaccine.
The DNA-based vaccine sent by candidate BNT162, is currently undergoing pre-clinical tests with clinical trials expected to start in April 2020.
In Italy, on March 17, 2020, Takis Biotech, an Italian biotechnology company, announced that it would get the results of pre-clinical tests in April 2020 and that the vaccine could start its final candidate testing in humans by autumn.
In France, on 19 March 2020, the Epidemiological Preparedness Innovations Coalition (CEPA) announced an investment of US$ 4.9 million in a Koped-19 vaccine research consortium, including the Pasteur Institute, Themis Bioscience (Vienna, Austria) and the University of Pittsburgh, which pushed the total investment of the Epidemiology Alliance in the development of the Koped-19 vaccine to US$ 29 million.
The partners of the Coalition for Epidemic Preparedness Innovations for the Development of the Coffide-19 Vaccine are Moderna, Curevac, Novax, the University of Hong Kong, Oxford University and the University of Queensland.
On March 20, 2020, Russian health officials announced that scientists had started testing animals for six different candidate vaccines.
Researchers at Imperial College in London announced on March 20, 2020 that they were developing a repository DNA vaccine that was self-inflicted for Coved-19.
The candidate vaccine was developed within 14 days of receiving the sequence from China.
In late March, the Canadian government announced $275 million in funding for 96 research projects on anti-cod-19 medical measures, including several candidate vaccines in Canadian companies and universities, such as the Medico Initiative and Saskatchewan University.
At about the same time, the Canadian government has announced Can$ 192 million specifically for the development of the Koped-19 vaccine, with plans to establish a national “vaccination bank” of several new vaccines that could be used in the event of another outbreak of the Corona virus.
On April 2, 2020, researchers at the University of Pittsburgh School of Medicine reported tests for BittCoVac, possible vaccine for Coved-19 in rats, where they stated that "the S1 sub-unit vaccines for SARS-KOV-2 microscopic needles triggered strong responses to specific antibodies [in mice] that were clear from 2 weeks after vaccination."
In Canada, on April 16, 2020, the College of Pharmacy at Waterloo University announced the design of a candidate vaccine based on DNA as a possible nasal spray.
Using the cogents, DNA will be designed for replication within human bacteria to produce non-immotive particles similar to the virus, which may stimulate the immune system to produce antibodies for SARS-2.
In March 2020, the U.S. government, industry and three universities pooled resources to access the giant IBM computers, along with the cloud computing resources of Hewlett Packard Enterprise, Amazon, Microsoft and Google.
Some vaccines have different effects, also called unspecified effects.
That means she can have benefits beyond the disease she's fighting.
Another random experiment in Australia seeks to register 4,170 health-care workers.
Vaccines under development are likely not to be safe or effective.
Early research to assess vaccine effectiveness using specific animal models of Coved-19, such as genetically modified mice with an Angiotin 2-transformed enzyme, other laboratory animals and non-human heads, indicates the need for level 3 biological safety containment measures to deal with living viruses, and international coordination to ensure standardized safety procedures.
Anti-Sars and Middle East Respiratory Syndrome vaccines were tested on non-human animal models.
As of 2020, there is no preventive treatment or vaccine for SARS that has proven to be both safe and effective in humans.
According to research papers published in 2005 and 2006, the identification and development of new vaccines and medicines for SARS treatment has been a priority for governments and public health agencies around the world. There is also no approved vaccine against Middle East Respiratory Syndrome.
When March spreads, it was thought that existing research on SARS could provide a useful model for developing vaccines and treatments against the Mars-Koff infection.
As of March 2020, there was one vaccine for Middle East Respiratory Syndrome (based on DNA) that had completed the first stage of clinical trials in humans, and three other vaccines under development, all of which were HIV-oriented vaccines, two vaccines for the glandary virus (ChAdox1-MERS, BVRS-GamVAC) and one vaccine for the MVA (MVA-MERS-S).
Social media publications have given rise to the conspiracy theory that the virus causing code 19 was known and that the vaccine was already available.
Patents cited in many social media publications refer to existing patents for gene sequences and vaccines for other strains of Corona viruses such as the Corona virus causing SARS.
The Corona 2019 (Coved-19) virus is caused by the Corona 2 virus associated with severe acute respiratory syndrome (SARS Cove 2).
Common symptoms include fever, cough, and shortness of breath.
Other symptoms may include fatigue, muscle pain, diarrhoea, throat infection, loss of smell, and abdominal pain.
The period between exposure and symptoms is usually about five days, but may range from two to fourteen days.
Although most cases show mild symptoms, some develop into viral pneumonia and multiple organ failure.
On April 17, 2020, more than 2.24 million people were reported injured in 210 countries and territories, resulting in more than 153,000 deaths.
More than 568,000 people recovered. The virus spreads mainly among people during mixing, mostly through spatter, sneezing, or talking.
When spray is dispersed during exhalation, it usually falls on the ground or on surfaces instead of being contagious over long distances.
People may also get hurt when they touch a contaminated surface and then touch their eyes, noses, or mouths.
The virus can survive on the surfaces for 72 hours.
The standard method of diagnosis is the sequenced ulomerase reaction of RRT-PCR via a nasal float.
It is recommended that masks be used for those suspected of HIV infection and their caregivers.
The recommendations for the use of masks by the general public vary, with some authorities recommending not to use them, others suggesting otherwise and others requiring their use.
At present, there is no specific vaccine or antiretroviral treatment for code 19.
Local transmission has been reported in most countries in all six WHO regions.
People living with HIV may not show symptoms or flu-like symptoms such as fever, cough, fatigue and respiratory distress.
Immediate medical care is advised if emergency symptoms of respiratory difficulty, pain or constant pressure in the chest area, disorder, difficulty waking up, or blue face or lips appear.
In less common cases, upper respiratory symptoms such as sneezing, nasal gonorrhoea or throat infection may be observed.
Symptoms of the digestive system such as nausea, vomiting and diarrhoea have been observed in varying proportions.
At first, some cases in China suffered from chest and beating only.
In some, the disease may develop into pneumonia, multiple organ failure and death.
It's called pre-school.
The period of custody of a child is usually five to six days, but it may be between two and 14 days.
97.5 percent of those who show symptoms will do so within 11.5 days of infection. Reports indicate that symptoms may not appear on all those infected.
The role of carriers without symptoms in transmission has not yet been fully identified; however, preliminary evidence suggests that they may be contributing to the spread of the disease.
The proportion of people with no known symptoms is currently under study, and the Korea Centers for Disease Control and Prevention (KCDC) report that 20% of all confirmed cases did not show symptoms while in hospital.
China’s National Health Commission began to include cases with no symptoms in the daily intake on April 1; of 166 cases on that day, 130 (78%) were not tested.
Pygmies and saliva can carry large proportions of the virus.
Talking out loud results in more spray than talking normally.
A study in Singapore showed that coughing without mouth cover could lead to spraying up to 4.5 metres (15 feet).
Although the virus is not normally airborne, the National Academy of Sciences has indicated that it can be transmitted through bioaerobic aerosols, and the examination of samples of air assemblies in the lobby outside the individual rooms has yielded positive results for viral reposi DNA.
Some medical procedures, such as CBR intubation and CPR, may cause respiratory discharges to be released in the form of spray, and then the virus spreads by air.
Although there are fears that it may spread through the faeces, it is believed that the risk is limited. The virus is more infected when people suffer from symptoms; while it may spread before symptoms appear, the risk is less.
The European Center for Disease Prevention and Control (ECCDC) says that although there is some ambiguity about how easily the disease spreads, one person can be infected from two to three people in general. The virus stays on the surface from hours to days.
Specifically, the virus was found to be present for up to one day on cardboard and up to three days on plastic (Polyproplin) and stainless steel (AIS 304), and up to four hours on copper 99%.
However, this is different based on humidity and temperature.
Soaps and disinfectants are also effective provided they are properly used; soap melts the virus's fatty membrane and shuts it down, in addition to removing the skin and other surfaces from it.
Other solutions, such as benzalconium chloride and chlorexidine glucone (surgical disinfectant), are less effective. In a study in Hong Kong, saliva samples were taken after an average of two days of hospitalization.
In five out of six patients, the first sample showed the highest viral load, and on the second day of the test, the sixth patient showed the highest viral load.
The Corona 2 virus associated with severe acute respiratory syndrome (SARS Cove 2) is an emerging Corona virus associated with severe acute respiratory syndrome (SARS), which was first isolated from three people suffering from pneumonia in the group of cases of acute respiratory disease in Wuhan.
The new SARS Cove-2 virus shares its properties with the relevant Corona viruses found in nature.
Outside the body, home soap destroys the virus, destroying its protective membrane. Sarse Cove-2 is closely associated with the original Sars Cove.
Lungs are the organs most affected by Coved-19 because the virus enters host cells with an Angiotin 2 conversion enzyme (ACE2), which is the most abundant in type II sarcophagus present in the lung.
The virus uses a special surface sugar protein called Spike to contact ACE2 and enter the host cell.
12% of the injured people who entered the hospital in Wuhan, China, suffered severe heart attacks, and were more common in critical cases.
Symptom rates are high due to systemic inflammation response and immune system disorders during the development of the disease, but acute heart muscle injury may also be associated with AC2 heart receptors.
ACE2's futures play a very important role in the heart and participate in its functioning.
The rate of clots (31%) and intravenous blood clots (25%) in patients in the ICU with C4-19 may be associated with poor forecasting of the condition. An autopsy of individuals who died from CFD-19 found widespread schizophrenic damage (DED), and an inflammation of lymphocytes in the lung.
Although Sars-Koff-2 went towards the aortic cells expressed as ACE2 in the respiratory system, severe Koed-19 patients suffer from symptoms of systemic hyperinflammation.
In particular, T cells that release GMSF pathogens have been found to be associated with the introduction of the only cells that release Interlocine 6 that cause inflammation and lung disease in Coffid-19 patients.
It was also reported that there was a lymphoma in the autopsy.
WHO has published several testing protocols for the disease.
The periodic RRTPCR is the standard method of testing.
The test is usually carried out using respiratory samples from a nasal utensils swab; however, a nasal swab or a sample with a mouth can also be used.
Results are generally available within a few hours to two days.
Blood tests can be used, but it requires taking two blood samples by two weeks and the results are of simple direct value.
Chinese scientists were able to isolate a strain of the Corona virus and spread the gene sequence so that laboratories around the world could independently develop PCR tests for HIV infection.
On April 4, 2020, antibody tests (which may detect active infection and whether a person has been infected in the past) were under development, but have not yet been widely used.
The Chinese test experience showed that accuracy ranges from 60 to 70 percent.
The US Food and Drug Administration approved the first clinical-care-point test on March 21, 2020 for use at the end of that month. Diagnostic guidance from Chongnan University of Wuhan suggested ways to detect infection based on clinical characteristics and epidemiological risks.
The polyclinic binary glass floats with an oceanic, asymmetric and backward spread are common features at the onset of infection.
There may be an underside spread and a stairwelling shape (the thickness of the schizophrenic diaphragm with an uneven shin filling) and an integration with the development of the disease.
There are few data available on microscopic pests and pathological physiology of code 19.
Main pathological findings from the autopsy:
Microscopic examination: pleural inflammation, pertussis, lung inflation and pulmonary edema
Four types of acute viral pneumonia can be observed:
Light pneumonia: pulmonary edema, hyperplasia of the pulmonary cells, large, non-standard schizophrenic cells, inflammation during me with amphibian leachate and the formation of multiple nuclei giant cells
Acute pneumonia: widespread schizophrenic damage (D.A.D.) with widespread schizophrenia.
Skin damage widespread causes acute respiratory stress syndrome (ARDS) and acute hypoxia.
Pneumonia treatment: organization of aberrations in senile cavities and cell pulmonary fibrosis
Blood: D.I.C. coagulation; white blood cell reaction
Preventive measures to reduce the risk of infection include staying at home, avoiding crowded areas, washing hands with soap and water for at least 20 seconds, exercising good hygiene of the respiratory system, and avoiding touching eyes, nose or mouth with unwashed hands.
CDC recommends covering mouth and nose with a handkerchief at cough or sneeze, and recommends using the inner part of the facility if no handkerchief is available.
It's recommended that the hands be cleaned well after any cough or sneeze.
CDC recommended the use of cloth face coverings in public places, partly aimed at reducing the transmission of non-constructive infections. Social dissociation strategies aim at reducing the mixing of large groups by closing schools and workplaces, restricting travel and cancelling large public gatherings.
The separation instructions also include that people are at least 6 feet (1.8 m) apart from each other.
There is no drug known for its effectiveness in preventing Koped-19. Given that no vaccine was expected to be invented until 2021 at the earliest, the main part of the control of Koed-19 is to try to reduce the peak of the epidemic, known as “spilling the curve.”
CDC also recommends that people wash their hands repeatedly with soap and water for at least 20 seconds, especially after going to the toilet or when the hands are clearly dirty, before eating, and after cleaning the nose, cough or sneeze.
It further recommends using hand sterilizers containing alcohol at least 60%, when soap and water are not available only. For areas where commercial hand disinfectants are not readily available, WHO provides two formulations for local production.
Antimicrobial activity in these two formulations arises from ethanol or isopropanol.
Hydrogen peroxide is used to help eliminate bacterial tobacco in alcohol; it is “not an effective material to cleanse hands”.
Add glycerol as moisturizer.
People receive supportive care, which may include fluid therapy, oxygen support, and other vital organ support affected.
CDC recommends those suspected of HIV infection wear a simple face mask.
Exterior membrane oxygen (ECMO) is used to address respiratory failure, but its benefits are still being studied.
It is recommended that personal hygiene and a healthy lifestyle and diet be used to improve immunity.
Supportive treatments may benefit those with mild symptoms during the early stage of infection. WHO and the China National Health Committee published recommendations for the care of those who were taken to hospital because of Koed-19.
In the United States, intensive care specialists and lung specialists collected treatment recommendations from a variety of bodies in a free resource, the critical case care book available online.
As of April 2020, there was no specific treatment available for code 19.
For symptoms, some specialist doctors recommend the use of paracetamol (Acetaminophen) instead of ibuprofen as the first treatment.
Precautions must be taken to minimize risks of HIV transmission, particularly in health-care settings, when implementing actions that may result in spraying, such as intubation or manual breathing.
For health-care professionals who take care of persons suffering from CFO-19, CCD recommends placing the person in the air-borne infection isolation chamber (AIR) in addition to the use of standard precautions, blending precautions and air-borne disease precautions. CCD explains the guidance for the use of personal protective equipment (PBE) during the pandemic.
Recommended tools: personal protective equipment aprons, respiratory or face mask, eye protection, medical gloves; respirators (instead of face masks) are preferred when available.
The N95 respirators have been approved for industrial facilities, but the Food and Drug Administration has authorized the use of masks under the Emergency Use Licence (EEUA).
They are designed to protect against airborne particles such as dust, but their effectiveness against a particular biological agent is uncertain in the case of uses for other unspecified purposes.
When masks are not available, the CDC recommends using facial protections, or homemade masks as the last solution.
Most of the Koed-19 cases are not so degraded as to require artificial breathing or alternatives, but some do.
The type of respiratory support provided to those suffering from respiratory failure associated with code 19 is actively studied for those in hospitals, with some evidence that intubation can be avoided by using a high-flow nasal canal or positive double-level pressure of the airway.
It is not known whether either option is equally beneficial to those in critical condition.
Some doctors prefer to continue to use gaseous industrial breathing when it is available because this technique limits the spread of aerosol particles compared to high flow nasal canals. There are many critical situations among older persons (those over 60 years of age, especially those over 80 years of age).
Many developed countries do not have enough hospital beds relative to the population, which limits the ability of the health system to deal with the sudden increase in the number of high-risk Koed-19 cases requiring hospitalization.
One study in China found that 5% of the cases were admitted to ICUs, 2.3% needed artificial respiratory support, and 1.4% died.
In China, nearly 30% of those who were hospitalized because of Koed-19 eventually enter intensive care units.
Synthetic respiration becomes more complex with the development of acute respiratory stress syndrome (ARDS) for those with code 19 and the supply of oxygen becomes more difficult.
Respiratory devices need to be characterized by high end-of-life pressure and pressure to maximize oxygen delivery while minimizing lung risk associated with respiratory and pneumocococcal rehydration.
High positive end-of-life hypertensive pressure may not be available in old respirators.
The search for possible treatments began in January 2020, and many antiretroviral drugs are in the clinical trial stage.
Seems like the most proselytizing of them.
Although new medicines may take until 2021 to develop, many tested medicines have already been approved for other uses or are already at an advanced stage of testing.
Antiviral drugs can be tested on those who have a critical condition.
The World Health Organization (WHO) has recommended volunteers to participate in trials of the efficacy and safety of possible treatments. The Food and Drug Administration has granted a temporary licence for the use of convalescent plasma as a trial treatment in cases where a person’s life is seriously or directly threatened.
He did not undergo the necessary clinical studies to prove that he was safe and effective against the disease.
In February 2020, China launched a mobile phone application to deal with the outbreak.
Users are required to enter the name and identity number.
The application can detect 'mixers' using surveillance data and thus the potential risk of infection.
Each user can also verify the status of three other users.
If a potential risk is detected, the application not only recommends self-immolation, but also alerts local health officials. Large data analyses of mobile data, facial recognition technology, mobile phone tracking, and artificial intelligence are used to track down infected people and those involved in South Korea, Taiwan, and Singapore.
In March 2020, the Israeli government enabled the security services to track the cell phone data of those presumed to be infected with the Corona virus.
Action has been taken to impose quarantine and protect potential mixers of infected citizens.
Also in March 2020, Dutsche Telekom shared the data of the collected telephone sites with the German Federal Government Agency, Robert Koch Institute, for research and prevention of the spread of the virus.
Russia used facial recognition to detect quarantine violators.
The Italian Regional Health Commissioner, Mr. Julio Gallera, stated that mobile phone companies told him that "40 percent of people still travel everywhere."
The German government ran Hakathon for 48 hours on weekends, in which more than 4,000 people participated.
The President of Estonia, Ms. Kirsti Kaliolaid, also presented a global call for innovative solutions to prevent the spread of the Corona virus.
Individuals may feel upset by quarantine, travel restrictions, side effects of treatment or fear of injury itself.
BBC published a saying by Rory O'Connor: "Increased social isolation, unity, health anxiety, tension and economic stagnation is a severe storm affecting people's mental health and well-being."
The disease may take a mild cycle with minor or no symptoms, similar to other common upper respiratory diseases such as the cold.
Minor cases usually recover within two weeks, while severe or critical cases take three to six weeks to recover.
Pregnant women may be more likely to be severely affected by Coved-19 based on data for other similar viruses, such as Sars and Mers, but there is still a lack of data for Coved-19. Coved-19 may affect the lungs in some people by causing pneumonia.
Koped-19 may rapidly develop into acute respiratory stress syndrome (ARDS), leading to respiratory failure, infection shock or multiple organ failure.
Complications associated with code 19 are infection, abnormal clotting of blood, heart, kidney and liver damage.
Six percent of those admitted to hospital were diagnosed with blood clotting abnormalities, specifically an increase in prothrombin time, while four percent of them had kidney dysfunction.
Nearly 20-30% of those infected with C4-19 showed high levels of liver enzymes (amino vectors).
According to the same report, the average time between symptoms and death was 10 days, including five days in the hospital.
However, the average period for those transferred to the ICU between hospitalization and death was seven days.
In a study of early cases, the average time from initial symptoms to death was 14 days, and the total number of cases was from 6 to 41 days.
In a study conducted by the National Health Commission (NHC) of China, the mortality rate for men was 2.8%, while the mortality rate for women was 1.7%.
Post-mortem pathological tests of lung samples show widespread hematoma damage with cellular fibromoxide secretions in both lungs.
Changes in viral cellular morbidity have been observed in skin cells.
The lung image shows acute respiratory stress syndrome (ARDS).
Heart damage was observed due to high levels of troponin or cardiac arrest in 11.8% of deaths declared by China’s National Health Commission.
According to data from the United States in March, 89% of those who were hospitalized were suffering from previous illness. The availability of medical resources and the socio-economic status of the region may also affect deaths.
Estimates of mortality from the situation vary as a result of these differences between regions, but also because of methodological difficulties.
The incomplete inventory of minor cases may lead to a higher assessment of mortality than the truth.
However, the fact that previous cases of death have occurred may suggest that the current mortality rate is lower than the reality.
Smokers are 1.4 times more likely to suffer severe symptoms of code 19 and 2.4 times more likely to die than non-smokers. Concerns have been raised about the long-term complications of the disease.
Hong Kong Hospital has detected a 20% to 30% reduction in lung capacity among some patients, and lung tests indicate damage.
It could also cause post-comfort syndrome after recovery.
As of March 2020, it was not known whether or not the previous infection would bring effective and long-term immunity to those recovering from the disease.
The acquisition of immunity is seen as a possibility, based on the behaviour of the other Corona viruses, but it was announced that there had been a recovery from Koved-19 and subsequently re-infected.
It is believed that these conditions are exacerbated more if infection persists than when it is repeated.
The virus is thought to be natural and of animal origin, given the prevalence of infection.
The actual origin is unknown, but by December 2019, the spread of infection was largely the result of human-to-human transmission.
A study of the first 41 confirmed cases of Coved-19, published in January 2020 in The Lancet, revealed that 1 December 2019 was the first date of symptoms.
Official publications from the World Health Organization (WHO) reported 8 December 2019 as the first date of symptoms.
Many actions are usually taken to determine the number of deaths.
These figures vary by region and over time and are influenced by the size of the tests, the quality of the health-care system, treatment options, the time taken since the onset of the outbreak and the characteristics of the population such as age, sex and public health.
In late 2019, in the 10th revision of the International Classification of Diseases, the World Health Organization (WHO) assigned U07.1 to laboratory-confirmed deaths of SARS Cove-2 infection and U07.2 to clinically or epidemiologically diagnosed deaths of SARS Coved-19. The mortality rate of cases is expressed as the number of deaths divided by the number of cases diagnosed over a given period of time.
According to Johns Hopkins University statistics, the global mortality rate for injuries is 6.9% (153,822/2,240,191), as of April 17, 2020.
The number varies by region. Other measures include the CFR, which reflects the percentage of those detected and died of a disease, and the IFR, which reflects the percentage of those infected (those detected and undetected) and those who died of a disease.
These statistics do not have a time frame, and they also follow a specific population from injury until the fate of the situation is known.
Although antibodies may not be produced by the bodies of all injured, their presence may provide information on the number of injured.
At the centre of the outbreak in Italy, Castellioni de Ada, a small village with a population of 4,600, 80 people (1.7%) have already died.
In Ganglet, the disease was spread by carnival festivals and passed on to young people, causing a relatively lower mortality rate, and perhaps not all Koed-19 deaths were officially classified as a result.
Moreover, the German health system has not been exhausted.
In the Netherlands, I may have about 3% antibodies, according to an evaluation done on blood donors.
The death of 69 (0.004 % of the population) was confirmed by Koved-19.
The impact of the pandemic and the resulting mortality rate vary between men and women.
The mortality rate is higher among men in studies in China and Italy.
The maximum risk for men is at 50 years of age, with the difference between men and women being eliminated at 90 years of age only.
In China, the mortality rate was 2.8 per cent for men and 1.7 per cent for women.
The exact causes of these sexual differences are unknown, but genetic and behavioural factors may be a cause.
Gender-based immune differences, non-prevalence of smoking among women and concurrent morbidity of men, such as high blood pressure at a younger age than women, may have contributed to the high mortality rate among men.
In Europe, 57% of infected men and 72% of those who died because of Koed-19 were men.
As of April 2020, the U.S. government does not track sex-disaggregated data on Koed-19 injuries.
Research has shown that viral diseases such as Ebola, HIV, influenza and SARS affect men and women differently.
The highest percentage of health workers, especially nurses, are women, and they are at higher risk of contracting HIV.
On February 11, 2020, the World Health Organization (WHO) declared the official name of the disease "Coved-19".
The Director-General of the World Health Organization (WHO), Tidros Adhanom Gebresus, explained that Ko was short for Corona, short for a virus and short for a disease, and 19 for the first time referred to the year of outbreak detection: December 31, 2019.
The name was selected to avoid reference to a specific geographical location (e.g. China), animal species or group of people, in line with international label recommendations aimed at preventing stigmatization. The virus that causes Kovid-19 with the Corona 2 virus associated with severe acute respiratory syndrome (SARS Cove-2) is called.
In addition, the World Health Organization (WHO) uses the terms “Coffid-19 virus” and “Coffid-19 virus” in public statements.
The disease and the virus are commonly referred to as the Corona virus.
During the first outbreak in Wuhan, China, the virus and disease were commonly referred to as the Corona virus and the Kuruna-Whan virus.
In January 2020, the World Health Organization (WHO) recommended the use of the two names of the new Corona virus 2019 and the acute respiratory disease associated with the new Corona virus 2019 as temporary names for the virus and disease in accordance with the 2015 directive prohibiting the use of sites in the names of diseases and viruses.
The official names Koved-19 and Sars Kauf-2 were released on February 11, 2020.
Due to limited capabilities in standard supply chains, digital manufacturers export health-care materials such as nose swabs and respiratory parts.
One example, when an Italian hospital urgently needed a ventilator valve, and the supplier could not deliver in time, a local start-up firm reversed its engineering and issued the required 100 valves in one night.
After the first outbreak of Coved-19, conspiracy theories, misinformed and misleading emerged with regard to the origin of the disease, its scale, prevention, treatment and other aspects and rapidly spread on the Internet.
Humans seem to be able to transmit the virus to some other animals.
The study failed to find evidence of virus reproduction in pigs, ducks, and chickens.
There are no approved medicines or vaccines for the treatment of the disease.
Government institutions, academic groups and industry researchers are conducting international research on vaccines and medicines for Koved-19.
In March, the World Health Organization (WHO) launched the Solidarity Experiment to assess the therapeutic effects of four existing antivirals that are most promising.
There is no vaccine available, but various bodies are actively developing candidate vaccines.
Previous studies on SARS Cove are used because it resembles SARS Cove-2 in the use of ACE2 receivers to enter human cells.
Three vaccination strategies are under study.
First, researchers aim to develop a complete vaccine for the virus.
The use of such a virus, whether inactive or dead, is intended to trigger an immediate immune response in the human body against a new infection in Coved-19.
The second strategy, micro-unit vaccine, aims to develop a vaccine that makes the immune system sensitive to certain micro-units of the virus.
In the case of SARS Cove 2, this research focuses on the SpykeS protein that helps the virus break into ACE2 enzyme receivers.
The third strategy is DNA vaccines (DNA or RNA vaccines, a new technique for developing a vaccine).
Experimental vaccines resulting from any of these strategies must be tested for safety and efficacy. On March 16, 2020, the first clinical vaccine trial began on four volunteers in Seattle.
The vaccine contains an harmless, cloned genetic code of the virus that causes the disease. Antibody pride was cited as a potential challenge to the development of SARS Cove-2 vaccine, but this is controversial.
There are over 300 active clinical trials under way from April 2020.
Seven trials of already approved treatments for malaria have been evaluated, four of which relate to hydroxychloroquine or chloroquine.
The proposed re-use of antiretroviral drugs in the treatment of the new disease constitutes most of the Chinese research, through nine phase III experiments on Rimdisivir across several countries, the results of which are due to be reported by the end of April.
A dynamic review of the clinical development of potential Koed-19 vaccines and real estate was carried out as of April 2020. Several existing antiretroviral drugs are being evaluated for the Coffide-19 treatment, including RM, Chlorokin, Hydroxychloroquin, Lupinavir/Ritunavir and Lupinavir/Tonavir integrated with Interferon Beta.
There is prima facie evidence of the effectiveness of the Raidsieve, starting March 2020.
A clinical improvement has been observed among patients treated with RMV for euthanasia.
Phase III clinical trials are being conducted in the United States, China and Italy. Chloroquin, formerly used for malaria treatment, was studied in China in February 2020, with preliminary results.
However, there are calls for peer review.
Korean and Chinese health authorities recommend the use of chloroquine.
However, the Wuhan Institute for Research on Viruses notes that, despite a recommended dose of one gram, the weakness of this dose is extremely serious and may cause death.
On March 28, 2020, the Food and Drug Administration issued an emergency licence for the use of chloroquine and chloroquine hydroxy, at the discretion of treating doctors for those suffering from Coffide-19. The 7th edition of the Chinese Guidelines also includes interferon, recapaverine or omefinover for the treatment of Coffide-19.
Preliminary data indicate that high doses of Repaverine are necessary to discourage SARS Cove-2 in the laboratory.
It was recommended that further study be undertaken of the effect of Nitazoxanede on organisms after it had been shown to discourage the low concentration of SARS Cove-2. Studies have shown that the initial preparation of the Spyke protein via the trans-serene protein 2 (TMPRS2) is necessary to enter SARS Cove-2 by interacting with the future of ACE2.
Studies of chloroquine and hydroxychloroquine with or without azithromycin contain major deficiencies that have prevented the medical community from accepting these treatments without further study. Osiltamivir Sars Cove-2 is not discouraged in the laboratory and has no known role in the treatment of Koped-19.
The cytokin storm may be one of the complications in the late stages of severe Koed-19.
There is evidence that hydroxychloroquine may have anti-stukin properties. The China National Health Committee added to the treatment guidelines after completing a small study.
It is subject to a national non-random phase 2 test in Italy, which has shown positive results for those suffering from severe illness.
In addition to being used in the blood serum to determine cytokin storms, it is intended to cope with such developments, which are believed to be the cause of death in some of the injured.
The Department of Food and Drug has adopted an anti-interlocine-6 metabolic anti-chemiri T-cell therapy based on the retrospective case studies for non-responsible cytokina syndrome treatment in 2017.
So far, there is no disciplined evidence that Tusilizomp is an effective cure for cytokine fusion syndrome.
The mode of transfer of anti-survivored and concentrated antibodies produced by the recovered immune systems from Coved-19 to those who need them is subject to study as a non-vaccinative method of passive inoculation.
This strategy was tested on SARS and its results were inconclusive.
The neutralization of the virus is the expected mechanism of action through which passive antibody therapy can act as an intermediary for the defence against Sarse Cove-2.
However, other mechanisms, such as cellular toxicity based on antibodies or blubber or both, may be used.
Other forms of passive antibody therapy, such as the use of manufactured single-chip antibodies, are under development.
The production of the pure serum, which consists of the liquid part of the recovered patients' blood and contains antibodies for the virus, can be increased for faster dissemination.
Corona viral diseases, a series of closely related syndromes.
Lee Win Liang, a doctor at Wuhan Central Hospital, was subsequently injured and died of Koved-19 after raising attention to the spread of the virus.
